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Preface to ”Untargeted Alternative Routes of
Arbovirus Transmission”
Arboviruses have emerged as global pathogens of significant importance in the past 50 
years. Globalization, unplanned urbanization, and climate change have all contributed to their 
developments. The main culprits that transmit these viruses are mosquitoes, mostly the species 
Aedes aegypti and Aedes albopictus. These mosquitoes thrive in man-made environments and 
have been dispersed throughout the world by global transport. Their ecological acquaintance with 
and proclivity to bite humans together with their susceptibility for arbovirus replication make them 
ideal vectors. Consequently, Ae. aegypti is considered the primary vector for flaviviruses such 
as dengue, Zika, and yellow fever viruses, and alphaviruses such as chikungunya and Mayaro 
viruses. All these viruses cause flu-like symptoms that can develop into life-threatening (hemorrhage 
for flaviviruses) or life-debilitating (arthralgia for alphaviruses) conditions. Because of the vectors’ 
worldwide distribution, close to half of the world population is at risk of being infected. Dengue 
virus (DENV) is the most widespread arbovirus and infect an estimated 400 million people per year, 
while Zika virus (ZIKV) became famous after spreading like wildfire in South America, where close 
to 70% of the population was infected in just 4 years. Based on this recent history, it is expected that 
other arboviruses will emerge as global threats.
This alarming situation has stimulated research to develop control methods. The difficulties in 
developing an effective vaccine (for example, the last DENV vaccine developed by Sanofi Pasteur) 
and therapeutic treatments favor interventions that target the vector. Tools using transgenic, 
radiation, or microbiome modifications of vector populations have been developed. The most 
promising tools make use of the bacterium Wolbachia to sterilize progeny and suppress populations 
or to reduce virus replication and block transmission. Both strategies are being tested in field trials 
with interesting results. The technologies can be deployed and restrict transmission at least in a 
limited area. However, these vector-based interventions mainly target the main vector, Ae. aegypti, 
making room for so-called “secondary” or alternative routes of transmission to become preponderant.
With regards to the potential for these new tools to significantly reduce the global burden of 
arboviruses, we thought it was time to gather information about the untargeted alternative routes of 
arbovirus transmission. These untargeted routes may become significant in arbovirus epidemiology. 
This Special Issue aims to present knowledge about potential substitutive transmission routes. This 
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Abstract: The past few decades have seen the emergence of several worldwide arbovirus epidemics
(chikungunya, Zika), the expansion or recrudescence of historical arboviruses (dengue, yellow fever),
and the modification of the distribution area of major vector mosquitoes such as Aedes aegypti and
Ae. albopictus, raising questions about the risk of appearance of new vectors and new epidemics.
In this opinion piece, we review the factors that led to the emergence of yellow fever in the Americas,
define the conditions for a mosquito to become a vector, analyse the recent example of the new
status of Aedes albopictus from neglected mosquito to major vector, and propose some scenarios for
the future.
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1. Introduction
In a time of major social, climatic and environmental changes, several old concepts are back in
fashion: “health is one” (one health approach), “the microbe is nothing, the context is everything”
(Antoine Béchamp, Louis Pasteur), “diseases will always continue to emerge” [1]. All these old, but
still very relevant views require a holistic approach, taking into account the complexity of interactions
between diseases, microbes, hosts, vectors, environment, and their evolution as described by Mirko
Grmek [2], under the term pathocenosis. Emergence of SARS-Cov2 viruses (Covid-19 disease) in 2019,
dramatically confirms these predictions.
It is generally accepted that, other than our own species, the “most dangerous animal in the world”
for humankind is the mosquito. This figure of speech, however forceful it may be, is misleading. Yes,
there are mosquitoes responsible for the transmission of major human pathologies (malaria, filariasis,
yellow fever, dengue, Zika, chikungunya, haemorrhagic fevers, encephalitis, etc.), and it is likely
that most blood-sucking mosquitoes transmit some pathogens to some vertebrates. However, given
that only a small minority of the thousands of mosquito species account for the vast majority of
human diseases, “the mosquito” should be afforded the principal of “habeas corpus”, innocent until
proven guilty.
In this opinion piece, we discuss the factors that lead to the emergence of a vector in the human
environment causing the transmission of viruses pathogenic to humans. A related, but distinct
phenomenon which we do not discuss, is the establishment of newly introduced pathogenic viruses in
sylvatic vectors, leading to new cycles of enzootic transmission.
2. Vector or not yet Vector: Guilty or Presumed Innocent
Two species of mosquitoes of particular relevance to human public health, Aedes aegypti and
Aedes albopictus, are good models for understanding, estimating and, if possible, anticipating and
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limiting the risk of emergence, establishment and transmission of pathogens to humans by vectors [3,4].
Aedes aegypti was suspected to be a vector of the yellow fever virus by Beauperthuy and later Finlay
since the middle of the 19th century [5,6], and experimentally demonstrated as a vector in 1900 by
Reed et al. [7], and therefore an enemy to be killed [8,9]. In contrast, Ae. albopictus became widely
known only over the last 40 years when it was gradually detected on all continents (except Antarctica)
outside its native region of Southeast Asia and implicated in the recent chikungunya pandemic [10,11].
These two species (aegypti and albopictus) of genus Aedes and subgenus Stegomyia are responsible for
virtually all major outbreaks of diseases caused by the major primate arboviruses: dengue, Zika,
chikungunya, and yellow fever. Both mosquitoes are invasive species, spreading thanks to man-made
means of transport, and are extremely well adapted to human environments.
Transmission of viruses to humans by mosquitoes seems to be the rule for many public health
officers. Actually, it is an exception. The vast majority of mosquitoes do not transmit human diseases.
Of the 3585 species of mosquitoes currently formally described, less than 30 transmit the yellow fever
virus, either naturally or in the laboratory. In other words, more than 3500 species of mosquitoes do
not transmit the yellow fever virus. They are not guilty. There are many reasons for this: (1) the virus
is not present in the geographical area of the vector mosquito species; either by “luck” because it was
never introduced, or due to the absence of vertebrate amplifying hosts allowing the maintenance of
cycles (primates in the case of yellow fever); (2) the mosquito is not competent to transmit (absence of
required receptors or innate immunity controlling the pathogen); (3) the biology of the mosquito is not
compatible with transmission (life span too short, does not take blood meals from primates, etc.).
However, our present understanding should not be taken as dogma. We must keep an open
mind and explore what factors can make a non-vector mosquito become a vector, or what can cause
a so-called “secondary” vector to become a major vector for humans. To continue our metaphor,
what turns an “innocent” mosquito into a “guilty” menace; then into an effective vector to humans?
In theory, it is very simple. Only two conditions are necessary: (1) the mosquito is physiologically
capable of sustaining a virus infection that spreads to saliva and takes multiple blood meals from
primates, i.e., was always a potential vector, (2) an event or several events occur in its environment
that allow it to express this vector potential. Subsequently, adaptive mechanisms, under selection
pressure, may cause this mosquito to become responsible for severe outbreaks. However, while this
seems simple, in reality, a large number of factors are necessary for the conditions to be met that allow
the emergence of a new vector.
3. Short History of Yellow Fever: Once Upon a Time in America
The yellow fever virus circulates in African forests from monkey to monkey, transmitted by forest
Aedes (Ae. africanus, Ae. luteocephalus, Ae. furcifer, Ae. simpsoni s.l., Ae. opok, etc.), with incursions
into villages where domestic anthropophilic Ae. aegypti are established, and able to replicate and
transmit YF virus [12]. These domestic Ae. aegypti are themselves the result of a slow adaptation of
forest ancestors to human habitats and blood [13]. The virus, once in humans, following cross species
transmission, can be introduced through the movement of humans into African cities, where it finds
Ae. aegypti populations adapted to urbanisation and able to generate outbreaks.
This village or urban yellow fever virus, already adapted to human and Ae. aegypti, was introduced
into tropical America, probably via viremic people and/or Ae. aegypti transported on ships, during
the triangular slave trade, which started in the 16th century [14,15]. Upon arrival to the Central and
South American rainforest, not only did the virus find susceptible New World monkeys but also new
competent endemic mosquitoes from two genera, Sabethes sp. and especially Haemagogus sp. Yellow
fever virus thus had a second phase of cross species transmission (African monkeys to American
monkeys, African Aedes mosquitoes to American mosquitoes).
The evolutionary history of Haemagogus genus mosquitoes, which are only found in the New
World, is not well known. Phylogenetically, they seem to be quite close to the Aedes (Figure 1), which
may explain their ability to transmit, more or less, the same viruses as Aedes aegypti: yellow fever,
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dengue [16], Zika [17], and chikungunya [18], all introduced into South America. New cycles of jungle
yellow fever have thus developed, involving South American primates and tree-dwelling Haemagogus
mosquitoes. These cycles have spread throughout South and Central America, where they are still
active, as shown by the 2016–2018 yellow fever epidemic in Brazil, with more than 700 deaths [19].
This combination of both a sylvan and an urban cycle for yellow fever in the Americas regularly
fuelled epidemics that greatly affected the history of colonization of the New World [20]. As Ae. aegypti
adapted to American cities, even non-tropical locations were subject to yellow fever epidemics, such as
the well-known Philadelphia epidemic in 1793 (5000 deaths). A largely successful eradication program
against Ae. aegypti began initially in the 1930s and was started by the Rockefeller Foundation [21],
and this continued with DDT after World War II. At the same time, wide vaccination coverage was
undertaken. This led to almost no outbreaks of yellow fever due to Ae. aegypti in the Americas, since
about 1970, although Ae. aegypti is again abundant [22], and able to transmit dengue fever virus
and the recently introduced Zika virus. It is thought that the Brazil 2016-18 yellow fever outbreak
was almost entirely due to spill over from the sylvan cycle and involved Haemagogus and Sabethes
mosquitoes [23,24].
 
Figure 1. Phylogenetic tree built by the method of maximumlLikelihood, from sequences of
mitochondrial genes COX1, COX2, NAD4, NAD5 and CYOB of Haemagogus janthinomys and other
species of Diptera, from da Silva Lemos et al. 2017 [25]. The bootstrap values are represented in
each node.
Interestingly, endemic yellow fever has never been reported in Asia, Madagascar or other Indian
Ocean islands, for reasons that are still poorly understood. Primates (monkeys and humans) from
these regions are susceptible, and Ae. aegypti and other experimentally competent Aedes mosquitoes
are present there [26–28]. Importantly, Haemagogus sp. and Sabethes sp. are absent from Africa, the
Indian Ocean and Asia.
4. The Necessary Conditions
The history of yellow fever leads us to the consideration of the factors necessary, but not always
sufficient, for a mosquito species that was initially of little interest to humans, to become a public
health problem and an enemy to fight.
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First of all, the mosquito, or to be precise, a given population of a given species of mosquito,
must be biologically able to transmit the virus. This ability is called vectorial capacity, which includes
vector competence (i.e., the ability of a mosquito to become infected after ingestion of an infected blood
meal and later transmit the virus via its saliva). Both terms, vectorial capacity and vector competence,
have been formalized since MacDonald [29], summarized by Cohuet and coll. [30], and include the
following parameters:
• The vector–host ratio (i.e. the vector density in relation to vertebrate host): m (the mosquito
abundance);
• The human feeding rate: the number of human bites per mosquito, per day: a (mosquito - human
contact);
• The daily survival rate (i.e. the probability of a mosquito surviving each day): p (mosquito
longevity);
• The extrinsic development time, the time necessary for viruses to complete development from
ingestion in midgut to the saliva: n;
• The infectiousness of the mosquito to the vertebrate host: b (largely dependent on virus titre
in saliva)
• The susceptibility of the vertebrate host to the virus (e.g., immune state, age, health, etc): c;
• The vertebrate host infectious period: 1/r (how long the virus titre in the vertebrate remains at a
level needed to infect a mosquito);
Knowing the values of these parameters makes it possible to calculate the basic reproductive rate
of the virus, R0.
R0 = (ma2 × pn / − ln p) × bc × 1/r (1)
R0 is the total number of cases derived from one infective case that the mosquito population
would distribute to vertebrate hosts. R0 must equal at least 1 for the disease to persist or spread. For
values less than 1, the disease will go extinct.
However, while we can write the simple equation above, in reality the parameters (m, a, p,
n, b, c, r) are themselves complex, being dependent on many other factors. For just the mosquito,
a non-exhaustive list includes mosquito genotype, mosquito microbiome including viruses, integrated
RNA virus sequences in mosquito genomes, predation, competition at larval and adult stage, previous
exposure to related viruses, etc. [31,32]. Moreover, it is not yet known which receptors in the cells of
the stomach and salivary glands of mosquitoes are involved in the entry and exit of flaviviruses, like
yellow fever virus [33].
Just this intrinsic biology of the mosquito is not sufficient to make it a vector. Its environment may,
or may not, allow this vector potential to manifest itself. According to Euzet and Combes [33], the
specificity of the vector–pathogen interaction passes through four stages, which they named encounter
and compatibility filters (Figure 2). These four stages are: (1) to co-occur in space and time, (2) to meet
each other (behavior), (3) to recognize each other (receptors), and (4) to accept each other (immunity).
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Figure 2. Encounter and compatibility filters, from Euzet and Combes [34].
All these conditions are rarely met, and it is therefore understandable why being a vector is an
exception. However, considering the very large number of mosquito species and large number of
viruses, while we are presently facing only a limited number of dangerous cycles, this must be a very
small fraction of thousands, if not millions, of other potential cycles that have failed. The understanding
of the current efficient cycles allows us to conceive possible future cycles.
We can hypothesize that only a few species in the genera Aedes, Haemagogus, and Sabethes have
the capacity to replicate and transmit yellow fever virus to primates, i.e. (1) possess the receptors for
cellular penetration of the virus, (2) have insufficient innate immunity to suppress virus replication,
(3) live in the same environments as viremic vertebrates (monkeys or humans), (4) take blood from
these vertebrates, and (5) survive long enough to retransmit the virus.
5. Aedes albopictus: From Local to Global Concern
Aedes albopictus became widely known only over the last 50 years, when it was gradually
discovered on all continents outside its native Asia and caused a chikungunya pandemic [10,11,35,36].
A total of more than 40 viruses can be transmitted naturally or experimentally by Ae. albopictus [36].
Experimentally, it will take blood from many vertebrate species [37]. It also lives longer than Aedes
aegypti [38]. Aedes albopictus therefore perfectly fulfils the necessary conditions in terms of biology and
events to be an excellent vector of virus to humans.
Aedes albopictus is considered to be phylogeographically native to Southeast Asia [10].
This assumption is based on the fact that this mosquito is present everywhere in the forested
areas of this region and that many species close to the Albopictus subgroup, member of the Scutellaris
group, are present in Southeast Asia. However, the notoriety of Ae. albopictus, compared to relatives,
comes from the fact that it has moved out of its area of origin, becoming worldwide in 50 years,
adapting perfectly to urbanization, temperate climates, and international transport, as well as being
involved in several dengue and chikungunya epidemics.
In tropical Southeast Asia, the five morphologically closely related species of the Albopictus
subgroup live in forests (Aedes novalbopictus, Aedes patriciae, Aedes seatoi, Aedes subalbopictus and Aedes
pseudalbopictus) and lay their eggs in tree holes and bamboo stumps [39,40]. These species are likely to
be vectors of arboviruses to vertebrates from which they take blood. These forest-confined viruses are
largely unknown, but may emerge through increased contact with humans or domestic animals (see
below). They could then be transmitted by domestic vectors, such as Ae. aegypti and Ae. albopictus, in a
pattern similar to the emergence of the yellow fever virus in Africa from forests to villages [12].
In Laos, Ae. albopictus is reported from deep natural forest [41], rubber forest and secondary
forest [42], as well as in towns and villages. In contrast, in neighbouring countries, such as in Cambodia,
this mosquito was found along hundreds of meters of forest edge, whereas Ae. pseudalbopictus, is found
in deeper natural forests. Aedes albopictus is frequently found in cities such as the capital, Phnom Penh
(Boyer pers. com.). Similarly, in Malaysia, Ae. albopictus is rare in forests [43], and in Yunnan Province,
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China, Ae. albopictus is sometimes more abundant than Ae. pseudalbopictus in bamboo forests, but is
often absent from deep forests [40].
Outside Asia, Ae. albopictus populations display highly variable success in invading the deep
forest. In Brazil, where Ae. albopictus was observed for the first time in the 1980s, Pereira dos Santos et
al. found that Ae. albopictus was able to enter degraded forest in the Manaus region, up to 750 metres
from the edge [44]. In Gabon, where Ae. albopictus was first reported in 2007, it was captured 12 years
later in the Lopé natural forest, several kilometres from villages or clearings (Paupy pers. com.).
In both its native range Asia and recently invaded South America and Africa, Ae. albopictus has
retained its ancestral capacity to colonize forest environments, laying eggs in natural pools of water
and taking blood from nondomestic vertebrates. It is logical to think that under these conditions,
Ae. albopictus populations would take blood from vertebrates carrying as yet unknown viruses, such as
from monkeys, terrestrial mammals, birds or reptiles. If these forest-breeding Ae. albopictus are able
to replicate these viruses, and then retransmit them to humans, they would then be excellent bridge
vectors, allowing the emergence of forest viruses hitherto confined to sylvatic Aedes-vertebrates cycles.
We can speculate that this is most likely to occur in Asia. In Africa, Ae. aegypti has already brought
many, perhaps most, human adapted viruses from the forest to human habitats, such as yellow fever,
dengue, chikungunya, and Zika viruses [13].
Mogi et al. [40], suggest that the spreading of Ae. albopictus from its original tropical forest region
was possible following evolution from an ancestral wild species, due to adaptation to man-made
habitats and then migration with humans to temperate climate regions, where Ae. albopictus developed
a winter diapause. In most introduced localities, it probably encountered only limited competition
from native mosquitoes and when it did, Ae. albopictus proved to be a robust competitor, e.g., with
Ae. aegypti [45]. It is likely that the ancestral wild species was already a vector of forest vertebrate
arboviruses, for example, dengue-like flaviviruses, or chikungunya-like alphaviruses, which are
monkey viruses [46].
From the foregoing, it appears that Ae. albopictus, while being ancestrally a forest-breeding
mosquito like its close relatives, among these relatives it is the most closely adapted to forest margins
(ecotone), the transition from forest to degraded or secondary forests, open grasslands or scrub. Aedes
aegypti in Africa is similar [47]. This may have pre-adapted these two Aedes, among all their congeners
in Asia and Africa, to come into contact with human settlements and thus to adapt to this new niche,
human settlements.
From regions recently colonized by Ae. albopictus, “modern” populations, highly adapted to the
urban environment and able to transmit viruses such as chikungunya, Zika and dengue, spread to all
continents. It is likely that invasive populations re-invaded regions where ancestral populations already
existed, such as in Asia and the Indian Ocean. These ancestral populations then found themselves in
unfavourable competition and modern Ae. albopictus replaced them [48].
It is not too difficult to predict the epidemiological future of Ae. albopictus. Its geographical
distribution will increase, especially in temperate regions, its control by insecticides will be more
difficult due to the emergence of resistance, and human pathogenic viruses will adapt to this new
vector, increasing its efficiency to transmit. Ae. albopictus-vectored epidemics are almost certain to
increase. It could be responsible for the epidemics of yellow fever, or of currently unknown viruses
transmitted by forest edge Aedes mosquitoes of South American, South East Asia or Central Africa.
A major unknown for Ae. albopictus’ impact in temperate regions is whether arbovirus replication at
lower temperatures is selected to be rapid enough to reach saliva before the female dies.
6. Scenarios for the Future: The Worst Doesn’t Always Happen
To quote Charles Nicolle [1], it is certain that new epidemics will appear. Mosquitoes and
viruses are poised to ambush humans following changes in vector ecosystems [49]. The process of
establishment may be abrupt and rapid, as was the recent Zika pandemic with Ae. aegypti as vector, or
6
Pathogens 2020, 9, 265
more gradual, going through adapting mechanisms, as was the case with the emergence of the West
Nile virus in several temperate cities, particularly in the USA [50].
The optimistic view, but not very realistic, is that the worst is already behind us. Urban environments,
where the majority of the humans now live, are already colonized by Ae. aegypti, Ae albopictus, and/or
Culex pipiens, which transmit or can transmit known viruses of tropical or equatorial origin: dengue,
chikungunya, Zika, yellow fever, West Nile, as well as, at least potentially, many other tropical
viruses like Japanese encephalitis and Rift Valley fever, with variable success depending on species
and environments [13]. However, this optimistic view needs to be tempered. With global changes
(environment, climate, demography, movements), the distribution areas of some of these human adapted
vectors and viruses will continue to expand and we will see a steady increase of epidemics of viruses,
including in temperate regions. While we cannot predict details of time and place, we know it will
happen, and we can prepare for it.
A more pessimistic view is that the reservoir of unknown forest viruses, not presently affecting
humans, but potentially transmissible to domestic animals and humans, is immense in Asia, Central
and South America, and Africa. More than 500 arboviruses have so far been identified and described,
but this is only the tip of the iceberg. From about 1930–1980, the Rockefeller Foundation sponsored a
repository for viruses from field-collected arthropods, primarily mosquitoes, that reached more than
4000 isolates of insect-specific viruses or arboviruses, the vast majority of which are undescribed [51],
and even this collection is far from complete. Consequently, several non-exclusive scenarios for the
emergence of new human viral epidemics are possible:
(1) Via primate-biting bridge vectors such as Ae. albopictus from forest edges in South America, Africa
and Asia, forest Aedes of the Albopictus group in South East Asia, Haemagogus in South America,
Stegomyia from forest galleries in Africa. In South America, Haemagogus and Sabethes are likely to
transmit any new potential human viruses among primates and, as displayed by yellow fever, if
these viruses are capable of transitioning to transmission in human habitats, it is likely to have
already occurred.
(2) By misfortune, as happened with the establishment of a sylvan cycle of yellow fever in Central and
South America 500 years ago, new viruses may appear in transmission cycles that are heretofore
unknown. The increase in trade and travel, and the establishment of invasive species (such as
Ae. albopictus, Ae. koreicus, and Ae. japonicus, and even Ae. aegypti in Europe) suggest that this risk
should not be overlooked.
(3) Via increased human contacts with wild cycles due to deforestation and irrational forest
exploitation. These ecological modifications favour the emergence of viruses from forest edges,
and then to the human environment.
(4) Via zoonotic cycles. For example, many viruses (West Nile, Japanese encephalitis, St Louis
encephalitis virus, Murray valley, usutu) which are bird viruses, can be transmitted from birds (or
mammals such as pigs) to humans, via vectors taking blood meals from both birds and humans,
such as Cx. tritaeniorhynchus or Cx. pipiens, Cx. quinquefasciatus. It is very likely that some of
these viruses, presently confined to wild cycles, will emerge in the coming years somewhere in
the world, as a result of socio-ecological changes. Their shift from endemic to epidemic will be
facilitated by close contact between humans and vertebrate hosts (urban commensal birds or
rodents, farm animals).
(5) By opening an ecological niche in urbanized areas. It is conceivable that local effective vector
control by way of elimination of Ae. aegypti or Ae. albopictus would open their ecological niche in
some areas, allowing a new species, such as Ae. malayensis in South-East Asia, already recognized
as a vector of dengue and chikungunya viruses, to begin to colonize even closer to human
populations. This scenario has not happened yet. Aedes albopictus may have replaced Ae. aegypti
or vice versa, but for the moment no third species, with high vectorial capacity, has occupied
their niches.
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(6) Via the evolution of viruses already known, but which have not yet found the conditions for
emerging and spreading. Genetic changes in virus strains could lead to better adaptation
to new vectors and a better transmissibility, as happened with the chikungunya virus and
Ae. albopictus [52]. Viruses may also evolve resistance to drugs, when any are used, or human
immune defences. Given the short generation time, large population size, and high mutation rate
of RNA viruses (like yellow fever, dengue, and most pathogenic arboviruses), virus adaptation to
efficient transmission by a human-preferring mosquito is rapid. That is, the virus more readily
adapts to the mosquito (and vertebrate host), not the mosquito to the virus [53].
Among the hundreds of wild animal viruses, several viruses are regularly cited as worthy of
surveillance. This is the case of the Mayaro alphavirus, closely related to the chickungunya virus. It is a
South American virus of mammals, including monkeys, mainly transmitted by Haemagogus mosquitoes,
and which could adapt to urban Ae. aegypti or Ae. albopictus, or to some other anthrophilic Culicidae.
However, these other mosquitoes are considered poor vectors [54,55]. In Africa, the Spondweni virus
is genetically close to the Zika virus, which places it on the list of viruses to keep an eye on. While it is
indeed pathogenic to humans, very few human cases have been detected; it has no known domestic
cycle. It is poorly transmitted experimentally by Aedes (Stegomyia), being efficiently transmitted by
zoophilic mosquitoes (Aedes circumluteolus, Mansonia africana), but this situation could change [56].
Indeed, this virus has already been found in Haiti [57] in Cx. quinquefasciatus, a human-biting mosquito
recorded in all tropical regions.
7. Conclusions
On a final note of optimism, it is expected that new outbreaks can be detected more quickly, thanks
to surveillance and warning systems that have improved greatly in recent decades and thanks to the
development of efficient, rapid and less costly diagnostic techniques. Moreover, not all emergences
will find favourable environments, including encounter and compatibility filters, and are likely to
quickly die out. For public health authorities to succeed in limiting new outbreaks, The International
Health Regulations, published in 2005 by WHO [58], provide a framework and obligations for member
states, and give hope that new epidemics could be brought under control through early detection,
efficient vector control, vaccination when available, and other public health measures. While worst
case scenarios should be planned for, they seldom actually arise. However, they happen regularly and
the recent Covid-19 pandemic, which was not caused by an arbovirus, reminds us that, although we
are aware that this can happen, we are not always properly prepared.
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Abstract: The growing expansion of mosquito vectors has made mosquito-borne arboviral diseases a
global threat to public health, and the lack of licensed vaccines and treatments highlight the urgent
need for efficient mosquito vector control. Compared to genetically modified control strategies,
the intracellular bacterium Wolbachia, endowing a pathogen-blocking phenotype, is considered
an environmentally friendly strategy to replace the target population for controlling arboviral
diseases. However, the incomplete knowledge regarding the pathogen-blocking mechanism weakens
the reliability of a Wolbachia-based population replacement strategy. Wolbachia infections are also
vulnerable to environmental factors, temperature, and host diet, affecting their densities in mosquitoes
and thus the virus-blocking phenotype. Here, we review the properties of the Wolbachia strategy as an
approach to control mosquito populations in comparison with genetically modified control methods.
Both strategies tend to limit arbovirus infections but increase the risk of selecting arbovirus escape
mutants, rendering these strategies less reliable.
Keywords: mosquito control; replacement strategy; Wolbachia; environmental factors; arbovirus;
viral adaptation
1. Half of the World’s Population Exposed to Arboviral Diseases
Mosquito-borne arboviral diseases such as chikungunya, dengue, yellow fever, and Zika have
been one of the major public health issues over the last few decades, threatening more than half of
the world’s population [1]. These arboviruses have dispensed with the need for amplification in
wild animals to cause outbreaks in the human population. Human hosts serve simultaneously as
the reservoir, amplifier, and disseminator, and the major vectors are the anthropophilic mosquitoes
Aedes aegypti and Aedes albopictus [2]. Due to their complex transmission mechanisms with interactions
between viruses, mosquito vectors, and vertebrate hosts, all three evolving in changing environments,
the control of arboviral diseases is still extremely difficult. The frustrating lack of development of
broad-spectrum vaccines against arboviruses has pointed out the importance of new alternatives for
arboviral diseases control [3,4].
Chikungunya is a rapidly reemerging arboviral disease. In recent years, as the Indian Ocean
lineage (IOL) evolved, this Ae. aegypti adapted chikungunya virus (CHIKV) has caused several
outbreaks in tropical countries [5]. The newly emerged CHIKV IOL contains a mutation from Alanine
to Valine at position 226 in the E1 protein, which influences the pH threshold for fusion, facilitating
the virus entry [6]. Moreover, the E1-A226V mutation also increases the vector competence for
Aedes mosquitoes, particularly for Aedes albopictus [7]. Therefore, the epidemic areas have extended
beyond tropical regions, reaching the temperate countries in Europe where Ae. albopictus mosquitoes
have been established since 1979 [8]; this species is now present in 20 European countries with the
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highest infestation levels in France [9,10] and Italy [11]. Dengue virus (DENV) alone contributes
to approximately 390 million infections and tens of thousands fatal cases annually [12]. There are
four DENV serotypes, namely dengue-1, -2, -3, and -4, which trigger distinct immune responses in
humans [13]. Although a life-long immunity against a given DENV serotype could be acquired after
a first infection, a secondary infection with another DENV serotype could facilitate dengue severe
syndrome or dengue hemorrhagic fever (DHF) that increases the burden of this disease even if a
secondary infection does not always necessarily lead to DHF [14,15]. Moreover, the nearly 80% of
dengue asymptomatic cases enhance the risk of DENV transmission, thus complexifying the disease
control. Yellow fever virus (YFV) has not yet become a global threat but heavily affects Sub-Saharan
Africa and South America (mainly in Brazil), causing between 94,336 and 118,500 infection incidents
annually [16]. In Africa, the urban cycle results from sporadic spillover transmission from the jungle
cycle, while in America, human infections are only acquired in forests [17]. Although the YFV
live-attenuated vaccine has been available since the 1930s, the global stockpile of YFV vaccines is still an
issue due to the production process that requires specific pathogens-free (SPF) eggs; the limited supply
of SPF eggs makes it difficult to launch an urgent vaccination campaign [18]. The recent outbreaks in
Brazil and the imported cases from Angola to China have raised many concerns on the potential risk of
major outbreaks, especially for the immune-naïve populations in Asia [19–21]. Zika virus (ZIKV) was
first isolated from an infected monkey in Uganda in 1947. Starting from Yap Island in 2007 [22], a much
larger outbreak in French Polynesian islands followed [23], and reached Brazil at the end of 2013 [24].
Although ZIKV infection formerly caused only mild illness and was self-limiting [22], more severe
outcomes were reported, including microcephaly in newborns and the neurological affections [25,26]
giving it the status of a Public Health Emergency of International Concern in 2016 by the World Health
Organization (WHO). It should be noted that other emerging arboviruses have not yet caused large
outbreaks; they could be the next arboviral threats owing to current global changes, including climate
warming and increasing international exchanges [27]. Aedes mosquitoes are also transmitting Mayaro
(MAYV; genus: Alphavirus), and Usutu (USUV; genus: Flavivirus) viruses that originated from South
America and Sub-Saharan Africa, respectively [28,29]. Since 2000, MAYV has caused several outbreaks
in South America, although the number of reported infections remains low. The spread of MAYV to
non-endemic areas was reported in Europe after 2008, expanding the risk area of this disease [30].
Similar to MAYV, the USUV was first identified in 1959 [29], but the first human infection was reported
at the beginning of 1981 in Africa [31]. Since then, USUV has been introduced into Europe and was
repeatedly reported in mosquitoes, birds, and horses in 12 European countries [32].
2. Virus Overcomes Mosquito Immune Barriers to Be Transmitted by Generating
Viral Quasispecies
Aedes mosquitoes are the major vectors in transmitting arboviruses. They have expanded
their geographic distribution as a consequence of population growth, human activities, and climate
change, creating conditions favorable for their proliferation and introducing the means of passive
transportation [33]. Their distribution is no longer restricted to tropical regions, spreading to new
geographic regions over long distances and stepping up the global impact of arboviral diseases [33].
A mosquito vector acquires an arbovirus by taking a blood meal from a viremic host, after which
the virus enters into the midgut epithelial cell and replicates. After infection of the midgut, the virus
needs to escape through the midgut basal lamina and disseminate into the hemocele, infecting different
tissues or organs including salivary glands. Finally, in a subsequent blood meal, the virus is excreted
from the salivary glands and transmitted by the mosquito bite [34].
From the midgut to the salivary glands, the virus encounters different mosquito immune responses,
such as RNAi (RNA interference), the Toll, IMD (immune deficiency), and JAK-STAT (Janus kinase
signal transducer and activator of transcription protein) pathways, limiting the virus infection,
dissemination, and transmission [35]. Viral infections in mosquitoes result from a subtle balance
between virus replication and cellular immunity, manifested by a persistent asymptomatic infection
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in vectors [36]. Considering the error-prone nature of viral RNA-dependent RNA polymerase, RNA
viruses generate a collection of variants (namely quasispecies) during replication that facilitates viral
adaptation and transmission by mosquitoes [37,38]. Thus, after passing all these filters, only a fraction
of the viral population is transmitted to the vertebrate host [39]. This remains dependent on each
pairing of virus-mosquito that conditions the mosquito vector competence [34].
3. Population Replacement Strategy to Control Mosquito-Borne Diseases
As the pivot for arboviruses transmission, the mosquito vector is considered the target for efficient
arboviral diseases control. Depending on the outcomes, the mosquito population control strategies
could be roughly divided into two categories, population reduction and population replacement,
which by reducing the target population size or introducing an anti-pathogen phenotype into the target
population, respectively, minimizes the contact between arboviruses-carrying mosquitoes and human
hosts. The current strategy is to reduce the mosquito vector population with insecticides; however,
in the absence of a vector surveillance program, the impact of insecticides on local biodiversity is
unpredictable, in addition there is the risk in generating insecticide-resistant mosquitoes that decreases
the control efficacy, calling for more species-specific alternative methods [40]. Instead of reducing the
target population from the field, which might cause ecological disruption [41,42] and risk of secondary
pest emergence, population replacement has been proposed as an alternative [43]. Replacing the target
population with a pathogen-refractory strain could specifically reduce the pathogens’ transmission
while maintaining the population in its original ecological niche, limiting the risk of secondary pest
emergence [43].
A modified genetic-based population replacement approach is composed of an anti-pathogen
gene and a gene-drive system, in order to suppress the pathogen replication and to spread the
phenotype within the target population [44]. Different mosquito antiviral factors such as siRNA [45,46],
miRNA [47–49], ribozymes [50,51], immune factors [52], and neutralizing antibodies [53], can act as
effectors to reduce the virus infection and transmission in genetically modified mosquitoes. Combined
with a proper gene-drive system, the genetically modified mosquitoes expressing a virus-refractory
phenotype can replace the wild population in a few generations, that is to say in a few months
for mosquitoes. Although the biosafety concerns about using genetically modified insects is still
debatable [54], the highly-specific synthetic antiviral immunity used as effectors (RNAi, antiviral
ribozymes, overexpressed immune genes, and neutralizing antibodies) has raised issues regarding the
selection of escape virus mutants. Thus, strategies generating weaker selection in virus populations
might be more sustainable [55].
4. Wolbachia-Based Mosquito Control
The microbiota of mosquito vectors has a strong impact on arbovirus infections [56,57].
The endosymbiont bacteria Wolbachia has been in the spotlight with the discovery of its properties in
suppressing the replication of vector-borne human arboviruses such as DENV, YFV, and ZIKV [58,59].
The Wolbachia-based insect control approach is more acceptable than the genetic modification-based
approach for the public as it is a naturally existing microbe. Wolbachia is a Gram-negative bacterium,
a member of the Alphaproteobacteria (Rickettsiales order). In arthropods, the genome of Wolbachia
ranges from 1.2 to 1.6 Mb and contains WO prophages (named after Wolbachia) [60]. It was first
discovered in the Culex pipiens mosquito in 1924 by Hertig and Wolbach [61], opening a new avenue of
research owing to its high diversity and wide distribution in arthropods [62]. To date, 18 supergroups
of Wolbachia have been identified, most of them present in arthropods [63], and more than 65% of insect
species harbor Wolbachia [64]. Horizontal transfers of Wolbachia have been demonstrated between
species within the same supergroup and, conversely, the same host species can host different Wolbachia
strains. Wolbachia bacteria are involved in different symbiotic interactions ranging from parasitic to
mutualistic [62]. Mainly transmitted vertically, it intervenes in manipulating the host reproduction in
order to optimize its maternal transmission through the eggs. Wolbachia can induce different sex ratio
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distortion phenotypes in the progeny to favor females: parthenogenesis, feminization, male-killing,
and cytoplasmic incompatibility (CI) [65]. In the CI phenotype, Wolbachia-infected females are favored
over the non-infected females and males (Figure 1). The molecular mechanisms controlling the CI are
today better understood: CI and its rescue are driven by toxin-antidote interactions, whose affinity
between partners determines the success of the rescue [65]. For example, in Cx. pipiens during the
first embryonic mitosis, cidA and cidB of wPip are the key elements of CI traits [66], where the B
factor expresses its toxic effect inducing the CI effect and the A factor acts as an antidote for the rescue.
In addition to colonizing reproductive organs, Wolbachia bacteria are also present in somatic tissues;
Wolbachia can be acquired from infected embryonic lineages or by passing from cell to cell [67].
 
Figure 1. Wolbachia-based mosquito control strategy can be viewed as a genetically modified control
approach, population replacement, or population suppression. (a) The population replacement strategy
is to release Wolbachia-infected female mosquitoes that, after mating with males (Wolbachia-infected or
not), produce viable offspring, allowing a wide spread of Wolbachia in the field population that harbors
less competent individuals, even as the total number of mosquitoes remains unchanged. (b) Population
suppression aims to release Wolbachia-infected male mosquitoes that, after mating with wild females,
do not produce viable offspring, thus reducing the total number of mosquitoes.
5. Wolbachia in Limiting Arbovirus Transmission
Wolbachia can provide fitness advantages for host fertility and/or survival and can alter
responses to infections to reduce arbovirus transmission. As an example, the wMel Wolbachia
strain artificially introduced in Drosophila melanogaster inhibited Drosophila C virus (DCV) infection,
and Wolbachia-infected flies were much more resistant to DCV than the uninfected flies [68,69].
Combining their ability to invade the host population by inducing CI and to interfere negatively
with the transmission of disease pathogens, Wolbachia-based control methods have been deployed
to prevent the transmission of mosquito-borne diseases [70,71]. The bacterium Wolbachia has been
introduced in natural populations of the mosquito Ae. aegypti, the urban vector of dengue, Zika,
chikungunya, and yellow fever [72]. Wolbachia bacteria are stably maintained in field mosquito
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populations and attributed to the pathogen-blocking phenotype [73]. The critical question is whether
this effect will persist and if adaptive changes in the mosquito vector, the bacteria, or virus may occur,
hampering the success of this strategy.
Wolbachia can share the same niche with the virus, colonizing ovaries, gut, and salivary glands,
organs that are essential for the replication and transmission of arboviruses [74]. Usually, high antiviral
resistance is associated with high densities of Wolbachia, which could reach several hundred bacteria
per cell [75] and cause a significant fitness cost (e.g., reduced fecundity, fertility, and survival) [76].
Mosquito adaptive changes may occur, leading to the evolution towards lower Wolbachia densities
and, therefore, a reduction or loss of the antiviral phenotype. Another concern is the evolution of
the virus itself; since Wolbachia block the replication of the virus, viral populations could be shaped
to overcome such inhibition. Variants able to replicate despite the presence of Wolbachia could be
advantaged and spread, weakening the sustainability of the Wolbachia control strategy. As an example,
in D. melanogaster, Wolbachia did not present antiviral effects for the Wolbachia-adaptive DCV, which
were genetically different from viral populations in Wolbachia-free controls [77]. These findings were
obtained from cell cultures, which are far from replicating the conditions in a natural host, with a
succession of reduction and restoration of viral diversities after crossing anatomical barriers (midgut
and salivary glands) in the mosquito vector [39].
6. The Hypothesized Mechanisms of Wolbachia-Mediated Pathogen Blocking Activity
Several mechanisms have been proposed to explain the molecular basis of the pathogen-blocking
phenotype: regulation of immune genes, indirect host gene regulation through other cellular machinery
(RNAi, sfRNA), production of reactive oxygen species, or competition for a limited resource such as
cholesterol. Growing evidence has shown that the mosquito transcriptome profiles were altered after
Wolbachia infection [52,70,78,79]. Insect immune pathways such as Toll, IMD, and JAK/STAT pathways
were activated in Wolbachia-infected Ae. aegypti, and led to an efficient reduction in replication
of CHIKV, DENV, and Plasmodium [52,70,78,79]. In addition to the immune factors, many genes
were reported to be upregulated and subsequently may be able to suppress virus replication; the
genes regulating reactive oxygen species production and the upregulation of Wolbachia-mediated
methyltransferase are also reported to suppress the replication of DENV in Ae. aegypti [52,80,81].
Mosquito non-coding RNA expression is also influenced upon Wolbachia infection, and might regulate
virus replication in infected cells [82]. Although the direct interaction between virus replication
and Wolbachia-induced miRNA is not fully understood, an extensively-expressed aae-miRNA-2940
in Wolbachia-infected mosquito cells was proven to upregulate methyltransferase expression and,
subsequently, reduce DENV replication [81]. Moreover, this methyltransferase upregulation negatively
controls the metalloprotease expression leading to a reduction in West Nile virus replication [83].
Recent studies have suggested that Wolbachia bacteria suppress virus replication through cellular
resources allocation (e.g., intracellular space in Wolbachia-infected cells [70,84]), vascular trafficking,
and lipid metabolism caused by Wolbachia-mediated cholesterol perturbation [85]. In fact, on one
hand, Wolbachia do not have any functional lipopolysaccharide synthase and need cholesterol for
membrane formation, while on the other hand, viruses rely on host cholesterol for replication. Therefore,
both behave as competitors for access to cholesterol ingested by the mosquito, which is auxotrophic for
this element [85]. Moreover, the limited intracellular space in Wolbachia infected cells is also reported
to restrict DENV replication [70,84].
7. Viruses Evolve towards an Adaption to Wolbachia-Blocking Activity
Recent studies have raised concerns regarding Wolbachia-mediated selection pressure for
arboviruses that might facilitate viral adaptive evolution and escape from pathogen-blocking effects [77].
Evidence has been brought that Wolbachia bacteria do not suppress the replication of viral RNA genomes
in mosquito cells and, consequently, are not able to accumulate adaptive viral genomes [86,87]. The same
alteration can be observed in Wolbachia-infected D. melanogaster for DCV, where Wolbachia-mediated
17
Pathogens 2020, 9, 404
selective DCV strains could be found after 10 passages in Wolbachia-infected flies. Despite the fact
that the adapted DCV strains did not exhibit the same resistance phenotype to Wolbachia in newly
Wolbachia-infected flies, evidence points to the risk of Wolbachia-mediated selection for virus adaptive
mutations. The resulting adapted viruses might have a better chance of escaping the Wolbachia-mediated
virus-blocking effects in drosophila [77]. Moreover, many studies have indicated the Wolbachia naturally
infecting Ae. albopictus, wAlbA, and wAlbB do not show significant pathogen-blocking activity against
virus infection in this mosquito [75,88–91]. Even if wAlbB is transinfected in other mosquito species,
it cannot trigger the pathogen-blocking phenotype, as observed with other Wolbachia strains [92,93].
These results raise the question of the outcome of co-evolution between Wolbachia and viruses,
highlighting the risk for viruses to escape from Wolbachia-mediated immunity (Figure 2a).
Figure 2. Viruses escaping from Wolbachia blocking activity. (a) After ingestion of an infectious blood
meal (1), viruses enter into the midgut epithelial cells and replicate (2). Newly produced viruses are
released into the hemocoel, infecting internal organs/tissues (3). After reaching the salivary glands
(4), viruses replicate (5), and new viruses are excreted with saliva expectorated (6) by females when
they bite. In the presence of Wolbachia in the midgut and salivary glands, escaping variants can
be produced, leading mosquitoes to transmit viruses less sensitive to the pathogen-blocking effect.
(b) Wolbachia blocking activity can be altered by environmental factors such as temperature. Mosquito
larvae submitted to high temperatures produce adults with a lower density of Wolbachia. (c) Mosquito
adults feeding on enriched diets (carbohydrates and amino acids) show reduced Wolbachia loads. Both
(b) and (c) lead to a diminished blocking activity of Wolbachia as their bacterial densities are much lower.
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8. Environmental Factors That May Affect Wolbachia-Based Control Programs
8.1. An Abiotic Factor, the Temperature
In the field, Wolbachia-infected mosquitoes are exposed (naturally or not) to fluctuating and even
extreme temperatures (Figure 2b). Larvae reared under cycling temperatures between 26 ◦C and 37 ◦C
resulted in adults with a lower density of Wolbachia, an effect persisting across generations [94], and a
diminished CI effect that resulted in the inability of Wolbachia to be transmitted vertically [95]. More
interesting is the possibility that these effects could be strain-dependent. Temperature significantly
affects wMel and wMelPop-CLA in Ae. aegypti, whereas no effect was observed with wAlbB, which
naturally colonizes the mosquito Ae. albopictus, suggesting that the Wolbachia adaptation might reduce
the pathogen-blocking activity. Infections with wAlbB seem to be more applicable in a population
reduction strategy than pathogen suppression in field conditions. The duration of heat stress also
alters Wolbachia density [96]. A long duration of heat stress of Ae. aegypti immature stages leads to
lower wMel densities in adults. Complementary studies using local mosquitoes and field temperatures
are required in Wolbachia-released sites [97].
Temperature might influence Wolbachia density in Ae. aegypti through bacteriophage WO
infection [98]. High temperatures may reduce Wolbachia densities in Ae. aegypti through interactions
with WO, which infects wMel [99] and wAlbB [100]. This phage undergoes cycles of lysogenic and lytic
phases; heat shock triggers the lytic phase during which the phage replicates and causes Wolbachia
lysis, reducing its densities [101]. However, the temperature has a positive effect on virus replication
with significantly higher titers of DENV at temperature > 28 ◦C in Ae. aegypti mosquitoes at day
10 post-infection in salivary glands [102]. More globally, high temperature is likely to weaken the
Wolbachia-mediated pathogen-blocking activity by shortening the extrinsic incubation period (the time
necessary for mosquitoes to become infectious after an infectious blood meal) [103–105], and reducing
Wolbachia density through bacteriophage WO.
8.2. A Biotic Factor, the Host Diet for Mosquito Vectors
Host diet notably influences Wolbachia load (Figure 2c) [106]. Flies reared with yeast-enriched
diets show reduced Wolbachia loads in the host female germline, and flies with a high sucrose diet
show an increase of Wolbachia titer in oocytes. Thus, Wolbachia bacteria rely upon host uptake of amino
acids and carbohydrates. Exposure to yeast-enriched food alters Wolbachia nucleoid morphology in
oogenesis [106]. The yeast-induced Wolbachia depletion is mediated by the somatic target of rapamycin
(TOR) and insulin signaling pathways. These findings are critical in programs combating arboviral
diseases by releasing Wolbachia-infected vectors [73,107]. Thus, the natural environment including host
diet (i.e., nature of blood and sugar absorbed by released mosquitoes) should be considered when
evaluating the efficiency of Wolbachia strategies in the field.
9. Obstacles for Population Replacement Program
9.1. Unclear Wolbachia Distribution in Wild Mosquito Populations
Ae. aegypti populations were thought to be free of naturally-harboring Wolbachia; as a result, many
Wolbachia-based mosquito control strategies were deployed worldwide to reduce or replace the target
mosquito populations via the CI nature of Wolbachia. However, accumulating evidence shows the
existence of naturally-occurring Wolbachia in wild Ae. aegypti populations in India [108], Malaysia [109],
Panama [110], Thailand [111], Philippines [112], and the United States [113–115]. Even though only
small proportions of Ae. aegypti were reported in naturally-harboring Wolbachia in field-collected
populations, the presence of naturally-infecting Wolbachia tends to increase the instability for replacing
the target populations, thus weakening the efficacy of mosquito control programs.
19
Pathogens 2020, 9, 404
9.2. The Robust CI Effect Limits the Solutions for Wolbachia Re-Replacement
On the one hand, the naturally existing Wolbachia in the target population might be an obstacle for
the mosquito population replacement program. On the other hand, the robust CI effect also increases
the difficulty to re-replace the target population that has been already replaced by Wolbachia-harboring
mosquitoes. Because of this, the Wolbachia-mediated pathogen-blocking strategy implemented can
deviate from the objectives initially planned. Thus, a more flexible replacement program is required to
adapt to this scenario. The results of computational modeling have suggested that unless a correct
Wolbachia strain is used, the selection could favor the strain with a lower fitness cost (commensal
infection), thus replacing the existing Wolbachia-harboring population. Furthermore, the second
replacement can be less efficient than the first one [116].
10. Conclusions
Mosquito control, as an essential step for mosquito-borne diseases transmission management,
either by reducing the target population size or replacing the target population with a pathogen-
refractory strain, could efficiently reduce the contact between mosquitoes and hosts, thereby interrupting
the disease transmission. Compared to a genetically modified control strategy, a Wolbachia-based
control strategy is considered a promising alternative to control mosquito populations due to its
natural and environmentally friendly features: It can carry a broad pathogen-blocking activity and
robust CI effect, which together ensure the efficacy in reducing mosquito-borne diseases transmission.
However, complex interactions and resulting co-evolution processes among mosquito, virus, host,
and the environment, make difficult any mosquito-borne disease control strategies. Thus, monitoring
and prevention programs to avoid escape mutants in viral populations must be attentively planned if
the targeted objective is to reach a sustainable control strategy.
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Abstract: Mosquito-borne arboviruses are increasing due to human disturbances of natural ecosystems
and globalization of trade and travel. These anthropic changes may affect mosquito communities by
modulating ecological traits that influence the “spill-over” dynamics of zoonotic pathogens, especially
at the interface between natural and human environments. Particularly, the global invasion of Aedes
albopictus is observed not only across urban and peri-urban settings, but also in newly invaded areas
in natural settings. This could foster the interaction of Ae. albopictus with wildlife, including local
reservoirs of enzootic arboviruses, with implications for the potential zoonotic transfer of pathogens.
To evaluate the potential of Ae. albopictus as a bridge vector of arboviruses between wildlife and
humans, we performed a bibliographic search and analysis focusing on three components: (1) The
capacity of Ae. albopictus to exploit natural larval breeding sites, (2) the blood-feeding behaviour of
Ae. albopictus, and (3) Ae. albopictus’ vector competence for arboviruses. Our analysis confirms the
potential of Ae. albopictus as a bridge vector based on its colonization of natural breeding sites in
newly invaded areas, its opportunistic feeding behaviour together with the preference for human
blood, and the competence to transmit 14 arboviruses.
Keywords: Aedes albopictus; emerging diseases; vector competence; spill-over; blood-feeding; bridge
vector; arboviruses; mosquito
1. Introduction
The human alteration of Earth’s natural systems has become a great concern and a threat to human
health. Indeed, these changes are likely to drive most of the global disease burden over the coming
century [1]. During the last decades, the burden of emerging infectious diseases has increased to
represent a substantial threat to global health, security, and economy growth. About 75% of emerging
infectious diseases are zoonotic diseases, mostly of wildlife origin [2,3]. The risk of zoonotic emergences
is considered high in tropical forest regions associated with a range of facilitating factors, particularly
high vertebrate species diversity and agricultural land use changes [4]. Understanding the mechanisms
of disease emergence allows the development of early detection and control programs for reducing
disease incidence and economic burden [5].
Zoonotic pathogens can be transmitted from animals to humans directly, or indirectly when
arthropod vectors are needed to accomplish their life cycle. Zoonotic vector-borne diseases are
maintained in enzootic cycles, but can be transmitted from animal reservoir populations to sympatric
human populations or to domestic animals during “spill-over events”, and also from humans to
animals during “spill-back events” [2,6]. The global emergence of vector-borne diseases is helped
by international travel and trade, after their local emergence has been driven by a combination of
environmental changes that are not yet completely understood [7]. Therefore, research is needed to
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determine the potential of these pathogens to emerge in the future, and to identify critical geographic
areas where early warning systems must be put in place to mitigate the pathogen’s impact on human
health [8].
Here, we focused on zoonotic arboviruses (arthropod-borne viruses) transmitted by mosquitoes
that are part of enzootic cycles evolving in wildlife or domestic animals, independently of mankind.
Animals might act as amplification hosts for spill-over events to humans [9], mainly in tropical forest
environments [10]. Some arboviruses, such as those causing epidemic Aedes-borne viral diseases
(dengue, chikungunya, and zika), have adapted to epidemic cycles in which viremic humans became
the source of infection in urban areas where Aedes aegypti, and to a lesser extent, Aedes albopictus [11,12]
ensure person-to-person transmission [13]. The burden of Aedes-borne diseases is dramatic. For
instance, dengue incidence has increased by 30 times over the last 50 years, with about 390 million
infections reported annually worldwide [14,15]. Dengue and chikungunya outbreak waves have
resulted in several million cases in the Southwest Indian Ocean region, India, and the Americas [16].
Zika virus (ZIKAV) disease emerged in 87 countries (or territories) [17]. ZIKAV infection during
pregnancy can cause microcephaly in newborns and is becoming a major threat due to its long-term
sanitary and economic impacts, especially in Latin America [18]. Although these infection outbreaks are
caused by independent urban cycles, enzootic cycles still remain essential sources of pathogens and/or
vectors that can be introduced, adapt, and disperse, causing new severe threats [2], as exemplified by
the recent re-emergence of Yellow Fever Virus (YFV) in Brazil, Angola, and the Democratic Republic of
Congo [19,20]. For YFV, spill-over events from non-human primates that involve mosquito bridge
vectors have been described in tropical Africa (e.g., involving Aedes africanus or Aedes furcifer) [21]
and in America (involving mosquito species from the Haemagogus and Sabethes genera) [20]. After
its introduction in the Americas, YFV has efficiently spilled back into sylvatic cycles via bridge
vectors. In African villages or cities, YFV transmission is supported by epidemic vectors, such as
Ae. aegypti [21,22]. These data indicate that mosquito bridge vectors play key roles in the early processes
leading to the emergence of enzootic viruses, before the urban transmission cycles [6,8].
We define a bridge vector as an “appropriate hematophagous arthropod” that ensures the
biological transmission of a pathogen across different landscapes and its circulation between enzootic,
domestic animal, and human hosts. In the absence of a bridge vector, pathogen transmission generally
remains restricted to a specific area within the enzootic or epidemic cycle and among hosts/reservoirs.
Bridge vectors are the key that interconnects animal reservoirs to new vertebrate hosts, including
humans, and that allows both spill-over and spill-back events. For this study, we considered that bridge
vectors show several bio-ecological traits that influence the shifting risks of pathogen transfer and that
are mainly related to their ecological distribution, blood feeding behaviour, and vector competence.
Regarding ecological habitats, high ecological and physiological plasticity favours the vector dispersal
and its establishment (breeding in specific microhabitats) across different ecosystems, landscapes,
or habitats (e.g., forest/rural/urban, forest/savannah, ground/canopy, natural/anthropic larval breeding
and adult resting sites). Regarding blood feeding behaviour, low specificity in blood-meal sources and
opportunistic feeding behaviour involving multiple hosts increases the probability of contact between
the vector and different animal reservoirs, and thus interspecies pathogen transfer. This probability
also depends on the vector and host density and on the host’s defensive behaviour. Regarding vector
competence, for the biological transmission of a pathogen after its acquisition on an infected vertebrate,
a bridge vector must be able to ensure its replication/multiplication, dissemination, and transmission
to subsequently bitten vertebrates. Arthropod species competent for a large panel of pathogens or
with high vector competence for one pathogen represent particularly suitable candidates to act as
(bridge) vectors.
Here, we evaluated the potential role of the Asian tiger mosquito Ae. albopictus as a bridge vector.
This invasive vector species originates from Asian tropical forests, but nowadays is present in all
continents [23], and has become a major public health issue. In its native area, sylvatic Ae. albopictus
populations complete their biological cycle by exploiting wild animals as blood sources, and natural
28
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water collection points (e.g., tree holes, bamboo stumps, or rock holes) as oviposition sites in the
woods [24], particularly at the forest edge [24]. The capacity to colonize artificial man-made containers
(together with desiccation-resistant and diapausing eggs) led to its “domestication”. Its ecological
plasticity to several habitats, its passive dispersion through the global transport of tires and inside
cars [25], and the inefficiency of control programmes have allowed Ae. albopictus to become one of
most invasive species worldwide [23,24]. In native and newly colonized areas, it has been found in
urban, rural, and forest habitats; however, unclear information is available on its natural breeding
sites and its presence in forested environments. Moreover, its presence in natural breeding sites in the
invaded territories has not been analysed. In general, Ae. albopictus is considered an opportunistic
feeder that is attracted to mammals, particularly humans, rather than other hosts [26,27]. However,
to our knowledge, a detailed and quantified analysis of its host preferences has never been done.
In relation to epidemic virus transmission, Ae. albopictus has been considered the vector for the
chikungunya virus (CHIKV), dengue virus (DENV), and ZIKAV in Gabon and Central Africa [28,29],
for DENV and CHIKV in la Réunion island [30], and for CHIKV in Madagascar and Mayotte [30,31].
In Europe, it has been incriminated in Italy and France during CHIKV and DENV outbreaks [32,33] and
in Japan in DENV transmission [34]. Moreover, this mosquito represents a potential risk of outbreaks in
many other areas, for example, in Brazil and USA where Ae. albopictus is widespread [35–38]. Different
studies have shown that Ae. albopictus can develop infection from up to 32 arboviruses [16,23,36];
however, to our knowledge, its ability to transmit any of them has not been clearly demonstrated yet.
In this work, we hypothesized that Ae. albopictus may have an active role as a bridge vector
for the transfer from vertebrate hosts to humans (spill-over events) and therefore, in the emergence
of enzootic arboviruses. To test this hypothesis, we reviewed and quantified: (1) Ae. albopictus’
capacity to exploit natural water collections as larval breeding sites (as a proxy for its establishment in
rural/sylvatic/forested areas) in native or invaded regions; (2) its feeding behaviour with regard to
humans, domestic, or wild animals (as a proxy for the contact between vertebrate hosts and humans);
and (3) its vector competence, tested experimentally for different arboviruses and natural infections
reported from the field in mosquitoes (as a proxy for its potential for virus transmission in the field).
Finally, we discuss the potential spill-over transmission risk from vertebrate hosts to humans and the
methodological issues and knowledge gaps that need to be tackled.
2. Results
2.1. Natural Breeding Sites
Based on the literature (see Methods and Supplementary Tables S1 and S2), we found 27 articles
that quantified the number and type of natural breeding sites exploited by Ae. albopictus in areas where
the species is considered native (n = 10 articles) or invasive (i.e., colonized areas) (n = 17 articles).
Preimaginal stages of Ae. albopictus were mainly detected in coconut shells (54.7%) [37–45], bromeliads
(19%) [46–50], bamboo stumps (8.3%) [39,40,51–54], tree holes (8.2%) [37,42,43,51,53–59], palm leaves
(3.6%) [51], rock holes (3.2%) [37,42,43,51,53,57,60], leaf axils (1%) [39,40,42,61], and sporadically (<1%)
in other natural breeding sites, such as snail shells [43,53], palm bracts [53], dead leaves [37,43], cacao
pods on the ground [43], dead cow horns [43], puddles [62], ground cavities [46], and hollow logs [53]
(Figure 1).
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Figure 1. Natural larval breeding sites exploited by Ae. albopictus. Number of reported natural breeding
sites (black bars) and number of articles that reported natural breeding sites (grey areas).
Coconut shells and tree holes were more often reported (11 articles each), followed by bamboo
stumps, bromeliads, rock holes, and leaf axils (7 articles each), and finally, the other natural breeding
sites (1–2 articles each). In native areas, most of the reported natural breeding sites were coconut
shells (83%), followed by bamboo stumps (11%), tree holes (5%), leaf axils (1%), and rock holes (1%).
In colonized areas, a great diversity of breeding sites was reported: bromeliads (50.8%), tree holes
(13%), palm leaves (9.6%), rock holes (8.4%), coconut shells (8%), bamboo stumps (3.8%), leaf axils
(1%), palm bracts (1.2 %), snail shell (1.7%), and others (<1% each).
2.2. Feeding Behaviour
Our quantification of the feeding behaviour indicates that Ae. albopictus has been mainly reported
as a species that prefers mammals (including humans) as blood sources (mean and standard deviation:
92.0% ± 8), compared with birds (8% ± 8) and other animals (3.7% ± 1.7) [26,27,63–82] (Figure 2A).
Among mammals, blood meals were mainly from humans (60%) than non-human species (30%). From
an “interspecies risk of transfer” perspective, it is relevant to note that Ae. albopictus seems to be biting
domestic animals (25%) more frequently than wildlife animals (10%) (Figure 2B). Importantly, there is
huge variability in the percentage of human blood meals in the different studies.
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Figure 2. Boxplots showing the host feeding preferences (i.e., percentage of bites) of Ae. albopictus
without taking into account host availability. (A) Mammals, humans, non-human mammals, and birds;
(B) Humans, domestic animals, and wildlife. Black line: median.
Among domestic and peri-domestic animals, dogs, rodents, and rabbits were reported as the main
blood sources for Ae. albopictus, followed by cats, bovines, chickens, horses, and pigs (Supplementary
Figure S1). When classified according to the biological family of blood sources, Ae. albopictus can
feed on 28 different host biological families, and preferentially on animals belonging to Hominidae
(60%), Muridae (15%), Canidae (12%), and Phasianidae (10%) (see Table 1 for detailed information and
Supplementary Table S3 for bibliographical information).
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Table 1. Mean biting frequency by Aedes albopictus in animals classified according to biological class
and family.































The mean frequencies were calculated using the data found in articles that described different Ae. albopictus
populations biting different animals in different locations. As these articles do not describe the same biological
families, the total mean bite frequency does not correspond to 100%.
2.3. Arbovirus Transmission
In the literature search, in addition to the epidemic DENV (serotypes 1, 2, 3, and 4), CHIKV and
ZIKV, we found reports on experimental infections of Ae. albopictus with the following 36 arboviruses:
Arumowot (AMTV) [83], Bujaru (BUJV) [83], Bussuquara (BSQV) [84], Cache Valley (CVV) [85],
Chandipura (CHPV) [86], Chilibre (CHIV) [83], Eastern Equine Encephalomyelitis (EEEV) [87–90],
Getah (GETV) [91], Icoaraci (ICOV) [83], Ilheus (ILHV) [92], Itaporanga (ITPV) [83], Jamestown Canyon
(JCV) [93], Japanese Encephalitis (JEV) [92,94–96], Karimabad (KARV) [83], Keystone (KEYV) [92,93],
Kokobera (KOKV) [92], Kunjin (KUNV) [92], La Crosse (LACV) [92,93,97–99], Mayaro (MAYV) [100],
Oropuche (OROV) [100], Orungo (ORUV) [101], Pacui (PACV) [83], Potosi (POTV) [102–104], Rift
Valley fever (RVFV) [105,106], Ross River (RRV) [107,108], Salehabad (SALV) [83], San Angelo
(SA) [84,92,109], St. Louis encephalitis (SLEV) [110], Tensaw (TENV) [111], Trivittatus (TVTV) [93],
Uganda S. (UGSV) [92], Urucuri (URUV) [83], Usutu virus (USUV) [112], Venezuelan equine encephalitis
(VEEV) [113–115], West Nile virus (WNV) [116–125], and YFV [108,126–130] (see Supplementary Table
S4 for bibliographical information). However, besides the addition to the epidemic DENV (serotypes
1, 2, 3 and 4) [131], CHIKV, and ZIKV [28], natural infections of Ae. albopictus were only reported
for eight viruses: CCV [85,132], EEEV [133], KEYV [133], LACV [99,132,134,135], POTV [102,132,136],
TENV [133], USUV [112], and WNV [118–120] (see Supplementary Table S5 for bibliographical
information). These infections were detected by virus isolation on cell lines, immunological or
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molecular methods (Vero cells, direct or indirect immunofluorescence, polymerase chain reaction).
These infections provide evidence of contact between Ae. albopictus and the hosts of these viruses, but
do not necessarily indicate their biological transmission by this mosquito. On the other hand, for the
BSQV, ILHV, KOKV, KUNV, and UGSV arboviruses, only intrathoracic injection experiments were
carried out to investigate transovarian transmission between different generations. Supplementary
Table S6 gives information on the taxonomic classification of these viruses, their geographic distribution,
their natural host family (i.e., vertebrate host family in which the virus was isolated or in which
serological evidence was found), the mosquito species from which the virus was isolated, and the
detection method in Ae. albopictus.
Among studies on Ae. albopictus vector competence, we found important variations concerning
the methodology used to perform the infection (intra-thoracic inoculation of viruses, oral challenge
using infected blood meals or infected animals), the mosquito strains, the viral strains and the
virus loads used, the conditions of mosquito incubation (e.g., time, temperature), and the methods
used to determine mosquito infection and transmission efficiency. Concerning the virus inoculation
methodology, intra-thoracic injection was used for 11 viruses to assess vector infection, and oral
infection was performed using infected hosts (n = 11 arboviruses), or membrane feeding methods
(n = 11 arboviruses).
The mean infection values in Ae. albopictus after infection by intrathoracic injection greatly varied
in function of the tested virus, and ranged from 100% ± 0 (AMTV, BUJV, and PACV) to 37.5% ± 17.67
(ORUV). Among these viruses, the transmission rate after intrathoracic injection was estimated only for
ORUV (37.5% ± 17.67) and RVFV (15.9% ± 7.3). The mean infection rate (IR) in Ae. albopictus that fed
directly on infected vertebrate hosts or on an infectious artificial blood-meal through a membrane also
hugely varied, from 100%± 0 for GETV to 6.6%± 5.2 for OROV. The mean Dissemination Efficiency (DE)
in Ae. albopictus varied from 89.85% ± 5.9 for POTV to 4.06% ± 1.32 for MAYV. The mean Transmissions
Rates (TR) in Ae. albopictus varied from 82.7% ± 11.5 (WNV) to 7.7% ± 0 (JCV). Finally, the mean
Transmission Efficiency (TE) by Ae. albopictus varied from 68.6% ± 18.6 (WNV) to 3.5% ± 0.69 (MAYV).
Whatever the methodology used for the experimental infection, transmission was confirmed for
14 viruses. Six displayed a mean TE higher than 30% (WNV, EEEV, RRV, JEV, VEEV, and ORUV),
and five had a mean TE between 10% and 30% (LACV, CVV, POTV, CHPV, and RVFV). The mean
TE for YFV, JCV, and MAYV was below 10%. All TE rates in Ae. albopictus (using both experimental
infections with infectious animals and infectious artificial blood meals) are summarized in Figure 3,
without taking into account the different mosquito populations used, the viral loads, or genotypes. For
more details on the infection parameters (IR, DE, TR, and TE) obtained using the different inoculation
methods, see Table 2.
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Figure 3. Transmission efficiency across studies that evaluated Ae. albopictus vector competence for
different arboviruses. Bridge Vector*Virus and Epidemic Vector*Virus pairs were added to compare the
transmission efficiency.
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Table 2. Infection rate, dissemination rate, dissemination efficiency, transmission rate, and transmission















Mean SD Mean SD Mean SD Mean SD Mean SD
Host feeding
CHPV 25.00 0.00 ND ND ND ND ND ND 12.50 0.00
EEEV 75.36 35.35 85.19 25.66 76.99 33.58 40.00 0 57.17 20.15
JEV ND ND ND ND ND ND ND ND 37.00 9.17
LACV ND ND ND ND ND ND ND ND 23.86 6.69
MAYV 11.88 3.31 20.00 0.00 4.07 1.32 ND ND 3.46 0.69
OROV 6.67 5.20 ND ND ND ND ND ND ND ND
POTV 26.26 17.06 ND ND ND ND ND ND ND ND
RRV 80.66 23.02 ND ND ND ND ND ND 41.40 16.57
RVFV 69.26 27.24 60.04 6.34 40.72 11.96 15.00 7.07 6.54 4.67
VEEV 71.20 20.49 89.48 10.48 64.78 22.53 59.94 26.57 38.09 23.53
WNV 73.41 23.81 94.39 3.91 69.80 23.98 82.72 11.49 68.63 18.62
Intrathoracic
injection
AMTV 100.00 ND ND ND ND ND ND ND ND ND
BUJV 100.00 ND ND ND ND ND ND ND ND ND
CHIV 96.88 ND ND ND ND ND ND ND ND ND
ICOV 40.91 ND ND ND ND ND ND ND ND ND
ITPV 81.25 ND ND ND ND ND ND ND ND ND
KARV 94.12 ND ND ND ND ND ND ND ND ND
ORUV 37.50 17.68 ND ND ND ND ND ND 37.50 17.68
PACV 100.00 0.00 ND ND ND ND ND ND ND ND
RVFV ND ND ND ND ND ND ND ND 15.93 7.35
SALV 92.86 0.00 ND ND ND ND ND ND ND ND
URUV 94.12 0.00 ND ND ND ND ND ND ND ND
Membrane
feeding
CHIKV 58.92 28.23 77.58 22.60 79.06 23.45 53.49 33.98 42.68 23.78
CVV 56.50 0.00 100.00 0.00 ND ND 29.60 0.00 17.39 0.00
DENV-1 60.18 16.01 63.79 23.97 39.56 23.90 8.33 0.00 6.25 0.00
DENV-2 58.10 30.93 53.12 22.93 34.83 18.81 12.47 13.20 10.13 12.29
GETV 100.00 0.00 ND ND ND ND ND ND ND ND
JCV 96.67 0.00 89.66 0.00 86.67 0.00 7.69 0.00 6.67 0.00
JEV 91.98 10.72 90.79 14.56 84.63 19.92 ND ND 40.50 15.98
KEYV 91.89 0.00 91.18 0.00 83.78 0.00 ND ND ND ND
LACV 89.72 7.38 86.83 13.70 71.03 22.93 35.84 14.25 29.93 16.75
POTV 93.55 6.59 96.13 3.21 89.86 5.96 ND ND 14.67 7.00
RVFV 10.53 0.00 25.00 0.00 2.63 0.00 100.00 0.00 2.63 0.00
TVTV 28.00 0.00 85.71 0.00 24.00 0.00 ND ND ND ND
USUV 64.40 31.2 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
WNV 32.61 24.53 64.59 25.58 20.33 16.96 ND ND ND ND
YFV 33.18 21.18 55.52 20.97 20.86 10.90 36.52 26.17 7.68 5.94
ZIKV 67.19 23.70 38.71 21.76 29.25 22.80 24.62 22.46 9.21 6.91
Infection rate: number of mosquitoes showing virus infection in the gut divided by the number of mosquitoes fed
with infected blood x 100. Infection: percentage of mosquitoes in which the virus was detected after 7–10 day of
incubation following intrathoracic injection of the indicated virus. For this test, the ground mosquito suspension
was inoculated in rats, or the virus presence was quantified by assays in Vero cells. ND: Not described SD: standard
deviation AMTV, Arumowot virus; BUJV, Bujaru virus; CHIKV, Chikungunya virus; CVV, Cache Valley virus; CHPV,
Chandipura virus; CHIV, Chilibre virus; DENV-1, Dengue virus serotype 1; DENV-2, Dengue virus serotype 2;
EEEV, Eastern Equine Encephalomyelitis virus; GETV, Getah virus; ICOV, Icoaraci virus; ITPV, Itaporanga virus;
JCV, Jamestown Canyon virus; JEV, Japanese Encephalitis virus; KARV, Karimabad virus; KEYV, Keystone virus;
LACV, La Crosse virus; MAYV, Mayaro virus; OROV, Oropuche virus; ORUV, Orungo virus; PACV, Pacui virus;
POTV, Potosi virus; RVFV, Rift Valley fever virus; RRV, Ross River virus; SALV, Salehabad virus; SAV, San Angelo
virus; SLEV, St. Louis encephalitis virus; TENV, Tensaw virus; TVTV, Trivittatus virus; URUV, Urucuri virus; USUV,
Usutu virus; VEEV, Venezuelan equine encephalitis virus; WNV, West Nile virus; YFV, Yellow fever virus; and ZIKV,
Zika virus. For BSQV, Bussuquara virus, ILHV, Ilheus virus, KOKV, Kokobera virus, KUNV, Kunjin virus, UGSV,
and Uganda S. virus, only transovarial transmission tests were described.
Comparison of IR, DE, and TE (see Methods and Supplementary Table S7) values calculated
for known efficient bridge vectors infected with different arboviruses, and those for Ae. albopictus
(Table 3) showed that the YFV TE rate for Ae. albopictus (7.68% ± 5.9) was similar to the rate calculated
for Haemagogus leucocelenus [127] (8.08% ± 2.0). Conversely, the TE rates varied more for WNV:
68.6% ± 18.6 for Ae. albopictus and 13.49 ± 14.8 for Culex pipiens (a primary vector of WNV in the
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field) [117,124,137–146]. Moreover, Ae. albopictus and Ae. aegypti (a recognized epidemic vector) showed
similar TE rates for CHIKV [126,147–152], DENV-1 [153–157], and DENV-2 [126,147,154,155,157–159],
but Ae. aegypti was more efficient at transmitting ZIKV [126,160–171] and YFV [127,128,172–175].
Table 3. Comparison of the infection rate, dissemination efficiency, and transmission efficiency (mean
and standard deviation) for Aedes albopictus and other mosquito vectors.
Mosquito Species Virus IR (%) DE (%) TE (%)
Aedes aegypti CHIKV NA 98.3 ± 3.8 42.92 ± 20.19
DENV-1 37.7 ± 27 34.4 ± 24.9 4.9 ± 4.6
DENV-2 44.4 ± 33.4 33.3 ± 24.2 5 ± 0
ZIKV 69.0 ± 27.4 44.0 ± 28.3 20.48 ± 26.87
YFV 46.4.0±23.6 21.3 ± 19.0 16.5 ± 17.7
Aedes albopictus CHIKV 58.9 ± 28.2 79.0 ± 23.4 42.68 ± 23.7
DENV-1 60.2 ± 16 39.5 ± 24.2 6.25 ± 0
DENV-2 58.0 ± 30.9 34.8 ± 18.8 10.13 ± 12.28
WNV 63.8 ± 29.2 58.1 ± 30.8 68.6 ± 18.6
YFV 33.1 ± 21.1 20.8 ± 10.8 7.68 ± 5.9
ZIKV 67.1 ± 23.7 29.2 ± 22.8 9.21 ± 6.9
Culex pipiens WNV 47.7 ± 33.7 30.4 ± 29.7 13.49 ± 14.8
Haemagogus leucocelenus YFV 50.9 ± 4.0 30.06 ± 1.6 8.08 ± 2.0
IR, infection rate; DE, dissemination efficiency; TE, transmission efficiency; CHIKV, Chikungunya virus; DENV-1,
Dengue serotype 1; DENV-2, Dengue serotype 2; WNV, West Nile virus; YFV, Yellow fever virus; ZIKV, Zika vírus.
3. Discussion
In the present work, we tried to understand the potential role of the Asian tiger mosquito
Ae. albopictus as a bridge vector that might favour the transfer of zoonotic arboviruses from enzootic
or domestic hosts to humans and vice-versa. To this aim, we evaluated its ability to colonize natural
breeding sites in newly invaded and native areas, its appetence for animal blood sources, and its global
efficiency for transmitting arboviruses. This mosquito species was described as capable of developing
infection from a large number of arboviruses in laboratory conditions [36]. However, based on the
published evidences of vector competence, we found that transmission by Ae. albopictus is proven only
for 14 of them, without considering the epidemic Aedes-borne CHIKV, DENV (4 serotypes), and ZIKAV.
In relation to the capacity of Ae. albopictus to establish in natural areas (rural/sylvan environments),
tree holes were described as the most common natural breeding sites, although it has been detected also
in bamboo stumps, and more sporadically in rock holes and plant axils [24]. Our analysis indicates that
coconut shells, bromeliads, and bamboo stumps might be as common as tree holes, whereas rock holes
and leaf axils of other plants are less frequently used. These results might be biased due to differences
across studies related to sampling efforts and the environmental characteristics of sampled areas.
Therefore, they should be confirmed by comparisons with larval sampling in natural and artificial
breeding sites in natural areas and forest edges. Moreover, when possible, the productivity in these
habitats should be described and compared by pupal sampling, with the same methodology used
for quantifying the productivity of anthropic containers in urban areas [176]. For example, a study
in Rio de Janeiro showed that the percentage of Ae. albopictus larvae in bromeliads corresponded to
0.18% of all sampled larva, demonstrating the low productivity of this breeding place [48]. However,
studies describing the productivity of natural breeding sites in the natural environment or at an
interface between natural and man-modified environments are lacking. In native forested areas,
natural containers of larvae (tree holes, bamboo stumps, rock holes) were observed at the forest edge,
like in a colonized forested area. Breeding sites in the deep forest have never been detected for this
species [24,27].
Our results also confirmed the opportunistic feeding behaviour of Ae. albopictus and its strong
preference for mammals, especially humans (humans = 60%, non-humans = 30%) compared with
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other groups, such as birds (4%). Ae. albopictus can feed on 28 different biological families. Reports on
Ae. albopictus biting on any primates other than man were lacking until very recently. Specifically, a study
described Ae. albopictus probing on a howler monkey that had just died due to YFV and was lying on
the forest edge in Brazil [177]. This mosquito also bites domesticated animals—Muridae, Canidae,
Phasianidae, Herpestidae, and Bovinae. Several studies suggested this opportunism. For instance,
laboratory experiments on the host choice showed that this mosquito preferentially bites humans
compared with other animals [30]. This opportunism was confirmed in studies on blood-fed mosquitoes
collected in the field [27,30,69,78]. From our literature analysis, birds appeared as a non-preferential
host group. Based on the reported proportion of blood meals, domestic and peri-domestic animals
(25%) should be considered more relevant than wildlife (10%) as sources of zoonotic pathogens for
Ae. albopictus. However, a limited number of studies were carried out in natural habitats where
wildlife is abundant. Therefore, additional research is needed in natural areas to precisely describe the
blood feeding patterns of Ae. albopictus and its interaction with wildlife. If possible, the availability
of vertebrate hosts should be taken into account by using field census procedure and by calculating
indexes of feeding preferences [178]. Such approaches should prevent the underestimation of the
Ae. albopictus’ potential to transmit pathogens from domestic/sylvatic vertebrate hosts to humans, but
also from domestic to sylvatic vertebrate hosts, and vice versa. Our analysis also highlighted a huge
variability in the proportion of human blood meals. This is a relevant factor for calculating the vector
capacity, the disease reproduction rate (Ro), and the spill-over risk that may be determined by several
parameters [178].
Concerning vector competence, this species was suggested as a potential vector for many viruses.
It is important to emphasize that the mean TE values of enzootic viruses, such as WNV (68.6% ± 18.6),
EEEV (57.16%± 20.14), RRV (41.39%± 16.5), JEV (39.3%± 13.5), VEEV (38.1%±), LACV (27.3% ± 12.87),
CVV (17.4% ± 0), and POTV(14.6% ± 7), were higher or comparable with those reported for epidemic
viruses, such as DENV-1 (6.25 ± 0), DENV-2 (10.13 ± 12.28), YFV (7.68 ± 5.9), ZIKV (9.21 ± 6.9), CHPV
(12.5% ± 0), YFV (8.2% ± 6), JCV (6.6% ± 0), RVFV (5.2% ± 3.9), and MAYV (3.5% ± 0.69). The large
difference in TE rates between enzootic and epidemic viruses is a reflection of the techniques employed
to assess parameters. Most of the analysis on enzootic viruses were performed mainly in the 1990s
and up to the beginning of the 2000s. Conversely, epidemic viruses were analysed using more precise
techniques during the last 5 years. Despite the biases of the older methodologies, Ae. albopictus
presented a high TE rate for enzootic arboviruses; therefore, it might transmit these viruses if taken
from viremic natural vertebrates.
Comparing the vector competence of Ae. aegypti and Ae. albopictus for different epidemic viruses
did not allow for a conclusion that there is a difference in their TE rates for ZIKV, CHIKV, DENV-1,
and DENV-2. However, for bridge vectors*virus pairs, WNV TE was higher for Ae. albopictus than
for Cx. pipiens, contrary to what was expected. Although the WNV transmission efficiency rate by
Ae. albopictus is high in experimental conditions, this species has never been incriminated as a WNV
vector in the field, possibly due to its low propensity to bite birds. Ae. albopictus presented similar TE
rates as Hg. leucocelenus, a primary YFV vector within and at the edges of Brazilian forests [27,179].
However, few studies have been carried out to assess Hg. leucocelenus vector competence. In general,
the contribution of laboratory studies for assessing the role of vector(s) in natural environments
is limited.
Based on vector competence and blood meal studies, we conclude that Ae. albopictus could act
as a bridge vector for many viruses (e.g., WNV, EEEV, ORUV, RRV, YFV, JEV, VEEV, LACV, RVFV,
CVV, CHPV, JCV, and MAYV) with a potential risk for disease emergence. One of our goals was to
identify in a quantitative way the viruses with a higher risk of emergence, and to develop an analysis
to quantify the relative risk of transfer to humans of each enzootic arbovirus that can be efficiently
transmitted by Ae. albopictus in laboratory conditions. The methodology used was based on two
previous published works [180,181] that quantified the risk of WNV transfer by Culex mosquitoes.
We then calculated the relative risk of Ae. albopictus-mediated virus transfer from its natural hosts to
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humans using a simplified version of Kilpatrick’s equation (see Supplementary Information for more
details concerning the methodology used and Figure S2) that takes into account Ae. albopictus vector
competence for a given virus (i.e., TE), and the mean relative feeding frequencies on humans (FHi) and
on animal hosts (FAi). Unfortunately, this analysis was hindered by the limited information available
on the enzootic/sylvatic reservoirs of several of these arboviruses (some hosts remain unknown or are
not sufficiently identified). Moreover, some viruses have many potential reservoirs, and their objective
weighting is difficult. Additionally, data on Ae. albopictus propensity to bite a given animal reservoir
species are often lacking (e.g., primates). Consequently, only biting frequencies at animal family levels
could be used, leading to overly unreliable and speculative risk transfer estimates. Therefore, we chose
not to include them here, although these estimates are crucial to better assess the risk of spill-over
and emergence of enzootic arboviruses in relation with the secondary invasion of Ae. albopictus in
forested areas.
Another important limitation of the present work is the great methodological variation and the
lack of standardization of the protocols used to assess the vector competence of Ae. albopictus. Vector
competence for arboviruses is influenced by genetic factors in the mosquito population and in the virus
strain, such as the geographical genetic origin of the vector population or the interaction between the
vector and arbovirus genotype [182,183]. Therefore, the intraspecific genetic variability in mosquito
species/populations, as well as the intra- and inter-specific variability of arboviruses can affect vector
competence and risk estimations. External factors, such as the incubation temperature, can also affect
vector competence, and consequently the transmission and analysis of the risk [184].
Other factors interfering with the vector competence results are the way of ingesting the
virus-infected blood (in vivo or in vitro), the viral load concentration, and the sensibility of the
method used to detect the virus in the mosquito body or saliva. We are aware that our study is limited
due to the methodological differences of the analysed articles, and also because the risk of arbovirus
emergence is a multifactorial process and it is actually impossible to estimate the interactions of all
factors with the limited evidences available. Thus, more standardized studies of vector competence
and blood feeding preferences are necessary. In this sense, the project Infravec2 (https://infravec2.eu) is
an important international initiative, and one of its themes is the standardization of methods.
In conclusion, data from the literature show that Ae. albopictus can colonize forest environments,
and has possible interactions with domestic animals and wildlife, suggesting a risk for interaction
with animal viruses. Such a risk is particularly high in areas that are considered to be biodiversity
hotspots, such as the Congo and Amazon Basin forests. The presence of Ae. albopictus in small
towns and hamlets in the Amazon Forest highlights the risk of spill-over of some arboviruses that
cause human diseases, such as OROV, YFV, and MAYV [27]. In Brazil, Ae. albopictus populations
are experimentally competent for YFV transmission, but this has not been confirmed by infecting
Ae. albopictus [127,185]. In Africa, many arboviruses could be investigated to elucidate their potential
transmission and emergence facilitated by Ae. albopictus, as done for CHIKV [152]. In the United
States, where this mosquito species is widespread, its potential role in LACV, EEEV, WNV, and POTV
transmission must be investigated [36,133,135]. In Asia and Oceania, the potential for inter-species
transmission of JEV and RRV must be evaluated. It is important to take into account that the risk of
arbovirus emergence is dynamic and in continuous evolution because mosquito populations, virus
genetics, and the possibility of their contact varies according to time and place, and adaptations could
be expected, particularly for invasive pathogens and vectors [186]. For instance, in the Indian Ocean
region, the interaction between Ae. albopictus and CHIKV led to the selection of a virus strain that
infects vectors and can spread around the world more easily. Studies on mutation selection for more
susceptible arbovirus strains are still limited, but can be useful for predicting spill-over events [187].
Also, vector competence must be evaluated with as many strains as possible to maximize viral diversity,
if possible using strains recently isolated from animals.
Our literature review showed that Ae. albopictus is competent for many different arboviruses, is
present in natural habitats and forest edges, and can feed on several animal groups [30]. All these
38
Pathogens 2020, 9, 266
features make of Ae. albopictus a potential bridge vector of several emerging arboviruses (at least
14 viruses [23,36]), thus increasing the risk of spill-over and spill-back events. We hope that our
approach will encourage more research to disentangle this risk in the field and the laboratory, with the
aim of preventing the emergence of zoonotic diseases and reducing potential health and economic
burdens, particularly for vulnerable populations.
4. Material and Methods
4.1. Natural Breeding Sites
First, a literature search was done in Google Scholar to identify articles reporting the presence of
Ae. albopictus in natural larval breeding sites and their types, using the keywords “Natural Breeding
sites Aedes albopictus” or “Oviposition sites Aedes albopictus” or “Larval habitats Aedes albopictus”. This
allowed for the identification of 16 articles [43,44,46,52,54,55,61,62,188–194] (Supplementary Table S1).
From these articles, the main natural breeding sites were listed: bamboo stumps, bromeliads, coconut
shells, leaf axils, rock holes, tree holes, snail shells, cacao shells, puddles, dead cow horns, dead
leaves, ground cavity, hollow log, palm bracts, and palm leaves. Then, a search on each type of
natural breeding site was carried out using PubMed, using the following words: (Aedes albopictus
[Title/Abstract] AND “Breeding type” [Title/Abstract]). The aim of this search was to quantify the
number of articles and the number of detections that described the presence of this mosquito in each
of the identified natural breeding sites (Supplementary Table S2). Articles that did not quantify the
number of times the breeding sites were found positive were excluded. The bibliographic search was
done between August and December 2018.
4.2. Feeding Behaviour
A literature search was done in Google Scholar with the key words “blood meal” and “host feeding”,
followed by “Aedes albopictus” until December 2018. Three studies were excluded because they were
considered unreliable: (i) the study by Gingrich and Williams, 2005 [67], which did not test for human
blood meals, thus bringing a potential bias into the results; (ii) the study performed in a zoo by Tuten
et al., 2012 [195]; and (iii) the study by Hess et al., 1968 [196] that was exclusively carried out in
a bird area on Hawaii Island. Finally, 22 studies were selected (see references and details for each
of them in Supplementary Table S3) to build a database of blood feeding preferences, based on the
Ae. albopictus biting frequency for each host species, biological family, or group of vertebrate hosts
(human, mammals, birds, domestic animals, wild animals). The database was used to quantify the
relative importance as a blood meal of each host group and of specific hosts, based on the reported
blood meal sources identified using different techniques (DNA sequencing, ELISA blond meal analyses,
agarose gel precipitin). Then, these preferences were analysed independently of the host availability,
which was quantified in very few studies.
4.3. Arbovirus Transmission
First, all referenced arboviruses that might be transmitted by Ae. albopictus were selected using
the arbocat database from Centers for Disease Control and Prevention (CDC) (https://wwwn.cdc.gov/
arbocat/VirusBrowser.aspx). Then, Google Scholar and PubMed were searched with the key words
“Virus name” and “Vector Competence”, followed by “Aedes albopictus”. Among the 49 articles obtained
with this search, articles containing data on virus detection/isolation from field-collected mosquitoes,
and data on vector competence parameters, including “susceptibility”, “infection, dissemination”,
or “transmission rates” were selected (see Supplementary Table S4 showing the viruses and the
bibliographic references). Data from each article were used to calculate the infection rates as the
number of mosquitoes showing virus infection in the gut divided by the number of mosquitoes fed
with infected blood x 100. Dissemination efficiency was calculated as the number of mosquitoes
with viruses disseminated in the legs, wings, or head divided by the number of mosquitoes fed with
39
Pathogens 2020, 9, 266
infected blood x 100. Transmission rates were calculated as the number of mosquitoes that could
deliver the virus with saliva (detection of virus in mosquito saliva, or demonstration of transmission
using animal hosts exposed to infected mosquito bites) divided by the number of mosquitoes with
viruses disseminated in the legs, wings, or head (body) × 100. Transmission efficiency was calculated
as the number of mosquitoes that could deliver the virus with saliva (detection of living viruses or viral
genome in mosquito saliva, or demonstration of transmission using animal hosts exposed to infected
mosquito bites) divided by the number of mosquitoes fed with infected blood [168]. In the present
work, infection performed from intrathoracic assays corresponds to mosquitoes that after intrathoracic
injection, were detected with the virus after a 7–10 day incubation period. For this detection, the ground
mosquito suspension was inoculated in rats, or the presence of the virus quantified by assays in Vero
cell cultures. After intrathoracic injection, infected mosquitoes may transmit the virus to another
animal. Some articles only described transovarial transmission tested after intrathoracic infection.
These works demonstrated Ae. albopictus susceptibility to develop infection by a given arbovirus.
However, these articles did not quantify the infection and transmission rates.
To compare the results, the same bibliographic search was performed to find the vector competence
values reported for efficient bridge vector–virus pairs, such as Culex pipiens * WNV and Haemagogus
leucocelenus * YFV, and for epidemic vector–virus pairs, such as Aedes aegypti * YFV, Aedes albopictus
*DENV_1, Aedes albopictus *DENV_2, Aedes aegypti *DENV_1, Aedes aegypti *DENV_2, Aedes albopictus
*CHIKV, Aedes aegypti * CHIKV, Aedes albopictus *ZIKV virus, and Aedes aegypti * ZIKV (Supplementary
Table S7). The bibliographic search was done between August 2018 and November 2019.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/4/266/s1,
Table S1. List of the 16 articles found by searching Google Scholar to characterize the types of natural breeding
sites exploited by Ae. albopictus, Table S2. Typology and number of reported natural containers exploited by
Ae. albopictus from articles found in PubMed, Table S3: List of references used to analyse the host feeding
preferences of Aedes albopictus, Table S4: List of references that reported infection, infections rate, dissemination
rate, dissemination efficiency, transmissions rate or transmission efficiency in Ae. albopictus for the indicated
arboviruses, Table S5: List of references used to analyse the vector competence of several mosquito-virus pairs:
Aedes aegypti*CHIKV, Aedes aegypti*DENV-1, Aedes aegypti*DENV-2, Aedes aegypti*ZIKV, Aedes albopictus*CHIKV,
Aedes albopictus*DENV-1, Aedes albopictus*DENV_2, Aedes albopictus*ZIKV, Culex pipiens*WNV, and Haemagogus
leucocelenus*YFV, Table S6: Natural detection or isolation of arboviruses in Ae. albopictus from field-collected
mosquitoes. CCV, Cache Valley virus; EEEV, Eastern Equine Encephalomyelitis virus; KEYV, Keystone virus;
LACV, La Crosse virus; POTV, Potosi virus; TENV, Tensaw virus; WNV, West Nile virus, Table S7: Geographic
distribution, vertebrate hosts and potential vectors of arboviruses isolated or tested for vector competence in Ae.
albopictus. Figure S1. Analysis of the host feeding patterns of Ae. albopictus for the different species of domestic
animals without taking into account the host availability.
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Abstract: Mayaro virus (MAYV), isolated for the first time in Trinidad and Tobago, has captured
the attention of public health authorities worldwide following recent outbreaks in the Americas.
It has a propensity to be exported outside its original geographical range, because of the vast
distribution of its vectors. Moreover, most of the world population is immunologically naïve with
respect to infection with MAYV which makes this virus a true threat. The recent invasion of several
countries by Aedes albopictus underscores the risk of potential urban transmission of MAYV in both
tropical and temperate regions. In humans, the clinical manifestations of MAYV disease range from
mild fever, rash, and joint pain to arthralgia. In the absence of a licensed vaccine and clinically
proven therapeutics against Mayaro fever, prevention focuses mainly on household mosquito control.
However, as demonstrated for other arboviruses, mosquito control is rather inefficient for outbreak
management and alternative approaches to contain the spread of MAYV are therefore necessary.
Despite its strong epidemic potential, little is currently known about MAYV. This review addresses
various aspects of MAYV, including its epidemiology, vector biology, mode of transmission, and clinical
complications, as well as the latest developments in MAYV diagnosis.
Keywords: Mayaro; emerging arbovirus; alphavirus; Togaviridae; Aedes; vector competence
1. Introduction
Following the major Zika virus (ZIKV) outbreaks in 2016, special attention has been given to
neglected arboviruses. Arboviral infections are likely to spread globally as a result of the expansion
of mosquitoes which, in turn, is caused by increased trade and climate change [1–3]. Mayaro virus
(MAYV) is a single-stranded RNA virus. It belongs to the Togaviridae family and was first detected
in 1954 in Trinidad in the sera of forest workers [4–6]. Like other alphaviruses, MAYV can infect,
replicate and disseminate in both vertebrate and invertebrate hosts [7–9]. In humans, the virus causes
Mayaro fever, which is characterized by long-lasting arthralgia similar to that occurring in Dengue
fever. Although mortality among infected people is low as yet, Mayaro fever may become a major
public health problem, particularly in rural areas, with increasing prevalence in the Amazon region due
to ecosystem changes [10]. Although several outbreaks of Mayaro fever have already been reported
more than three decades ago in Northern Brazil [11], MAYV is now spreading rapidly to other regions
in Latin America [12]. It is likely that the global burden of Mayaro fever is still largely underestimated
because of the lack of adequate and accurate diagnostics. At the same time, the Aedes mosquito,
which can spread MAYV and other viruses, is invading new habitats and regions at an alarming
pace [13]. Perhaps the most significant threat of a potential MAYV epidemic comes from increased
colonization of urbanized areas by Aedes aegypti. In order to better predict the capacity of the virus to
Pathogens 2020, 9, 738; doi:10.3390/pathogens9090738 www.mdpi.com/journal/pathogens51
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spread and infect new areas, further studies are urgently needed. At present, it cannot be excluded
that MAYV infections, like those of ZIKV and Chikungunya (CHIKV) viruses, will one day become a
major health issue. At present, MAYV is still neglected and few studies have been carried out on its
pathogenesis, the biology of its potential vectors or the dynamics of its transmission. We present here a
current and comprehensive review of published scientific research and technical reports on MAYV,
focusing on its vectors, in addition to the epidemiological and clinical aspects of Mayaro fever.
2. Distribution and Significance to Health
Mosquitoes are responsible for the transmission of a variety of deadly pathogens, including
MAYV, that affect the lives and livelihoods of millions of people across the world each year. The global
expansion of the two major urban vectors (Ae. aegypti and Ae. albopictus) and the increasing number
of international travelers is certain to increase the risk of MAYV transmission [14]. There has been
an underestimation of reported Mayaro fever cases reported since its first detection in 1954 which is
not only due to its shared symptoms with Dengue and Chikungunya fever, but also to the occurrence
of unreported asymptomatic cases [4,15,16]. Figure 1 illustrates the spatial distribution of the virus
that was isolated from vectors, non-human primates (NHP) or humans. The presence of MAYV has
been mainly reported in Latin America, with Brazil having the highest number of reported cases of
Mayaro fever [4,6,10,17–33] and MAYV infections that were reported in Haiti indicate that the virus is
also likely to circulate in the Caribbean [31,34]. A phylogenetic study carried out on whole-genome
sequences of viruses isolated from Haitian patients suggests that the virus has been introduced into
Haiti on three separate occasions [34]. Several imported cases of MAYV infections have also been
reported from 1997 onwards in tourists returning from endemic areas of South and Central America,
with several cases reported in Europe [14,35–39]. This scenario shows the importance of the potential
role of air travel in the global spread of MAYV [14,35–38]. Due to a lack of information and reporting
in Africa and Asia, it is as yet uncertain whether MAYV is present in these continents.
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Figure 1. Global distribution of Mayaro virus (MAYV). The virus was detected in vectors, non-human
primates and humans. The first imported cases were reported in the United States in 1997 and in
Europe in 2008. The origin of imported cases is shown in parentheses. These reports do not exclude
the possible presence of MAYV in other countries, notably Africa and Asia. MAYV is not necessarily
present throughout the countries/territories shaded in this map. ArcGIS Desktop V 10.5 software was
used to generate this map (ESRI 2019, Redlands, CA, USA: Environmental Systems Research Institute;
https://desktop.arcgis.com/en/).
3. Clinical Manifestations and Pathogenesis of Mayaro Fever in Humans
Phylogenetically, MAYV is closely related to CHIKV and, like the latter, causes a debilitating flu-like
illness in the infected host that is indistinguishable from Chikungunya fever. The main symptoms
include chills, fever, gastrointestinal manifestations, eye pain, myalgia and arthralgia [18,29] (Figure 2).
In particular, arthralgia can last for months to years, making the Mayaro fever even more debilitating
than flavivirus infections, whose symptoms last only one to three weeks [4,11,15,40,41]. Acute symptoms
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generally last three to five days in most patients with Mayaro disease [15,25]. Arthralgia and myalgia
account for 50–89% and 75% of infected patients, respectively [42]. Dizziness and itching are the other
clinical manifestations of the disease [20,38]. Severe complications can occur due to MAYV infection,
among which are myocarditis, hemorrhagic and neurological manifestations [17]. After a bite from an
infected vector, MAYV spreads via the blood vessels into the body of the susceptible host (Figure 3).
The virus replicates in white blood cells (e.g., monocytes, macrophages) and spreads to bones, muscles
and joints via the main sites of replication, the spleen and the liver [15,43–48]. The severity of Mayaro
fever is associated with the production of pro-inflammatory cytokines and mediators (MCP-1, IL-2,
IL-9, IL-13, IL-7, VEGF, IL-17, and IP-10) both in humans and experimental mouse models [49–51].
Some of these cytokines have been shown to be associated with other pathologies involving bones
and joints [47,52,53]. Mayaro fever can also induce oxidative stress (OS) in the liver of infected mice
and in vitro infected HepG2 cells [54,55]. The induction of OS has also been observed in several other
arbovirus infections, including Chikungunya [56–58]. The latter process is likely to play a role in the
pathogenesis of MAYV, because of its important role in the initiation and control of the production
of many soluble mediators such as reactive oxygen species (ROS), and is furthermore involved in
apoptosis and inflammation [59]. Currently, little is known about the beneficial or detrimental effects of
this process on the infected host. Many cell types have been shown to be implicated in the pathogenesis
of MAYV. The role of macrophages, being targets for MAYV infection, in the development of arthritis
has been demonstrated through the secretion of TNF-α and ROS [60]. In this respect, it is of interest
to note that high serum levels of TNF-α have previously been reported in MAYV-infected patients
and mice [50,61]. A recent study has also shown that in vitro infection of bone marrow-derived
macrophages with MAYV results in the overexpression of key inflammasome proteins such as NLRP3,
AIM2, ASC and caspase 1 [61]. Interestingly, the authors demonstrated that the induction of ROS was
linked to the activation of the NLRP3 pathway. Because many studies have shown that ROS production
can be associated with immune regulation [62], it would be of interest to investigate whether ROS
secretion impacts the polarization of macrophages during MAYV infection. Results from studies using
experimental mouse models and human cell lines have revealed that osteoblasts are susceptible to
infection with alphaviruses, resulting in the secretion of MCP-1, IL-6, and IL-1β [43,63,64]. We have
previously shown that primary human chondrocytes, osteoblasts and synoviocytes, which are the main
cell types involved in arthralgia, are permissive to MAYV infection, indicating that these cells may be
involved in the pathogenesis of the disease, notably as a result of the overexpression of arthritis-related
genes [65]. Infection of the host by MAYV results in the sensitization of monocytes and the induction
of their osteoclastogenic activity which leads, in turn, to bone erosion and cartilage damage. Taking
into consideration the debilitating condition of MAYV-infected patients, which can last for months to
years, further studies should be carried out to determine the mechanisms leading to severe arthritis
as a result of MAYV infection. This also begs the question as to why some patients develop arthritis
and others do not. It would also be interesting to develop studies leading to the identification of
biomarkers or risk factors associated with severe forms of the disease. There is considerable variation
in antibody production and persistence from one host to another. MAYV infection induces a transient
production of immunoglobulin M (IgM) antibodies, indicating the occurrence of recent infection that
generally lasts for at least three months after the onset of clinical symptoms [29,66,67] (Figure 2).
In addition, the presence of virus-specific immunoglobulin G (IgG) serum antibodies that persists
throughout the lifespan of an infected person is an indicator of prior infection with MAYV, in particular
when present at increased levels [29,66,67]. Interestingly, a study by Santiago et al. shows that
neutralizing antibodies alone are not sufficient to prevent the occurrence of chronic arthritis [50].
Earnest and collaborators generated a series of neutralizing broad-spectrum mouse antibodies by the
use of recombinant MAYV E2 protein [68] and showed their therapeutic utility against MAYV, thereby
underscoring the importance that should be given to IgG subclasses and their effector functions.
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Figure 2. Pathogenesis of Mayaro fever. Time course of MAYV viremia and detection of immunoglobulin
M/G (IgM/IgG) after the inoculation of MAYV into a susceptible host by an infected mosquito. Duration
of clinical manifestations that may appear in an infected individual. The figure was designed using
Adobe Creative Cloud apps (https://www.adobe.com/creativecloud.html).
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Figure 3. Diagram showing the probable dissemination of MAYV in humans, based on animal
experiments and clinical data for similar alphaviruses. Transmission of MAYV occurs following its
inoculation by an infected mosquito (Haemagogus janthinomys, Aedes aegypti, etc.). The virus then
replicates in the skin (more precisely at the inoculation site of the virus by the competent vector) and
propagates into the target tissues (muscle, the liver, joints, etc.) via the numerous blood vessels, followed
by the recruitment of inflammatory cells in these tissues. Most of the target cells have not yet been
identified for MAYV but the diagram shows an extrapolation based on other alphaviruses. The figure
was designed using Adobe Creative Cloud apps (https://www.adobe.com/creativecloud.html).
4. Diagnosis
The symptoms caused by MAYV infection are often difficult to be recognized because of the
limited diagnostic laboratory facilities in many of the endemic regions. In addition to the variety
of symptoms, which are not very specific, diagnosis of MAYV infection is rendered difficult by the
existence of coinfections and the lack of rapid tests [25,69]. In MAYV surveillance, the discriminating
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diagnosis must also consider possible concomitant CHIKV, DENV, and ZIKV infections due to the
co-circulation these viruses [20,31,33]. Neutralization and reverse-transcription polymerase chain
reaction (PCR) tests are now available in almost all laboratories and can help in the confirmation of
MAYV infection [31,38]. In a cross-sectional study in Ecuador, the prevalence of MAYV was estimated
by evaluating the presence of IgM and IgG antibodies by ELISA [70]. It is of note that when samples
are collected after the acute phase of clinical signs (which then no longer represents the viremia
phase, lasting two to three days for MAYV), testing based on isolation is impractical. Nevertheless,
this technique, which is generally performed in vivo in mice or in vitro by inoculation into cell cultures
of arthropods (C6/36, Aag2, etc.) or vertebrates (Vero, BHK-21, etc.), remains the most accurate method
for virus detection [20]. It is generally performed in vivo in mice or in vitro by inoculation into the cell
cultures of arthropods (C6/36, Aag2, etc.) or vertebrates (Vero, BHK-21, etc.). In some circumstances,
the isolation method is not the most appropriate due to several factors, including the costs involved
and the need for additional tests, which increase the time required to deliver results. Complement
fixation and neutralization tests are among the serological methods that can also be used in certain
contexts for the diagnosis of MAYV. The detection of circulating IgM antibodies has the advantage of
being specific and also constitutes the fastest technique. Indeed, the production of IgM usually occurs
about five days after infection with MAYV [11,67]. For MAYV diagnosis, possible cross-reactions must
be taken into account, in particular those between MAYV-, CHIKV- and O’nyong-nyong virus-specific
antibodies [71–74]. In recent years, modern, more sensitive and faster methods using molecular
biology techniques (i.e., PCR) have been widely used for the diagnosis of several pathogens of medical
interest [75]. Accurate diagnosis of MAYV in human communities can also be rendered difficult due to
the high prevalence of asymptomatic cases [25,31].
5. Genomic Structure and Viral Life Cycle
The genome of MAYV, the causative agent of Mayaro fever, is a single-stranded RNA virus with
positive polarity and a length of approximately 11.5 kilobases (kb). Its genomic structure forms two
open reading frames, one coding for structural proteins and the other coding for non-structural proteins
(Figure 4). The latter are expressed as a polyprotein that is cleaved both during and after translation
into four non-structural proteins (nsP1, nsP2, nsP3, and nsP4), whereas the structural genes generate
the six structural proteins (C, E1, E2, E3, 6K, and transframe) [71]. The viral particles are icosahedral,
comprising a closed nucleocapsid in a compact envelope consisting of the host cell membrane sealed
with E1-E2 complex [8,9,76]. The life cycle of MAYV starts with the fusion of the viral envelope with
the plasma membrane of the target cells via specific receptors on their surface such as MXRA8, which
has recently been revealed to be a receptor for several arthritogenic alphaviruses [7,77]. This fusion
process, however, merits further study to determine the precise mechanisms involved. Next, the virus
enters inside the cell by endocytosis and is subsequently found within the endosomal compartment.
Once in the cytoplasm, the pH of the endosome decreases and the virus disassembles its basic structure
and releases the genomic RNA which is translated into non-structural proteins that generate messenger
RNA and various structural proteins. The latter are then transformed into a nucleocapsid and its
glycoproteins, which, after combination with the plasma membrane, leads to the release of new viral
particles outside the cell. The released particles then infect other cells and the cycle repeats itself [71].
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Figure 4. The replicative cycle and genomic structure of MAYV. E: envelope; nsP: nonstructural
protein; UTR: untranslated region; nt: nucleotides. A: nsP1 is required in the formation of the viral
RNA and the RNA capping processing; B: nsP2 presents several enzymes required in transcription;
C: nsP3 is one element of the replication complex; D: nsP4 is known as the viral RNA polymerase.
1: endocytosis through a clathrin-coated pit or, alternatively, through a caveolin-coated pit; 2: start
of virus internalization with receptors of the host cell; 3: the low pH obtained in the endosome
leads to structural modifications in the envelope of the virus that reveal the E1. The latter mediates
cell membrane-virus fusion; 4: endosomal cell membrane-virus fusion; 5: release of the capsid core
and genome of the virus; 6: from the mRNA of the virus, a pair of nsP precursors are generated;
7: the replication complex is obtained from the gathering of nsP proteins. This complex thus allows the
synthesis of a minus-strand RNA; 8: this RNA is used as the model to generate both genomic (49S)
and subgenomic (26S) RNAs; 9a: processing of the polyprotein precursor by an autoproteolytic serine
protease; 9b: genomic RNA involved in nucleocapsid core assembly and genomic RNA packaging;
10: processing and maturation of glycoproteins pE2 and E1; 11: in the Golgi, processed glycoproteins
are associated. Then they are transported into the cell membrane; 12a: at the cell membrane, the pE2
is split into E2 and E3; 12b: association of the viral RNA with the capsid C and the recruitment of
E1 allows viral assembly; 13: particles of MAYV associated with the core are released outside of
the host cell through the membrane. The figure was designed using Adobe Creative Cloud apps
(https://www.adobe.com/creativecloud.html).
6. Phylogeny
The complete nucleotide sequence of MAYV was determined in 2005 [78]. MAYV is part of
the Semliki Forest Complex due to its antigenic composition and is phylogenetically close to other
alphaviruses such as CHIKV, Sindbis, and Ross river viruses that induce an identical clinical illness in
infected patients [4,15]. Its antigenic resemblance to CHIKV has been well described [72]. Nucleotide
sequence homologies and recent phylogenetic analysis carried out on MAYV strains isolated from the
Americas indicate the existence of three major phylogroups: disseminated (D), limited (L), and new
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(N) [79,80]. D is the more widely disseminated group and contains strains identified in several
countries in the Americas (Trinidad and Tobago, Peru, French Guiana, Venezuela, and Bolivia), while
the phylogroup limited (L) is found only in a few countries (Haiti and Brazil) [31]. A minor genotype,
new (N), which is limited to only one known sequence, was isolated in 2010 in Peru [81].
7. Transmission Cycle
In MAYV-endemic regions in Latin America, a viral transmission cycle in the sylvatic environment
is observed. This cycle mainly involves the mosquito Haemagogus janthinomys and non-human primates
(NHP), considered to be the primary hosts of the virus [82–84] (Figure 5). To a lesser extent, this
cycle may involve not only other vertebrates or secondary hosts (rodents, reptiles, etc.), whose role
is not clearly identified, but also other types of mosquitoes such as Mansonia, Culex, Sabethes, Aedes,
and Psorophora which may play an accessory or occasional role in this transmission cycle [10,26,85–87].
Due to both the zoophagous nature of Haemagogus spp. and their limited biotope in rural areas close
to forests, humans are only sporadically infected [88]. At present, no animal reservoir of MAYV has
been formally documented in Africa, Asia, and Europe. In urban areas, domestic mosquitoes are
potential vectors of MAYV that could transmit the virus to humans under appropriate conditions.
The introduction of MAYV into urban habitats and their establishment a domestic cycle is increasingly
likely. If this process becomes a reality, this situation could be a real burden, not only for endemic
regions but also on a global scale, especially when possible mutations of the virus will favor more
efficient dissemination by domestic vectors [25]. In addition to this classical mode of transmission,
there is also vertical transmission (passage of the virus from an infected female to her offspring),
a mechanism by which the vector contains the virus for long periods of time, thereby constituting a
true reservoir. Vertical transmission was revealed by the isolation of MAYV from two pools of adult Ae.
aegypti which were collected from the egg stage in Brazil in 2017 [89]. Further studies are needed to
identify the importance of vertical transmission during epidemics and the molecular mechanism that
underlies viral maintenance in the vectors during unfavorable periods [90]. It is, however, clear that the
effectiveness of this mechanism depends on climate change, geographical location, arbovirus genotype,
and vector population dynamics [91]. Although this mechanism has been extensively reported for
DENV, CHIKV, ZIKV, and Yellow fever virus infections [92–95], very few studies have addressed its
role in MAYV and other arboviruses [89]. Airborne transmission of MAYV has also been reported
among laboratory personnel [96].
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Figure 5. MAYV transmission cycles in endemic South and Central Americas. The list of arthropod
and vertebrate species or groups mentioned in this figure may not be exhaustive due to the lack
of data for certain regions. The figure was designed using Adobe Creative Cloud apps (https:
//www.adobe.com/creativecloud.html).
8. MAYV Vectors: Field and Laboratory Observations
To incriminate a mosquito species as a vector of MAYV, two conditions must be met, preferably
in this order: 1) first, the virus must be detected in natura from specimens of the species and 2)
experiences in controlled conditions must provide evidence of its capacity to transmit the virus. Several
entomological surveillances across the world have provided the suspicious involvement of many
species but have not given enough formal evidence for the incrimination of a particular species. Indeed,
any pathogen is likely to be detected in blood ingested by an arthropod [97]. On the other hand,
although transmission experiments are able to clarify potential implications, the number of species to
be tested for vector competence is limited by certain technical restrictions and this approach is not
always relevant due to the lack of contact between the arthropod and humans in natura [98]. Therefore,
the synthesis of all observations obtained from these studies will enable us to define the true MAYV
vectors implicated in the viral transmission cycles (Figure 5).
8.1. Evidence from the Field
MAYV isolates have been obtained from diverse mosquito genera (Haemagogus, Culex, Mansonia,
Sabethes, Psorophora, Aedes) (see Table 1). Haemagogus spp., especially Hg. janthinomys, appears to be the
primary vector [84]. In 1957, a strain of MAYV was isolated from a pool (49 specimens) of the mosquito
Mansonia venezuelensis, collected in northeastern Trinidad. This isolation was the first one recorded
from arthropods collected in natura [99]. Subsequently, isolates were frequently obtained from Hg.
janthinomys and less regularly from other mosquito species [83,100,101]. In addition, many MAYV
isolates were reported in 1978 in Brazil from Hg. janthinomys [84]. Cx. quinquefasciatus mosquitoes
found naturally infected with MAYV were also reported in Brazil [28]; nevertheless, their ability to
transmit the virus is still unproven [102].
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Table 1. Mosquito species in which MAYV was detected in natura.
Country of Origin Species References
Brazil Aedes aegypti [28,89]
Panama Sabethes spp. [21]
Brazil Haemagogus janthinomys [20,83,84]
Colombia Aedes serratus [101]
Brazil Cx. quinquefasciatus [28]
Panama Cx. vomerifer [26]
Trinidad and Tobago Mansonia venezuelensis [99]
Colombia Psorophora ferox [101]
Colombia Psorophora albipes [101]
8.2. Vector Competence Studies
There are a few studies on vector competence for MAYV [26,98,103,104] and those carried out
concern Ae. aegypti populations from Iquitos, Florida and French Polynesia, and Ae. albopictus
from Brazil, Florida and Reunion [98,103–106]. These studies have shown that Ae. albopictus and
Ae. aegypti are capable of transmitting MAYV. In addition, several other geographically divergent
Anopheles species can transmit MAYV (Table 2) [98,103,104]. The latter observation suggests the
possible involvement of some species of this genus in the amplification of MAYV in naïve areas.
Table 2. Vector species found experimentally competent.
Country of Origin Species References
Iquitos, Peru Ae. aegypti [98,102,106]
Bora-Bora, French Polynesia Ae. aegypti [105]
Florida, USA Ae. aegypti [103]
Brazil Ae. albopictus [104]
La Reunion Ae. albopictus [105]
Florida, USA Ae. albopictus [103]
Trinidad and Tobago Ae. scapularis [86]
Virginia, USA An. freeborni [102]
Maryland, USA An. gambiae [102]
Virginia, USA An. quadrimaculatus [102]
Maryland, USA An. stephensi [102]
9. Major Urban MAYV Vectors: Extension and Risk to Developed and Developing Countries
9.1. Aedes aegypti
The mosquito Ae. aegypti is a highly anthropophilic and extremely opportunistic species, with a
nearly worldwide distribution. This is a domestic vector involved in arbovirus transmission at a global
scale [1,107]. This vector has not yet been reported in European countries, except for some regions
(Figure 6), although global warming could lead to their colonization in the near future. The delay of this
phenomena will be determined particularly by global climate policies such as the Paris Agreement [108].
A few studies are have also dealt with climatic factors and mechanisms involved in the invasion and
proliferation of this species [107,109–111].
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Figure 6. Worldwide distribution of Ae. albopictus and Ae. aegypti. The “tiger mosquito”, Ae. albopictus,
has currently conquered several temperate regions including France, Italy, and Spain as shown on this
map. The species is indeed a competent vector for several alphaviruses and flaviviruses which raises
concerns when considering the occurrence of imported cases reported in the USA and Europe. On the
other hand, Ae. aegypti is present in almost all tropical regions across the globe. On many occasions,
the World Health Organization and the Rockefeller foundation have tried unsuccessfully to eradicate it.
These two main urban vectors are not necessarily present throughout the countries/territories shaded
in this map. ArcGIS Desktop V 10.5 software was used to generate this map (ESRI 2019, Redlands, CA,
USA: Environmental Systems Research Institute; https://desktop.arcgis.com/en/).
9.2. Aedes albopictus
Ae. albopictus, commonly known as the “tiger mosquito”, is native to Southeast Asia. In recent
years, the species has established itself in several regions across the world (Figure 6). In this process
of invasion, scientists incriminate the transport of used tires which can harbor desiccation-resistant
eggs. Following recent evidence from laboratory experiments on the ability of this species to transmit
the virus, health officials expressed their concern and warned about the potential threat of a MAYV
epidemic in areas already colonized by this species, as well as those threatened by its introduction.
10. Other Potential Vertebrate Hosts for MAYV
The presence of MAYV and/or anti-MAYV antibodies has been detected in vertebrate hosts in
diverse localities in South America. In French Guiana, MAYV has been isolated from a wide variety of
mammals, although their relevance in MAYV transmission is as yet unknown [112]. The virus has also
been isolated from various other wild animals, including birds [113]. Anti-MAYV antibodies have
been detected in marmosets (Callithrix argentata) as well.
11. MAYV Transmission in Nonhuman Primates
The rainforests in the Amazon region harbor diverse NHP species [114]. This diversity underlines
the importance of identifying the level of involvement of each species in the bio-ecology of MAYV in
order to acquire the necessary tools to better prepare or to avoid a worst-case scenario that could be
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generated by a possible amplification in human populations, starting from an enzootic cycle. As we
are aware of these issues, it is important and urgent to carry out studies on the nature of NHPs present
in this MAYV-endemic region. This lack of knowledge can be overcome by encouraging scientists who
take an interest in this field and by setting up adequate infrastructure.
12. Emergence Mechanisms of Urban MAYV Transmission
Generally, the use of inappropriate vector control, coupled with the high density and the large
distribution of urban Aedes spp., including Ae. albopictus and Ae. aegypti, is crucial in MAYV
spreading [13]. Specifically, in low-income settings, it is mainly deforestation, unplanned policies
concerning urbanization and infrastructure, as well as a lack of resources that benefit mosquito
development and their contact with humans. Human movement may also increase the spread of
MAYV, as shown for other similar vector-borne viruses [115–118]. Nevertheless, the incidence of
disparities in transmission should be determined for vulnerable or minority communities most in
need by improving access to high-quality telemedicine, increasing the use of mobile care and testing,
in addition to reforming public health data practices, not only for MAYV, but also for other arboviruses
as well.
13. Entomological Surveillance
At present, no surveillance system has been put in place for Mayaro fever and the first detections
were obtained incidentally during investigations of febrile illnesses. During the epidemics of 1995 in
Peru and 2008 in Brazil, results from surveillance efforts were based exclusively on reports provided
by sentinel structures based on different techniques in use by the virology community. The occurrence
of imported cases stresses the importance of global MAYV entomological surveillance. Such detection
programs could provide an opportunity to bring together forces around the “one health” concept with
an emphasis on vectors. The ambition, above all, would be to act more widely, more efficiently and
more quickly on these issues in both the short and long term. Generally, entomological surveillance
in a MAYV epidemic situation involves making an inventory of the mosquito species present at that
time in the affected locality from the larval and adult stages, determining their abundance and, where
appropriate, their distribution and potential involvement [15]. The latter can be provided by the
results of attempts to isolate the virus from specimens collected in the field, including forests and
human habitations. Until now, no efficient entomological surveillance of MAYV has been established.
At present, the “human-landing catch” method is the preferred method for collecting those vectors
likely to come into contact with humans, but unfortunately it is not appropriate in epidemic situations
and is more expensive compared to other methods [119,120]. However, alternative methods (although
they are less effective, but safer for the operator), through the use of different types of traps, can
be used as well. In addition, surveillance of animal fauna (both wild and domestic) could provide
additional details and thus allow us to refine the decision-making process to control MAYV. Taken
together, the overall interpretation of the results from these surveys will provide a reliable estimation
of the MAYV risk in the affected area.
14. Prevention and Control
In concrete terms, the prevention of Mayaro is contingent on the suppression of mosquito bites
and, consequently, of human–vector contact. In the case of Haemagogus and Aedes vectors, whose peak
activity coincides at the beginning or the end of the day, the use of insecticide-treated nets does not
fully protect against these vectors. Because of the lack of a specific vaccine, the only effective way
of managing the spread of the disease in endemic areas is vector control. This strategy, feasible in
both domestic and peridomestic settings, focuses primarily on the suppression of mosquito breeding
sites through the use of predators, larvicides, etc., which can be reinforced by global and multisectoral
coordination across the fields of healthcare, community engagement and social communication [121].
The latter can be carried out among the local population and can take the form of awareness-raising
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actions about MAYV disease and individual protection measures against mosquito bites using different
broadcasting channels and available media (TV, radio, social networks, etc.). Other vector control
methods focusing on the elimination of adult stages by spraying with insecticides, particularly in
epidemic situations, can also be implemented [84]. Unfortunately, the range of available molecules
and formulations is limited, hence the importance of focusing on resistance levels in MAYV vector
populations and understanding the underlying mechanisms. In the past, measures that were considered
effective, based on the management of household water storage, were implemented in Brazil during
the 1981 epidemic. Being among the less studied mosquito-borne diseases, MAYV is still neglected
by health authorities and the general public across the world, specifically in non-endemic regions.
Communities need to be aware of Mayaro fever epidemics, the damage the virus can cause to their
health, and preventive measures, including cleaning their homes and cleaning water containers and
the environment around their households. All necessary actions including social and behavior change
should be taken in order to inspire community members to engage more strongly to prevent MAYV for
a safer future. Surveillance, diagnosis of MAYV and vector control are the three main pillars in terms
of prevention of the disease. In terms of vaccine research, efforts are being made and two promising
vaccines are currently being developed and will hopefully soon be tested in clinical trials [122]. In order
to respond to this crucial issue, the activities carried out in this field must be the culmination of
a collective approach. At present, many questions about MAYV remain unresolved and require
additional efforts by all multidisciplinary actors (virologists, entomologists, sociologists, statisticians,
etc.) in order to find appropriate or alternative solutions.
15. Factors Associated with MAYV Emergence and Invasion
Nowadays, most outbreaks of MAYV are restricted to rural settings close to tropical forests,
but a possible future urbanization of MAYV is to be expected, as suggested by the following
observations [40,123]: (1) urbanization as a possible result of the virus being carried by travelers
or infected birds [14,124]; (2) the strong homology between MAYV with CHIKV, an alphavirus that
circulates in urban areas; (3) the frequent observation of MAYV cases near tropical cities in which
Ae. aegypti, the principal urban vector, is endemic [15]; (4) results from laboratory studies showing that
both Ae. albopictus [103–105] and Ae. aegypti [98,103,105] are able to transmit MAYV (Table 2). Features
related to the emergence of MAYV include (1) anthropic disturbances in the ecosystem, notably caused
by farming and agrobusiness activities, urbanization, a demographic boom, poor sanitary conditions,
deforestation and human migration (Figure 7) [3,125–127], (2) the genetic mutation of the virus and its
adaptation to other arthropod vectors [128], (3) the ability of these vectors to tolerate a lethal dose of
major insecticides, as well as increased pathogen resistance to drugs [129] and, finally, (4) changing
weather conditions that favor the invasion of mosquito vectors into new areas in which humans
have not encountered the virus and have not yet acquired a protective immune response [2,130,131].
Ultimately, is it fair to state that changing climatic conditions are mainly responsible for the increased
incidence and risk of viral spread to humans. These act in favor of the vectors that subsequently occupy
hitherto unscathed areas and consequently allow the virus to emerge in these areas, as illustrated by
the MAYV epidemic in Haiti in 2015. The positive correlation between the occurrence of epidemics
and the peak density of vector populations during the wet season in tropical regions are further proof
of the impact of climate on the transmission of MAYV [2,5,31,113].
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Figure 7. Schematic diagram showing the ecological factors that affect MAYV transmission. The dashed
line and double arrows illustrate possible interactions between factors. * Population-level susceptibility.
The figure was designed using Adobe Creative Cloud apps (https://www.adobe.com/creativecloud.
html).
16. Future Trends
Like CHIKV and ZIKV, MAYV could grow significantly and become one of the most widespread
arboviruses on the planet. This scenario could be triggered by an evolution of the virus, changes
in the host–vector relationship, etc. To anticipate possible adverse trends in Mayaro fever, there is
a need to implement improved strategies and strengthen existing diagnostic platforms. The lack
of optimal sampling methods for mosquitoes remains one of the major gaps in MAYV surveillance.
The “human-landing collection” method remains the only effective method for the correct estimation
of human–vector relationships, but its use is being questioned and debated because of ethical
considerations [119,120]. For the coming years, it will therefore be urgent to think about implementation
of alternative methods that can provide more perfect sampling data. Given the complexity of
vector-borne diseases, experiments on vector competence for MAYV should include, in addition to
species of the genera Aedes and Haemagogus, both An. gambiae and Cx. quinquefasciatus, which are
species of great importance and whose presence is strongly dependent on human habitation. Studies
on the efficacy of antiviral drugs and vaccines are generally supported by animal models, but not all
models are suitable for a particular scientific question. In the case of MAYV, it is necessary to define
which animal model (NHP, mouse, hamster, etc.) is suitable for vaccine research. For this purpose,
we can learn from past years of alphavirus research and refer to available and relevant studies. Brazil,
French Guyana, Peru, Colombia and Panama are among the regions in the world most affected by
Mayaro disease. To help fight MAYV, it is necessary to combine simple community-based experiments
with scientific innovation. Mobile phones have become important for disease mapping and surveillance
through the use of short messaging services in affected areas. Adapting user-friendly innovations
to the living conditions of people in remote locations can change the dynamics of disease control.
The development of innovative scientific products from research and development takes time, but easy
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access to those innovations is needed to combat vector-borne diseases. Public–private partnerships,
as well as university and national programs should be promoted to develop innovative tools for
prevention. Technology is and will continue to be undoubtedly changing the way we monitor health
information systems and discover new innovative diagnostic or control strategies against arboviruses.
From sample collection, to diagnostics, to data sharing, technology has firmly taken its place in our
day-to-day research activities.
17. Conclusions
Variabilities in susceptibility and ability to disseminate and transmit MAYV have been reported
depending on the extrinsic incubation conditions, the virus strains used and the mosquito species
tested. These variations in the expression of oral receptivity have been repeatedly described in
natural populations of vector mosquitoes. Several factors, both intrinsic and extrinsic to the vectors,
may explain these variations. Among these, possible interactions between the virus and the microbiota
of the mosquito’s midgut seem to be particularly important, knowing that this symbiosis could provide
important physiological functions to the host, including the synthesis of essential nutrients, resistance
to infection and stimulation of the immune system. In many studies on the involvement of the immune
system, bacteria have been used, but it was only very recently that their role in the immune response
against virus infections was discovered. Differences in the expression of genes involved in the immune
response are probably due to changes in the specific composition of the bacterial flora present in
the midgut of the host mosquito and are important factors influencing the variation in transmission.
To date, no data on potential vectors are available on this aspect. Therefore, for further analysis,
studies should be carried out on the diversity and relative proportions of the different taxa of this
midgut microbiota. Given that virus–host interactions are often accompanied by variations in viral
proteins, resulting in the emergence of disease, it would be interesting to investigate the contribution of
recombination phenomena to the natural evolution of MAYV strains and the epidemiological risk that
recombinant strains may present. From a technical point of view, the identification and subsequent
inactivation, by homologous recombination, of genes involved in the replication or adsorption of viral
particles, for example, could significantly reduce transmission. It would also be helpful to improve our
knowledge of the mechanisms underlying MAYV replication in mosquitos. In this respect, further
studies providing valuable information on the basic ecology and spatiotemporal dynamics of vector
abundance and their association with MAYV should be carried out. Transmission probability models
could be used to estimate the natural periodicity of virus incidence cycles in each potential host.
These predictive models will certainly make it possible to improve monitoring methods, thereby
providing predictive capacity for the identification and early warning of emergence risks, as well as
their control, by appropriate and accepted preventive methods. From the same perspective, two axes
should be explored: (i) understanding how human contact with MAYV via vectors may increase
with intensive use of forest resources; (ii) understanding how wildlife populations and communities,
acting as reservoirs and potential vectors, respond to changes in the environment. These modifications
will have an impact on wildlife populations, leading to the displacement of native forest species and
the introduction of new ones capable of colonizing disturbed areas, resulting in the emergence of
arboviruses, including MAYV, which were previously confined to the biotopes of natural reservoirs,
thereby increasing the risk of contact with new mammalian and human hosts.
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Abstract: While the Zika virus (ZIKV) 2014–2017 pandemic has subsided, there remains active
transmission. Apart from horizontal transmission to humans, the main vector Aedes aegypti can
transmit the virus vertically from mother to offspring. Large variation in vertical transmission (VT)
efficiency between studies indicates the influence of parameters, which remain to be characterized. To
determine the roles of extrinsic incubation time and gonotrophic cycle, we deployed an experimental
design that quantifies ZIKV in individual progeny and larvae. We observed an early infection of
ovaries that exponentially progressed. We quantified VT rate, filial infection rate, and viral load per
infected larvae at 10 days post oral infection (d.p.i.) on the second gonotrophic cycle and at 17 d.p.i.
on the second and third gonotrophic cycle. As compared to previous reports that studied pooled
samples, we detected a relatively high VT efficiency from 1.79% at 10 d.p.i. and second gonotrophic
cycle to 66% at 17 d.p.i. and second gonotrophic cycle. At 17 d.p.i., viral load largely varied and
averaged around 800 genomic RNA (gRNA) copies. Longer incubation time and fewer gonotrophic
cycles promoted VT. These results shed light on the mechanism of VT, how environmental conditions
favor VT, and whether VT can maintain ZIKV circulation.
Keywords: Zika virus; Aedes aegypti; vertical transmission
1. Introduction
Zika virus (ZIKV) is a mosquito-transmitted Flavivirus that recently emerged as a pandemic
virus [1]. From 2014–2017, ZIKV infected more than 1.5 million people mostly in Polynesia and Latin
and South America. Although Zika symptoms are mild (flu-like) to absent, it can have life-debilitating
and life-threatening consequences, such as microcephaly for prenatally infected newborns and
Guillain–Barre syndrome in adults [2]. The wide distribution of and health risks associated with the
infection prompted the World Health Organization (WHO) to declare a public health emergency of
international concern in 2016. However, after 2018, records of Zika cases sharply dropped in the
Americas and Polynesia [3] and the emergency status was lifted. The collapse of the epidemic was
likely caused by herd immunity, given that almost 60% of the population had immunity against ZIKV
in the Americas and Polynesia [4,5]. Nonetheless, Zika cases are still reported in Asia and suspected in
Africa [3], and autochthonous transmission in France occurred at the end of 2019 [6]. These reports
indicate that ZIKV circulation persists. A better understanding of ZIKV ongoing circulation will
help prevent future outbreaks. Identification of the mode of transmission to target will help curb
residual circulation.
While ZIKV is transmitted horizontally from mosquito to human, it is also vertically transmitted
from mother to offspring in mosquitoes as for many pathogenic flaviviruses [7,8]. Moreover, ZIKV
can be transmitted between humans during sexual intercourse and by maternal–fetal infection [9].
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Aedes aegypti is the most likely horizontal vector of ZIKV, although Aedes albopictus is also competent to a
lower extent [9–11]. Evidence of mosquito vertical transmission (VT) comes from laboratory studies that
evaluate the ability of the virus to be passed onto the next generation and from detection of the virus in
immature stages in the field. In controlled conditions, following oral infection, which is more relevant
than intrathoracic inoculation, ZIKV VT has repeatedly been shown for Ae. aegypti [12–14]. ZIKV
was also repeatedly detected in eggs and larvae collected in urban and forested environments [15–18].
However, a few other studies report an absence of VT in the laboratory or lack of detection in immature
stages in the field [19,20]. Altogether, there is enough evidence to support the existence of VT for
ZIKV in Ae. aegypti. However, VT efficiency varies with several parameters including mosquito
and virus genetics, temperature, gonotrophic cycle, and extrinsic incubation period [7]. Variation in
these parameters may explain the lack of VT experimental observation and absence of detected VT in
the field. To understand how ZIKV circulation persists and especially how horizontal and vertical
transmissions are balanced, it is important to determine the conditions that promote ZIKV VT.
In arthropods, two mechanisms can result in VT [21]. Infection of eggs when fertilized or
oviposited can occur in the oviduct and is called trans-ovum transmission. Alternatively, infection
of the female germinal tissues results in infected progeny and is called transovarial transmission.
Both mechanisms have been proposed for arbovirus VT in Ae. aegypti [22,23]. Following uptake of
an infectious blood meal, the viruses first infect the mosquito midgut and then disseminate to other
tissues including muscles, legs, wings, trachea, and salivary glands [24]. ZIKV salivary gland infection
can occur as early as three days post infection, leading to virus secretion in saliva and horizontal
transmission to another host [10]. The whole mosquito body can virtually be infected by arboviruses
at late incubation time. There is evidence of virus infection of ovaries and oviduct [25], supporting
both trans-ovum and transovarial mechanisms. Importantly, the impact of gonotrophic cycle (i.e., the
reproductive cycle between two consecutive egg laying events, encompassing search for a host, blood
feeding, oogenesis, and oviposition) and extrinsic incubation period (i.e., duration between infection
onset in mosquitoes and the transmission, vertically in this study) on VT should vary depending on
the mechanism. Trans-ovum transmission should be independent of the gonotrophic cycle as it is
related to a tissue that is not altered by the oogenesis cycle, whereas transovarial transmission should
be affected by oocyte development and release. The combined and separate impacts of gonotrophic
cycle and incubation period for ZIKV VT in Ae. aegypti remain to be fully characterized.
In this study, we aimed at improving our understanding of ZIKV circulation by determining
the impacts of gonotrophic cycle and extrinsic incubation period on VT in Ae. aegypti. To this end,
we developed an experimental design that singled out progeny and larvae, allowing us to precisely
determine: (i) oviposition rate, calculated as the proportion of blood-fed females that laid eggs; (ii) VT
rate, defined as the proportion of infected females that transmit the virus to their progeny (at least one
individual); (iii) filial infection rate, calculated as the proportion of infected larvae per progeny; and
(iv) viral load per infected larvae, as determined by copy number of ZIKV genomic RNA (gRNA) [26].
The results shed light on the VT mechanism and help understand the balance between horizontal or
vertical transmissions. By identifying the factors that influence ZIKV circulation in mosquitoes, our
study will provide information to understand ZIKV persistence and inform vector control strategies.
2. Results
2.1. Infection of Ovaries Increases with Extrinsic Incubation Time
Transovarial VT requires infection of mosquito female germinal tissues [21]. To quantify ovary
infection, we collected ovary pairs from female Ae. aegypti at 3, 7, 10, and 14 days post oral infection
(d.p.i.) with ZIKV and quantified gRNA copies by RT-qPCR. The different time points covered infection
initiation up to complete infection of the whole mosquito body [10]. To orally infect mosquitoes, we
used an infectious titer of 105 particles forming unit (pfu) /mL, which is epidemiologically relevant as
it corresponds to blood titers quantified in patients in Polynesia and the Americas [27,28]. We observed
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infection of ovaries as early as 3 d.p.i. with 80% of ovary pairs infected (Figure 1). Infection progressed
to 100% of ovary pairs at 7, 10, and 14 d.p.i. Similarly, copies of ZIKV gRNA per infected ovary pairs
gradually increased from an average of about 20,000 at 3 d.p.i. to an average of about 1.8 × 107 at
14 d.p.i. (Figure 1). ZIKV gRNA copies were significantly lower at 3 d.p.i. than at 7 and 10 d.p.i., while
gRNA level at 14 d.p.i. was significantly higher than at all earlier time points. The results support the
early infection of Ae. aegypti ovaries following oral infection and indicate that virus load increases with
extrinsic incubation period.
Figure 1. Kinetics of ovary infection. Zika virus (ZIKV) was quantified in single pairs of ovaries at 3, 7,
10, and 14 days post oral infection. Bars represent geometric means ± 95% CI. Each circle represents a
pair of ovaries from one individual mosquito. N = 20 pair of ovaries per condition. * p-value < 0.05 from
other conditions as calculated by Z-test. Different letters indicate significant difference (p-value < 0.05)
as calculated by Tukey’s test.
2.2. Experimental Design to Test the Impacts of Gonotrophic Cycle and Extrinsic Incubation Time on VT
We designed an experiment to test the separate and interacting impacts of gonotrophic cycle and
extrinsic incubation time on VT (Figure 2). Female mosquitoes were orally fed with 105 pfu/mL of ZIKV
as above, resulting in 100% infected mosquitoes (Figure 1). To minimize variation due to mosquito
batch, the same batch of ZIKV-infected mosquitoes was divided into two cages. For each cage, we
separated individual blood-fed mosquitoes in tubes prefilled with water and monitored oviposition at
3 d.p.i. The eggs from the first gonotrophic cycle were discarded as it has been shown that VT does not
occur or is minimal in the first gonotrophic cycle for other arboviruses [29,30]. Mosquitoes that had
oviposited and, thus, gone through their first gonotrophic cycle, were regrouped in their respective
original cages.
In one of the “sister” cages, mosquitoes were offered a non-infectious blood meal at 7 d.p.i.,
whereas the other cage was maintained on sugar feeding. To obtain a precise picture of VT, we
separated individual blood-fed mosquitoes in tubes prefilled with water and collected eggs at 10 d.p.i.
Each progeny was reared separately until fourth instar larvae. ZIKV was quantified in 10 single larvae
randomly selected from each progeny. By separately analyzing blood-fed mosquitoes and larvae, we
were able to record ovipositing females, proportion of infected larvae in a sub-sample of each progeny,
and to quantify the viral load per individual infected larva.
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Mosquitoes that oviposited a second time had undergone a second gonotrophic cycle and were
regrouped in the same cage. This cage and the one maintained on sugar feeding were then offered
a non-infectious blood meal at 14 d.p.i. As previously, blood-fed mosquitoes from each cage were
isolated in water-containing tubes. We collected the eggs at 17 d.p.i. and reared them until fourth
instar larvae to quantify ZIKV in 10 single larvae per progeny. This experimental design quantified VT
at 10 d.p.i. on the second gonotrophic cycle and at 17 d.p.i. on the second and third gonotrophic cycle.
Figure 2. Experimental design to test the impact of gonotrophic cycle and time post infection on
vertical transmission.
2.3. Oviposition Rate Moderately Increases with Incubation Time and Decreases with Additional
Gonotrophic Cycle
Oviposition rate influences VT efficiency as absence of eggs prevents VT. We observed the highest
oviposition rate for the second gonotrophic cycle at 17 d.p.i. with 79% of blood-fed mosquitoes laying
eggs (Figure 3A). At the same extrinsic incubation time (17 d.p.i.), mosquitoes that had undergone
an additional gonotrophic cycle (third) had a significantly lower oviposition rate at 54%. A shorter
extrinsic incubation period at the second gonotrophic cycle reduced oviposition rate as compared to
17 d.p.i., although not significantly (p-value = 0.06, as indicated by Z-test). Our results indicate that
oviposition rate is maximized by longer extrinsic incubation time and fewer gonotrophic cycles.
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Figure 3. Impact of gonotrophic cycle and time post infection on vertical transmission. ZIKV was
quantified in single fourth instar larvae on the second or third gonotrophic cycle at 10 or 17 days post
oral infection. (A) Oviposition rate per condition. The number of mosquito females that laid eggs
was divided by the total number of females that were blood fed. N blood-fed mosquitoes >24. (B)
Vertical transmission rate. The number of progeny with at least one infected larva was divided by
the total number of tested progeny. N progeny >14. (A,B) Bars indicate arithmetic means ± s.e. (C)
Filial infection rate. Each circle represents the infection rate calculated from 10 single larvae randomly
selected from all larvae from one infected mother (one progeny). Bars indicate arithmetic means ±
s.e.m. (D) ZIKV genomic RNA (gRNA) copies per infected larvae. Each point represents one larva.
Bars indicate geometric means ± 95% CI. (C,D) Larvae for each condition were collected from at least
14 progeny. * p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001, as calculated by Z-test (A,B) and
Tukey’s test (C,D). Number of samples analyzed in each condition are detailed in Supplementary
Table S1.
2.4. VT Rate Drastically Increases with Incubation Time and Moderately Decreases with Gonotrophic Cycle
In each tested progeny, we quantified ZIKV in 10 randomly selected larvae. Although this
experimental design may underestimate the VT rate by missing infected larvae in progeny with a
low VT rate, the analysis of multiple progeny subsamples should provide an accurate observation.
Strikingly, we observed that 100% of progeny were infected at 17 d.p.i. on the second gonotrophic cycle
(Figure 3B). VT rate was significantly reduced to 76% when mosquitoes had undergone an additional
gonotrophic cycle at 17 d.p.i. A larger reduction was caused by a shorter incubation time at the second
gonotrophic cycle with only 21% of progeny infected. These results indicate that higher VT rate is
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mostly due to longer extrinsic incubation time, while processes associated with the gonotrophic cycle
lower the VT rate.
2.5. Filial Infection Rate Increases with Incubation Time and Decreases with Gonotrophic Cycles
Calculation of filial infection rate was based on ZIKV detection in 10 single larvae randomly
selected per progeny. Others quantify viruses in pools of larvae and calculate the minimum infection
rate (MIR) based on the number of individuals per infected pool [7]. Both methods have pros and cons.
However, our strategy also allowed us to calculate a complementary parameter: the exact viral load
per infected larva (see below).
Similarly to the VT rate, we observed the highest filial infection rate for the second gonotrophic
cycle at 17 d.p.i. with 66% of infected larvae per progeny (Figure 3C). At 17 d.p.i., the filial infection
rate was significantly reduced by an additional gonotrophic cycle (38%), while a shorter incubation
lowered the infection rate even more at the second gonotrophic cycle to 8.5%. These results indicate
that, similarly to the VT rate, a higher filial infection rate results from longer incubation time and fewer
gonotrophic cycles.
2.6. Viral Load per Infected Larva Increases with Incubation Time Only
We quantified the copy number of ZIKV gRNA per infected larva as an indication of viral load.
Viral load was similar for larvae produced at 17 d.p.i. either from the second or third gonotrophic cycle
(Figure 3D). The gRNA geometric mean was 816 for the second and 723 for the third gonotrophic cycle
with values ranging from 103 to 108 gRNA. A shorter incubation time (10 d.p.i.) significantly reduced
the larval viral load at the second gonotrophic cycle to a geometric mean of 203 ranging from 106 to
1610 gRNA. The larval viral load most probably reflects the number of viruses that initially infect the
eggs. These results indicate that the number of viruses transferred from mother to eggs increases solely
with extrinsic incubation time.
3. Discussion
Most importantly, our results confirm the ability of ZIKV to be vertically transmitted up to fourth
instar larvae in Ae. aegypti and reveal a surprisingly high VT efficiency. Our experimental design, which
separated individual ovipositing mosquitoes and individual offspring from each progeny, provided
a precise evaluation of VT including VT rate, filial infection rate [26], and the exact viral load per
infected larva. VT efficiency was then calculated by multiplying the VT rate by the filial infection rate.
With regards to the VT rate, we observed that 100% of progeny contained at least one infected larva
in the most optimal condition (second gonotrophic cycle at 17 d.p.i.), whereas in the least optimal
condition (second gonotrophic cycle at 10 d.p.i.), VT rate was 21%. Although we did not quantify
VT at the first gonotrophic cycle at 3 d.p.i., the observed impact of incubation time suggests that VT
rate would have been minimal. We found only one other study that separated progeny to assess
dengue virus (DENV) VT rate in another Aedes species; the authors found a similar range of VT rates,
from 12.5% to 94.7% [31]. In most other studies, larvae from different progeny were analyzed as a
pool [12–14], preventing the calculation of VT rate. Our results provide the first evaluation of ZIKV
VT rate in controlled conditions and reveal that the VT rate can be extremely high, while confirming
that VT can largely vary. With regards to the filial infection rate, we reported 8.5–66% in the worst
(second gonotrophic cycle at 10 d.p.i.) and best (second gonotrophic cycle at 17 d.p.i.) conditions,
respectively. Usual pooled analyses underestimate the filial infection rate because it is calculated by
making the conservative assumption that only one larva is infected per pool. For ZIKV and Ae. aegypti,
three studies calculated a filial infection rate of 1.7–.3% by studying pools of 20 individuals [13], 2.13%
by studying pools of 30 [12], and 5.5% by studying pools of 10 [14]. Actual filial infection rates for
these three studies could be as high as 66%, 64%, and 55%, respectively, if all pooled individuals were
infected. These numbers are definitely overestimates but are within the range of our results when
calculated from a single larva from the same progeny. Another study quantified vertically transmitted
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ZIKV in single salivary glands and found a filial infection rate of 17% when eggs were collected at
5 d.p.i. [12], which is in line with the 21% we calculated in larvae from eggs collected at 10 d.p.i. Higher
filial infection rate in salivary glands may be obtained when eggs are collected later, as observed for
larvae from eggs we collected at 17 d.p.i. With regards to the viral load per infected larva, the best
conditions (17 d.p.i. for either second or third gonotrophic cycle) averaged a bit lower than 1000 ZIKV
gRNA per infected larva with a large variation among individual larvae. This is also the first time
vertically transmitted viral load was calculated for individual larvae. The lowest infection levels we
reported at the fourth larval instar may not persist through the mature phase and explain the lower
filial infection rate observed in the mature than in the immature phase [7]. However, average and
higher viral loads should be enough to infect the whole body of adults, including salivary glands.
Vertically transmitted ZIKV infects salivary glands, enabling horizontal transmission to humans [14].
Overall, our precise results obtained by analyzing individual progeny and individual larvae indicate
that VT efficiency in optimal conditions can be high (VT efficiency = VT rate × filial infection rate =
100% × 66% = 66%).
Several lines of evidence suggest that ZIKV is vertically transmitted by transovarial infection.
Infection of germinal cells is a prerequisite for transovarial infection. We detected ZIKV in ovaries
as early as 3 d.p.i., as previously reported [12]. We quantified an exponential increase in viral loads
until 14 d.p.i., suggesting active replication in ovaries. In support of germ cell infection by flaviviruses,
particles of dengue virus (DENV), another mosquito-borne Flavivirus, are present in the germarium and
oocytes of Ae. aegypti [25]. As compared to trans-ovum infection, which occurs through the oviduct,
transovarial infection occurs in the germinal cells [21] and, thus, should be affected by oogenesis.
We observed that an additional gonotrophic cycle reduces VT and filial infection rates. A similar
impact for the gonotrophic cycle in Ae. aegypti was previously observed for DENV [32] and another
mosquito-borne Flavivirus, yellow fever virus [33]. Eventually, during transovarial infection, longer
incubation time should provide more time for the virus to infect more germinal cells. We observed that
incubation time increased VT for ZIKV, as for DENV [25]. However, for the same incubation time, an
additional gonotrophic cycle reduced the egg infection rate (as evaluated by VT rate and filial infection
rate) but not infection intensity (as determined by viral load in individual larvae). This suggests that
infection occurs during a stage of oogenesis that is renewed by subsequent cycles. In other words,
oviposition shortens the actual incubation of the infected stage. The viral load received depends on
the infection intensity in ovaries, which is identical for the same incubation time. During oogenesis,
oocytes mature, are fertilized, and deposited, and another round of oocyte production is initiated from
the germline cells. We thus propose that ZIKV infection occurs during oocyte maturation, although
this hypothesis requires further testing. Strongly supporting transovarial infection of flaviviruses, VT
for DENV was reported after egg surface sterilization [25]. Transovarial transmission should be more
efficient than trans-ovum transmission [34] and could explain the high VT efficiency we observed.
Our results shed light on the balance between VT in mosquitoes and horizontal transmission to
humans. We revealed that VT is higher for a longer extrinsic incubation time and lower number of
gonotrophic cycles. These same conditions also favor oviposition rate, further increasing VT efficiency.
Horizontal transmission occurs through blood feeding, which then stimulates oocyte maturation and
search for an oviposition site [35]. The relationship between blood feeding and oviposition is central to
balance horizontal transmission and VT; frequent blood feedings will favor horizontal transmission at
the expense of VT and vis versa. Aedes aegypti is highly anthropophilic [36] and the limited availability
of humans can reduce blood feeding. Alternatively, oviposition induces host seeking for blood feeding,
which, when acquired, will initiate a subsequent gonotrophic cycle [37]. The alternation of gonotrophic
cycles can then be driven by the availability of oviposition sites. Arid weather, for instance, should
reduce Ae. aegypti preferred oviposition sites in artificial containers [38], delaying oviposition, and
favoring VT. Mathematical models predict that in endemic settings, DENV would not persist by VT
unless efficiency was higher than 20–30% [39,40]. Based on available data from pooled analyses, the
authors of the model concluded that VT for DENV has a minimal impact on epidemiology. The model
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was based on Ae. aegypti biting habits and should partially apply to ZIKV. Our results showing VT
higher than 30% for ZIKV suggest that VT can maintain the virus, at least when conditions limit
availability of human hosts or oviposition sites.
There is evidence that arboviruses can adapt to VT in mosquitoes. Laboratory studies showed that
DENV can persist through several generations by VT [41–43]. DENV acquired by VT in Ae. albopictus
females was then more efficiently vertically transmitted than DENV acquired by blood feeding [41]. It
remains to be tested whether VT-adapted viruses conserve the ability to infect humans. Intriguingly,
a meta-analysis found that VT efficiency was higher when flaviviruses were isolated from an arid
climate [7], which, based on our results, corresponds to the optimal conditions for ZIKV VT. However,
any adaptation to VT would have to be balanced with the potential fitness cost incurred to mosquito,
as observed for slower growth of ZIKV vertically infected larvae [14]. The immune response in ovaries
should also be taken into account. In our study, we used a low-passage ZIKV collected from humans
(horizontally transmitted) in Brazil, which should not be adapted to VT.
In conclusion, we deployed an original experimental design that allowed us to precisely calculate
VT in Ae. aegypti for ZIKV and reveal VT efficiency higher than that quantified from pooled analysis.
We further show that incubation time increases whereas successive gonotrophic cycle decreases VT,
informing about the conditions that favor VT. Altogether, while horizontal transmission to humans
remains the most epidemiologically relevant transmission mode, our study indicates that ZIKV VT
may maintain the virus when conditions are not amenable for horizontal transmission. Consequently,
it is advisable to maintain vector control when horizontal transmission (evidenced by outbreaks) is
low in order to curb residual vertical transmission.
4. Material and Methods
4.1. Mosquitoes
An Ae. aegypti mosquito colony was established from a thousand eggs collected in Singapore in
2010 and maintained in the laboratory. Eggs were hatched in tap water, larvae were fed a mix of fish
food (TetraMin fish flakes, Melle, Germany) and liver powder (MP Biomedicals, Illkirch, France), and
adults were held in rearing cages (Bioquip, Rancho Dominguez, CA, USA) supplemented with 10%
sucrose and water. Adults were fed pig’s blood (Primary Industries Pte Ltd., Singapore) twice weekly
to produce eggs for maintaining the colony. The insectary was held at 28 ◦C with 50% humidity on a
12:12 h dark:light cycle.
4.2. Zika Virus
The strain BeH815744 was collected in the Paraiba state (northeast region), Brazil, in 2015 from
a febrile non-pregnant woman with rashes. The virus was given from Pr. da Costa Vasconcelos,
propagated in C6/36 (ATCC CRL-1660) cells and used after three passages. The virus stocks were
titrated thrice by plaque assay in BHK-21 cells as previously described [10].
4.3. Oral Infection
Three- to five-day-old female mosquitoes were sugar deprived for 24 h before offering a blood
meal containing a 40% volume of washed erythrocytes from serum pathogen free (SPF) pig’s blood
(SingHealth, Singapore), 5% of 10 mM ATP (Thermo Scientific, Waltham, MA, USA), 5% human serum
(Sigma, St Louis, MO, USA) and 50% volume of virus in RPMI (Gibco, Waltham, MA, USA). The
final blood viral titer was 105 pfu/mL and was confirmed by a BHK-based plaque assay on blood
samples collected before and after feeding. Mosquitoes were exposed to the artificial blood meal for
one hour using a Hemotek membrane feeder system (Discovery Workshops, Accrington, UK) with a
porcine intestine membrane. Fully engorged females were selected and maintained with free access to
a 10% sugar solution and water in an incubation chamber with conditions similar to those used for
insect rearing.
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4.4. Virus Quantification
Single ovary pairs or single larvae were homogenized in 350 μL of TRK lysis buffer (E.Z.N.A. Total
RNA kit I (OMEGA Bio-Tek, Norcross, GA, USA)) using a bead Mill homogenizer (FastPrep-24, MP
Biomedicals, Illkirch, France). Total RNA was extracted using the E.Z.N.A. Total RNA kit I (OMEGA
Bio-Tek) and following the manufacturer’s instruction with 30 μL of DEPC-treated water for filter
elution. ZIKV genomic RNA (gRNA) copies were quantified with a one-step RT-qPCR with SensiFAST
SYBR No-ROX one-step kit (BioLine, London, UK). Primers, targeting the conserved region in the
envelope, were: 5’- AGGACAGGCCTTGACTTTTC -3’ and 5’- TGTTCCAGTGTGGAGTTC -3’, as
previously used [10]. The 10 μL reaction mix contained 400 nM of forward and reverse primers, and 3
μL of RNA extract. Quantification was conducted on a CFX96 Touch Real-Time PCR Detection System
(Bio-Rad, Hercule, CA, USA). The thermal profile was 45 ◦C for 10 min, 95 ◦C for 1 min, and 40 cycles
of 95 ◦C for 5 sec and 60 ◦C for 20 sec.
An absolute standard curve was generated by amplifying fragments containing the qPCR targets
using the qPCR forward primers tagged with a T7 promoter and the qPCR reverse primer. The
fragment was reverse transcribed using a MegaScript T7 transcription kit (Ambion, Austin, TX, USA)
and purified using the E.Z.N.A. Total RNA kit I. The total amount of RNA was quantified using a
Nanodrop (Thermo Scientific) to estimate copy number based on an averaged base pair weight of 649
g/mole. Ten times serial dilutions were made and used to generate an absolute standard equation
(Supplementary Figure S1). In each subsequent RT-qPCR plate with samples, we quantified four
standard aliquot dilutions to adjust for threshold variation between plates.
4.5. Experimental Design to Test the Impact of Gonotrophic Cycle and Extrinsic Incubation Period
About 200 24 h starved 2- to 5-day-old female mosquitoes were offered a ZIKV infectious blood
meal. Fully engorged mosquitoes were selected, and equally divided in two halves that were placed in
separate 30 cm cubic cages (BioQuip, Rancho Dominguez, CA, USA). One day post-infectious blood
feeding (d.p.i.), blood-fed mosquitoes were singled out in cylindrical vials of 2 cm diameter and 10 cm
height. Vials were prefilled 1 cm high with distilled water and closed with a cotton plug. These eggs
corresponding to the first gonotrophic cycle were collected at 3 d.p.i. and discarded. Only mosquitoes
that oviposited were regrouped in their original cages. At 7 d.p.i., after 18 h of starvation, only one of
the two cages was provided a non-infectious blood meal containing full SPF blood (SingHealth) for one
hour using the Hemotek membrane feeder system with a porcine intestine membrane. Fully engorged
mosquitoes were selected and kept in the cage, whereas non-fed mosquitoes were discarded. The
other cage was identically starved but provided 10% sugar solution instead of a blood meal. At 8 d.p.i.,
mosquitoes that were fed a non-infectious blood meal were singled out as above in the cylindrical
vials prefilled with distilled water. At 10 d.p.i., mosquitoes that oviposited were collected and kept
in the same 30 cm cage. Eggs from each vial were reared in separated pans until the fourth instar
larvae. At 14 d.p.i., after 18 h of starvation, the two cages were provided a non-infectious blood meal
as above. Fully engorged females were selected and kept in their respective cages, whereas non-fed
mosquitoes were discarded. At 15 d.p.i., mosquitoes from both cages were singled out in the vials
prefilled with water. At 17 d.p.i., mosquitoes that oviposited were recorded and eggs were reared
in separate pans until the fourth instar larvae. For each tested condition, we quantified ZIKV in 10
larvae randomly selected from one progeny. We analyzed 13–17 progeny per condition. During the
experiment, mosquitoes were provided with 10% sugar solution when they were not offered a blood
meal. Starvation consisted of removing the sugar solution. The experiment was repeated twice with
different mosquito batches.
4.6. Statistics
Infection rate in the ovaries was calculated by dividing the number of infected ovaries over the
total number of ovaries that were tested. VT rate was defined as the percentage of infected females
83
Pathogens 2020, 9, 366
that transmitted the virus to their progeny [21] and was calculated by dividing the number of progeny
with at least one infected larva to the total number of females that oviposited. Filial infection rate was
calculated by dividing the number of larvae with detectable levels of ZIKV gRNA out of 10 tested
randomly selected larvae within progeny. Oviposition rate was calculated by dividing the number
of female mosquitoes that oviposited over the total number of mosquitoes that were singled out in
the vials prefilled with water. Differences in infection rates per progeny and ZIKV gRNA copies were
evaluated using Tukey’s multiple comparison tests. After evaluating distribution normality with
D’Agostino omnibus K2 test, ZIKV gRNA copies were log-transformed before statistical analysis.
Differences infection rates in ovaries and oviposition rates were evaluated using Z-test. All tests were
performed with Prism v8.0.2 (GraphPad, San Diego, CA, USA), except for Z-tests that were conducted
with Systat v13.1 (Systat Inc., San Jose, CA, USA).
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/5/366/s1,
Figure S1: Standard curve for absolute quantification of ZIKV gRNA. Table S1. Number of mosquitoes analyzed
in the VT assay presented in Figure 3.
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Abstract: Culicoides sonorensis biting midges are well-known agricultural pests and transmission
vectors of arboviruses such as vesicular stomatitis virus (VSV). The epidemiology of VSV is complex
and encompasses a broad range of vertebrate hosts, multiple routes of transmission, and diverse
vector species. In temperate regions, viruses can overwinter in the absence of infected animals
through unknown mechanisms, to reoccur the next year. Non-conventional routes for VSV vector
transmission may help explain viral maintenance in midge populations during inter-epidemic periods
and times of adverse conditions for bite transmission. In this study, we examined whether VSV could
be transmitted venereally between male and female midges. Our results showed that VSV-infected
females could venereally transmit virus to uninfected naïve males at a rate as high as 76.3% (RT-qPCR),
31.6% (virus isolation) during the third gonotrophic cycle. Additionally, VSV-infected males could
venereally transmit virus to uninfected naïve females at a rate as high as 76.6% (RT-qPCR), 49.2% (virus
isolation). Immunofluorescent staining of micro-dissected reproductive organs, immunochemical
staining of midge histological sections, examination of internal reproductive organ morphology,
and observations of mating behaviors were used to determine relevant anatomical sites for virus
location and to hypothesize the potential mechanism for VSV transmission in C. sonorensis midges
through copulation.
Keywords: vesicular stomatitis virus; Culicoides midges; non-conventional transmission; venereal
transmission; reproductive anatomy; mating behavior
1. Introduction
Vesicular stomatitis virus (VSV) (Rhabdoviridae: Vesiculovirus) is a single-stranded, negative-sense,
RNA pathogen responsible for vesicular stomatitis (VS) disease in cattle, horses, and swine [1].
VSV causes annual outbreaks in enzootic regions from northern South America to southern Mexico,
infecting a large percentage of susceptible species [1]. In the U.S., VSV re-emerges sporadically with
incursions originating from these southern enzootic regions moving northward into southwestern
states at approximately 3 to 10-year intervals [1–3]. Epizootic viruses can overwinter, in an as yet
identified natural reservoir, resulting in a second-year outbreak of the same viral genotype [3,4].
The epizootiology of VS is complex and comprises a wide variety of variables from a broad vertebrate
host range, with variation in clinical outcome due to host species and site of initial infection, to the
rapid transmission within animal herds by direct contact and fomites [1,5]. Furthermore, there is
a diversity of suspected and potential transmission vector species acting as both mechanical and
biological vectors throughout temperate and tropical ecosystems [6]. During VSV outbreaks in the U.S.,
Culicoides biting midges (Diptera: Ceratopogonidae) and Simulium black flies (Diptera: Simuliidae)
have important roles in the initial introduction of VSV into animal herds and contribute to outbreak
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spread in the absence of animal movement [1–3,7]. Specifically, Culicoides sonorensis is one of the most
common midge species associated with livestock agriculture [8,9] and a known biological transmission
vector of VSV [10–15].
Transmission of VSV via Culicoides female bites is dependent upon available viremic hosts or
infected hosts exhibiting skin-associated vesicular lesions containing large amounts of virus [16].
Blood feeding midges may acquire virus from blood [6], vesicular lesions, or from feeding on intact
skin contaminated by vesicular fluid or virus-laden saliva [17,18]. However, the resulting pantropic
systemic infection of C. sonorensis midges following oral ingestion of VSV [10], suggests that the
interrelationships between the virus and vector may not be restricted to a bloodmeal-midgut-salivary
gland-bloodmeal transmission route [6]. VSV infection and replication in reproductive tissues indicate
that non-conventional routes of transmission might also occur. Specifically, VSV replication has been
shown to occur in the ovarial epithelium and within the developing oocytes, suggesting that transovarial
transmission might be possible [10]. Likewise, VSV infection of other relevant reproductive tissues
and the rectal ampulla [10] suggests potential scenarios for trans-ovum transmission and transmission
during sexual contact. Previously, VSV infection in Culicoides males has not been of interest because
males were not believed to be involved in the transmission of viruses [19]. Since only females feed
on blood, studies have been confined to the role females play in transmission and virus maintenance.
However, in recent years, it has been suggested that males of some vector species might have a
synergistic involvement in arbovirus transmission [20,21].
Therefore, determining the role of males, specifically the role venereal transmission (VNT) plays,
in VSV maintenance in Culicoides populations, could lead to a more comprehensive understanding
of 1) potential virus persistence in nature during interepidemic periods; 2) the overwintering of
some viral genotypes leading to multi-year outbreaks; and 3) vector transmission dynamics during
outbreaks. Herein, we report the first evidence for venereal transmission of any arbovirus in Culicoides
spp. biting midges, and the first evidence for venereal transmission of VSV in any vector species.
Additionally, we detail the mating behavior and morphological descriptions of C. sonorensis female and
male reproductive anatomy with localization of VSV to provide insights into the potential mechanism
of VNT.
2. Results
2.1. Venereal Transmission from Orally Infected C. sonorensis Females to Naïve Males
Colonized C. sonorensis midges typically survive an average of 14–21 days depending on the
number and types of manipulations to which they are subject. If provided blood meals and allowed
to cohabitate with males, female survival rates are adequate to analyze three gonotrophic cycles.
To determine rates of venereal transmission from infected females to age-matched naïve males, four
mating experiments, two tested by RT-qPCR and two tested by virus isolation (VI), were conducted
through three sequential bloodmeal-induced gonotrophic cycles (GC). Naïve adult males were made
available for copulation by cohabiting with VSV-fed females from 0 to 4 days post-feeding (dpf) (1 GC),
4 to 8 dpf (2 GC), and 8 to 12 dpf (3 GC) (Figure 1A). All 88 surviving males collected at the end of 1 GC
tested negative for viral RNA (Table 1). During the second GC, 15.2% and 20% of the surviving males
paired with orally infected females tested positive for viral RNA by RT-qPCR and for infectious virus
by cytopathic effects (CPE) in cell culture, respectively. Cycle threshold (Ct) values of males paired with
2 GC females ranged from 34.7 to 32.9 (101 to 102 genome equivalents) (Figure 2A). At the end of 3 GC,
31.6% of the males were CPE positive and 76.3% RT-qPCR positive (Table 1) with Ct values ranging
from 34.7 to 31.1 (101 to102 genome equivalents) (Figure 2A). Additionally, orally infected females
(10 to 20 from each of two mating experiment) were collected at the end of each bloodmeal-induced
gonotrophic cycle to be tested by RT-qPCR (Figure 2B). Ct values for females collected at the end of
1 GC ranged from 35.4 to 30.3, 35.6 to 29.3 for 2 GC, and 34.9 to 30.8 for 3 GC.
88
Pathogens 2020, 9, 316
Figure 1. Experimental design to test venereal transmission of vesicular stomatitis virus (VSV) in
Culicoides sonorensis midges. (A) Venereal transmission from VSV-fed females to naïve males. (B)
Venereal transmission from intrathoracically VSV-injected males to naïve females. (C) Venereal
transmission from 3rd gonotrophic cycle (GC)-mated males * (obtained in experiment (A)) to
naïve females.
Table 1. Venereal transmission rates from orally infected females to naïve non-infected males during
three gonotrophic cycles (GC) as detected by whole-body RT-qPCR or CPE.
GC Initial Number of Midges Surviving ♂(%) 1 VSV RT-qPCR+ ♂(%) 2 VSV CPE+ ♂(%) 3
1 240 ♀and 120 ♂ 88/120 (73.3%) 0 ND
2 199 ♀and 100 ♂ 59/100 (59%) 9/59 (15.2%) ND
2 104 ♀and 52 ♂ 30/52 (57.7%) ND 6/30 (20%)
3 131 ♀and 65 ♂ 38/65 (58.5%) 29/38 (76.3%) ND
3 64 ♀and 32 ♂ 19/32 (59.4%) ND 6/19 (31.6%)
1 Surviving males were sampled 4 days after initial cohabitation, which was determined as the end of each blood
meal-induced gonotrophic cycle (GC). 2 Vesicular stomatitis virus (VSV)-positive males detected by RT-qPCR.
3 VSV-positive males detected by cytopathic effect (CPE). ND, not determined.
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Figure 2. RT-qPCR cycle threshold (Ct) values (left Y-axis) and Log10 viral genome equivalents (right
Y-axis) for individual VSV-positive (Ct ≤ 36) C. sonorensis midges. Non-parametric tests were used
to compare distributions of Ct values between gonotrophic cycles. (A) C. sonorensis males infected
with VSV following cohabitation with orally infected females at the end of the second (2 GC) and
third (3 GC) gonotrophic cycles (p value = 0.196; NS, not significant). (B) C. sonorensis females orally
infected with VSV tested at the end of each bloodmeal-induced gonotrophic cycle (1 GC, 2 GC, 3 GC)
(p-value = 0.0002; *** p < 0.001).
2.2. Venereal Transmission of VSV from Intrathoracically Injected C. sonorensis Males to Naïve Females
Mating experiments were conducted to determine whether males 4 days post-injection (dpi)
can venereally transmit VSV to age-matched naïve adult females, as tested by RT-qPCR and CPE
(Table 2, Figure 1B). Of females surviving 7 days after the first exposure to infected males (11–14 days
post emergence for both males and females), 49.2% were CPE positive (Table 2). To determine if the
virus acquired by venereal transmission could disseminate into the salivary glands of females, we
separately tested bodies (n = 77) and then tested heads with glands from RT-qPCR-positive bodies
(n = 59). The bodies of 76.6% of the females tested positive for viral RNA (Table 2) with Ct values
ranging from 34.8 to 22 (101 to 105 genome equivalents) (Figure 3). The heads of 11.63% of the females
tested positive for viral RNA (Table 2) with Ct values ranging from 34.8 to 32.3 (101 to 102 genome
equivalents) (Figure 3). Additionally, a sub-sample of the inoculated males was tested at 4 dpi (when
introduced into the mating cages) and at 7 dpi (when removed from mating cages) for the presence of
VSV RNA (N = 5) and infectious virus (N = 5). All tested males were positive, with titers ranging from
1.35 × 105 to 2.8 × 105 PFU/mL by plaque assay.
Table 2. Venereal transmission from VSV-injected Culicoides males (4 dpi) to age-matched naïve females
as detected by RT-qPCR of individual bodies and heads and CPE of whole midges.
Initial Number of
Midges
Surviving ♀(%) 1 VSV RT-qPCR+♀Bodies (%) VSV RT-qPCR+♀Heads (%) VSV CPE+Whole♀(%)
58 ♂and 116 ♀ 77/116 (66.4%) 59/77 (76.6%) 6/59 (10.2%) ND
39 ♂and 78 ♀ 61/78 (78.2%) ND ND 30/61 (49.2%)
1 Surviving females were sampled 7 days after the initial cohabitation.
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Figure 3. RT-qPCR cycle threshold (Ct) values (left Y-axis) and Log10 of viral genome equivalents
(right Y-axis) for positive (Ct ≤ 36) C. sonorensis female bodies and heads infected with VSV following
cohabitation with males infected by microinjection.
2.3. Venereal Transmission of VSV from Venereally Infected C. sonorensis Males to Naïve Females
Mating experiments were conducted to test venereal transmission of VSV from venereally infected
males to younger naïve females (Figure 1C). Males used in these experiments had cohabitated with
orally infected females during the third blood meal-induced gonotrophic cycle (3 GC). Younger females
were used instead of age-matched in order to increase the chance of female survival at 7 days post
mating. Of the 84 surviving females at 7 days post mating, 9.5% tested positive by RT-qPCR (Table 3)
with Ct values ranging from 36.3 to 33.2 (101 to 102 genome equivalents) (Figure 4).
Table 3. Venereal transmission of VSV from venereally infected Culicoides males (4 days post-mating)
to naïve females as detected by whole midge RT-qPCR.
Initial Number of Midges Surviving ♀(%) 1 VSV RT-qPCR+Whole ♀(%)
100 ♂and 200 ♀ 84/200 (42%) 8/84 (9.5%)
1 Surviving females were sampled 7 days after the initial cohabitation.
Figure 4. RT-qPCR cycle threshold (Ct) values (left Y-axis) and Log10 of viral genome equivalents
(right Y-axis) for positive (Ct ≤ 36) C. sonorensis female bodies infected with VSV following cohabitation
with venereally infected males.
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2.4. VSV Infection in Reproductive Tracts
We conducted three trials using VSV-immunofluorescent staining of reproductive organs of
intrathoracically inoculated males and females to establish tissue tropism for VSV in the reproductive
tract of midges at 4 dpi. Initially, virgin females were used; however, the underdeveloped ovary
morphology did not allow visualization of precise locations for VSV. Consequently, to add clarity
to the virus location within developing oocytes, mated and blood-fed females were used in all
subsequent trials.
The VSV-positive fluorescent puncta in males (Figure 5B,E, Table 4) indicated viral infection of the
epithelial layer at the base of the testes (91.7%), in the outer epithelial surface of the accessory gland
(58.3%), and throughout tissues in the hindgut and the rectal region (100%). In contrast, vas deferens,
ejaculatory duct, and terminalia did not show positive fluorescence.
The intensity of positive fluorescence puncta in whole reproductive organs of females (Figure 5G,
Table 4) was detected in the tracheal branches located in the space between ovarian sheaths (91.7%) and
throughout tissues in the hindgut and the rectal region (100%). There were no apparent positive puncta
in the spermatheca and spermathecal gland. Due to the inability to get intact whole reproductive tracts
with undamaged ducts, we examined sagittal sections from 19 sequentially sampled virus fed females
(9–13 dpf, time corresponding to 3 GC) used to first describe the temporal and spatial progression
of VSV infection in Culicoides [10]. The positive staining (Figure 6B,C,E,F, Table 5) was detected in
the ovaries (Ov) (36.8%), oviduct (Od) (16.8%), spermathecal duct (Sd) (26.3%), gonotreme (Go) and
gonopore (Gp) (57.8%), and throughout tissues in the hindgut (Hg) and the rectal region (R).
 
Figure 5. Immunofluorescent VSV-staining of intrathoracically infected C. sonorensis. (A) Testis (Ts)
and (D) accessory gland (Ag) dissected from non-infected (negative control) males. (B) Testis (Ts) and
(E) accessory gland (Ag) dissected from males 4 days post inoculation. Arrows denote VSV-positive
staining (FITC-green puncta) in the epithelial layer of the testis base and outer epithelial layer of the
Ag. Cellular nuclei were stained with DAPI (blue). (C) Male reproductive anatomy (brightfield 200×).
Abbreviations: Ae: aedeagus, Ag: accessory gland, Bs: basistyle, Ds: dististyle, Gg: glutinous gland,
Sv: seminal vesicle, Ts: testis, Vd: vas deferens. (F) Ovaries (Ov) dissected from non-infected (negative
control) females. (G) Ovaries (Ov) dissected from females 4 days post inoculation. Arrows denote
VSV-positive staining (FITC-green puncta) with DAPI nuclear stain (blue). (H) Female reproductive
anatomy (brightfield 200×). Abbreviations: VIII: 8th abdominal segment, IX: 9th abdominal segment,
Ce: cerci, Ov: ovary, S: spermatheca.
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Table 4. Organs with positive fluorescent puncta staining of intrathoracically inoculated C. sonorensis
midges 4 dpi.
Males Females
Testes Accessory Glands Ovaries Spermatheca
15/17 (88.2%) 7/17 (41.2%) 11/12 (91.7%) 0/12 (0%)
 
Figure 6. Immunohistochemical VSV-staining of orally infected C. sonorensis females. (A) Ovaries (Ov)
and (D) abdomen of non-infected (negative control) females. (B) Ovaries (Ov) and (C,E,F) abdominal
sections from females 9–13 days post feeding with VSV-positive antigen staining of viral nucleocapsid
in red and counterstained with hematoxylin (blue). (B) VSV antigen staining in the ovarial sheaths and
trachea. (C) VSV antigen staining in hindgut (Hg), gonopore (Gp), gonotreme (Go), lateral oviduct
(LOd), spermathecal duct (Sd), and ovaries (Ov). (E) VSV antigen staining in hindgut (Hg), gonopore
(Gp), gonotreme (Go), and lateral oviduct (LOd), with negative ovaries (Ov) and spermatheca (S).
(F) VSV antigen staining in rectum (R) and gonotreme (Go), with negative spermatheca (S).
Table 5. Organs with VSV-positive staining of sections of orally infected C. sonorensis females (8–13 dpf).
Ovaries Oviduct Spermathecal Duct Gonotreme Gonopore
7/19 (36.8%) 3/19 (16.8%) 5/19 (26.3%) 6/19 (31.6%) 11/19 (57.8%)
2.5. Behavioral Observations of C. sonorensis Copulation
There is little information on the mating behavior, comparative function of the sex organs during
mating, and the timing for efficient sperm transmission in Culicoides midges. In order to better
understand the mating behavior of C. sonorensis and provide insight into the mechanism of VSV
venereal transfer, we conducted observations of midge-matings under laboratory conditions.
C. sonorensis copulation occurred on the bottom of the cages without a swarming flight.
When specimens of both sexes were introduced at 1 to 3 days post-emergence, they often rested
for long periods with frequent antennal and wing movements. Mating attempts were initiated by males
following the females with rapid walking movements and continual antennal vibrations culminating
with the efforts of the male to climb onto the back of the female. If a blood meal was not offered, most
females showed resistance behavior when males approached. The resistance behavior consisted of
the females running rapidly, kicking males with their hind legs, and anteriorly curving the dorsal
segments of the abdomen to avoid contact with the male claspers. However, 10–15 min after a
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blood meal was offered, fed females were receptive to the multiple attempts of males to establish
genital contact. Males approached the female terminalia with curved abdomens and open claspers.
After attachment, males would then rotate around the female until they were positioned 180◦ to the
female. Culicoides nubeculosus also presents this 180◦ torsion, but for other species only a gentle torsion
has been reported [22]. The genital contact (attachment) time was 420 ± 15 s. Detachment following
copulation occurred rapidly by the claspers opening while the female pushed with their hind legs
until separation.
From our observations in the laboratory, the presence of males stimulates female blood feeding,
and subsequently, blood ingestion incites copulation. Moreover, C. sonorensis can repeatedly mate
within each gonotrophic cycle, as previously reported for the variipennis complex (which includes
C. sonorensis) [22]. Together these behaviors may impact VSV epidemiology by increasing viral exposure
opportunities by blood-feeding females. Furthermore, the relatively long copulation time, and the
possibility of multiple matings in a lifetime, makes the implications of VSV venereal transmission
from females to males and males to females more likely to impact viral maintenance in C. sonorensis
midge populations.
2.6. Anatomical Descriptions of C. sonorensis Male Reproductive Tract
Little information exists in the literature relative to the internal anatomy of males of the family
Ceratopogonidae. Thus, to better understand how the venereal transmission of VSV is occurring from
C. sonorensis males to females, we describe our morphological and anatomical observations of the male
reproductive tract.
The outer male abdomen is slender with the 9th segment, the tergum, and sternum fused in
the shape of a sclerotized ring to which a prominent terminalia is attached (Figures 5C and 7A).
Two distinct sclerotized curved claspers are formed by a basal basistyle (Bs) and a claw-like apical
dististyle (Ds) (Figure 5C). The aedeagus (Ae) is Y-shape and is held by a sclerotized structure on the
ventral side (Figure 5C). The testes (Ts) are elongated pyriform concerted to a tubular vas deferens
(Vd) (Figure 5A,B and Figure 7B). Each vas deferens is connected to the base of the accessory gland
(Ag) (Figures 5C and 7B) and directs the sperm through to the distal portion of the Ag which contains
two circular seminal vesicles (Sv) on each side (Figures 5C and 7B). Each Sv is surrounded by a layer
of large secretory cells. Below each seminal vesicle is a pair of broadly ovoid glutinous glands (Gg)
(Figures 5C and 7B), which in other Culicoides species are known to contain secretory cells [23,24].
The spermatozoa and ejaculatory secretions (most likely transferred to a female in a spermatophore as
reported in Culicoides nubeculosus [25] and Culicoides melleus [22,23]) are released through a common
ejaculatory duct (Ed) at the base of the accessory gland which is connected to the aedeagus (Figure 7B).
The sperm transferred during mating consists of a mix of proteins, lipids, carbohydrates, salts,
and steroid hormones produced in the male accessory glands, and possibly in the testes [25]. Despite
the potential impact that this ejaculatory complex may have on the reproductive physiology and
behavior of females, the sperm ejaculation route (Figure 7B) contributes to VSV maintenance in midge
populations by allowing the efficient transmission of virus particles from the male into the female
upon copulation.
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Figure 7. Anatomy of Culicoides sonorensis male (A) External male morphology. (B) Male reproductive
tract detached from the terminalia. Arrows indicate sperm ejaculation pathway. Abbreviations: Ag:
accessory gland, Ed: ejaculatory duct, Ts: testis, Vd: vas deferens.
2.7. Anatomical Descriptions of C. sonorensis Female Reproductive Tract
Venereal transmission from females to males has rarely been reported in the literature [26], mainly
because the male produces all of the secretions that are exchanged during copulation. To better
understand how the venereal transmission of VSV is occurring from C. sonorensis females to males, we
describe the morphology and anatomy of the female reproductive tract.
The outer morphology of the female reproductive system is relatively simple, with a stout abdomen
ending in a pair of small rounded cerci (Ce) with long sensory hairs visible below the 9th tergum (IX)
(Figures 5H and 8A). Internally, the female reproductive system is complex, presenting two ovaries
(Ov) located at the anterior end of the female’s abdomen, usually internally located between the 5th
and the 6th abdominal segments (Figures 5H and 8B). The ovaries contain oocytes at similar stages of
development. Each oocyte is surrounded by follicular cells and contain 3 to 5 nurse cells. The oocytes
are held together by an epithelial sheath surrounded by a network of fine, branching tracheae. At the
base of each ovary, there is a lateral oviduct (LOd) that fuses into a common oviduct (Od) which is
attached to the 8th sternum (Figure 8B). The common oviduct posteriorly enlarges to a gonotreme (Go),
which receives the sperm during copulation. The posterior end of the gonotreme is bifurcated into a
hyaline duct known as the spermathecal duct (Sd), which contains a minute globular spermathecal
gland (Sg) (also known as a female accessory gland) and ending in one sclerotized mushroom-shaped
(convex or campanulate) spermatheca (S) (Figures 5H and 8C) for sperm storage. The last section
of the posterior end of the gonotreme, located in close proximity to the rectum (R), exits the female
reproductive tract at the distal end of the female terminalia, the gonopore (Gp), which also serves
to oviposit eggs. The polyandric behavior observed in C. sonorensis females, combined by the rich
virus load in the anal region and gonopore, contribute to maintenance of VSV in midge populations by
favoring virus transmission from females to multiple males in a lifetime of copulation events.
95
Pathogens 2020, 9, 316
 
Figure 8. Anatomy of Culicoides sonorensis female (A) External female morphology. (B) Ovaries (Ov)
joined by common oviduct (Od) attached to the 8th sternum (VIII-S). (C) Detailed portion of the
spermatheca (S), spermathecal gland (Sg), and spermatheca duct (Sd).
3. Discussion
Vesicular stomatitis outbreaks in temperate regions peak during summer and fall and typically
stop after the first hard freeze, corresponding with the decrease in the number of vectors in
affected areas [2]. Outbreak viruses can overwinter with the same viral genotype re-emerging
for a second-year outbreak [3,27], as occurred in 2004–2005, 2005–2006, 2014–1015, and in the most
recent 2019–2020 outbreaks. Several hypotheses have been proposed to explain the maintenance
of VSV during inter-epidemic periods, mainly by suggesting the presence of a yet to be identified,
natural mammalian reservoir [28,29]. However, from a vector perspective, the vertical and venereal
transmission of arboviruses are possible maintenance mechanisms during inter-epidemic periods in
which the virus is maintained in a vector population independent of feeding on viremic animals [30].
Among hematophagous Diptera, the venereal transmission of viruses of human and veterinary
importance has been observed with bunyaviruses [31–33], flaviviruses [34–41], rhabdoviruses [42,43],
and togaviruses [44,45] in mosquitoes and sand flies. However, no previous studies have reported
venereal transmission by Culicoides biting midges for any arbovirus, nor for any insect species with VSV.
In this study, we have demonstrated the presence of VSV RNA and infectious virus in previously
uninfected midges of both sexes following cohabitation with VSV-infected mates. Our study also
revealed the location of viral antigen in the reproductive tracts of both males and females. For the first
time, VSV infection of female C. sonorensis midges has been shown to occur not only during blood
feeding but also during copulation. Venereal transmission of VSV from orally infected females to naïve
males and from venereally infected males to naïve females suggests the virus could be maintained in
midge populations at a low threshold during inter-epidemic periods and then reinitiate an outbreak
when conditions for bite transmission are once again ideal. The testing of heads from positive VNT
females was used as an indication of both dissemination and transmission potential. Although virus
detected in the heads would include infected neural and optic tissues, previous in situ hybridization
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staining of infected midges showing significant VSV replication in salivary gland epithelium, and
immunohistochemical staining showing VSV in the lumen of salivary glands ready for excretion [10],
strongly suggest positive midge heads correlate to bite transmission potential.
Venereal transmission of VSV from females to males was shown to occur at higher rates during
the females third gonotrophic cycle (8 to 12 days post-infectious feeding). This particular timing
might be explained by the addition of subsequent blood meals which induce midgut expansion,
increasing the number of midgut basal lamina micro-perforations and enhancing the likelihood of
virus dissemination [46] as well as the stretching of follicular epithelial cells that facilitate higher viral
infection rates of reproductive tracts [36,47].
The VSV-positive staining in female reproductive tracts suggests the mechanism of sexual
transmission from infected females to males occurs by transmission of virus particles located at
the distal end of the female terminalia (gonopore and rectum) upon contact during copulation.
The VSV-positive fluorescent puncta in male reproductive tracts suggests the mechanism of sexual
transmission of VSV from infected males to females likely follows the sperm ejaculation pathway
in which virus particles are released from the base of the testis into the accessory gland where the
spermatozoa are mixed with ejaculatory secretions passing through the ejaculatory duct and are
released into the female reproductive tract upon copulation.
It has been demonstrated in mosquitoes that males and copulation activities have a synergistic
effect on transmission by influencing the female vectorial capacity [20,48]. To date, the role of male
midges in the transmission dynamics of VSV or other midge-transmitted viruses has not been reported.
Our results of venereal VSV transmission between males and females suggests a potentially important
role for males in the natural survival and maintenance of interepidemic VSV. Although male midges
are not hematophagous, our study shows they can acquire virus and become infected after copulation
with infected females and then transmit VSV to naïve females during subsequent mating. From the
ecological and epidemiological perspective, males not only contribute to the overall virus overwintering
and transmission, but from our behavioral observations, they also increase the percentage of females
that successfully blood feed.
A caveat to mating midges in cages requires the consideration that VSV could have been
transmitted between the sexes not only during mating but also through other types of contact with
salivary or anal secretions. To undoubtedly determine if infection occurred during the act of mating,
we tested if VSV could be transmitted when an induced mating technique was used [49]. This way,
only a brief contact of the genitalia would be allowed. Unfortunately, successful copulation was not
achieved due to the complex C. sonorensis mating physiology and the long duration of attachment
required for successful copulation, which is possibly due to spermatophore formation and transfer
observed in other Culicoides species [23,24].
While there are limitations to confined laboratory experiments in induced mating, our research
shows VSV midge-to-midge transmission after cohabitation with orally infected, microinjected, or
venereally infected midges of the opposite sex. Our description of C. sonorensis mating behavior
and the morphological descriptions of the internal reproductive systems of both sexes extends the
knowledge of Culicoides midges and relates to previous studies on Culicoides melleus [23,24,50] and
Culicoides nubeculosus [51]. This research shows the importance of males in VSV transmission dynamics
and in the maintenance of VSV in nature. Additionally, the significant VSV-positive staining of female
reproductive tissues suggests vertical transmission may also play a role in VSV maintenance. While
further studies are needed to determine the effects of VSV vertical transmission, venereal transmission
to oviposition, mating behavior, and mate choices of infected/uninfected midges, these results highlight
the need to incorporate alternative routes of transmission in understanding arbovirus outbreaks.
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4. Materials and Methods
4.1. Virus and Cells
The New Jersey serotype of VSV (1982 bovine field isolate) was grown in porcine epithelial cells
(AG08113; Coriell Institute, Camden, NJ, USA)) in Eagles MEM with Earle’s salts (Sigma, St. Louis,
MO, USA) and 199E Media (2% FBS, 100U penicillin/streptomycin sulfate) at 37 ◦C with 5% CO2. Vero
MARU cells (VM; Middle America Research Unit, Panama, Panama) grown in 199E media at 37 ◦C
with 5% CO2 were used to detect and titer infectious virus in midge samples by standard plaque assay.
4.2. VSV Infection of Culicoides sonorensis Midges
Adult C. sonorensis midges used were from the AK colony maintained by USDA, Agricultural
Research Service, Arthropod-Borne Animal Diseases Research Unit at the Center for Grain and
Animal Health Research in Manhattan, KS, USA. Midges were reared as previously described [52].
Virgin female C. sonorensis midges (1–3 days post emergence) were allowed to feed on a glass, 37 ◦C
water-jacketed bell feeder with a parafilm membrane/cage interface for 60 min. The VSV-blood meal
consisted of defibrinated sheep blood (Lampire Biological Products, Pipersville, PA, USA) containing
4.25 × 108 PFU VSV-NJ. Fully engorged blood-fed females were sorted from unfed and partially fed
females and placed in cardboard maintenance cages. For positive controls, 1–3 day post emergence
virgin midges were anesthetized with CO2, intrathoracically inoculated with VSV-NJ, and placed
in maintenance cages. Intrathoracic injections were made dorsally at the prescutellar area using a
volume of 46 nl (1.4 × 104 PFU) for males and 60 nl (1.8 × 104 PFU) for females using a Nanoject II
injector (Drummond Scientific Company, Broomall, PA, USA). Injected volumes were determined
as the maximum capacity for the male and female body size. Adult midges were maintained in
environmental chambers at 25 ± 1 ◦C and 80% relative humidity with a 13:11 light: dark cycle and
offered 10% sucrose solution ad libitum.
4.3. Venereal Transmission Assays
Venereal transmission of VSV from infected females to naïve males was tested (Figure 1A) for
each of the three-blood meal-induced gonotrophic cycles (1–3GC). VSV-blood-fed virgin females were
placed in cages with age-matched naïve males at a ratio of 2:1 females to males. Four days post-mating
(dpm), all surviving males were individually collected in 300 μL of TRIzol (Invitrogen; Thermo Fisher
Scientific, Inc., Waltham, MA, USA) for RT-qPCR testing, or in 500 μL of antibiotic medium (199E cell
culture medium, 200 U/mL penicillin, 200 μg/mL streptomycin, 100 μg/mL gentamycin, and 5 μg/mL
amphotericin B) for plaque assays and CPE. Collected midges were stored at −80 ◦C until further
processing. Surviving females were moved to new cages and age-matched naïve males were again
added at a ratio of 2:1. Midges were offered non-infectious blood meals for 60 min at the start of each
cohabitation to initiate a gonotrophic cycle.
To test venereal transmission of VSV from infected males to naïve females (Figure 1B), four days
post intrathoracic injection (dpi), males were transferred to a cage containing age-matched naïve
females in a ratio of 2:1 females to males. Midges were offered a non-infectious blood meal for 60 min
to initiate a gonotrophic cycle. Following three days of cohabitation, all surviving males were collected
as above, and all surviving females were transferred to a new cage and kept for an additional four
days. Seven days after cohabitation/mating (7 dpm), all surviving females were collected as above.
To determine the VSV titer in males during the cohabitation period, a subsample of the infected males,
4 dpi and 7 dpi, was tested for virus by plaque assay.
To test venereal transmission of VSV from venereally infected males to naïve females (Figure 1C),
we used surviving males at the end of the cohabitation period with orally infected females at the third
blood meal-induced gonotrophic cycle. Venereally infected males were transferred to a cage containing
naïve females in a ratio of 2:1 females to males. Midges were offered a non-infectious blood meal for
60 min to initiate a gonotrophic cycle. Following three days of cohabitation, all surviving males were
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collected as above, and all surviving females were transferred to a new cage and kept for an additional
four days. Seven days after initial cohabitation, all surviving females were individually collected in
300 μL of TRIzol for RT-qPCR testing.
4.4. RNA Extraction and RT-qPCR for VSV Detection
Frozen TRIzol midge samples were thawed on ice and homogenized by high-speed shaking
with a Bead Mill Homogenizer (Omni, Kennesaw, GA, USA) for 2 min at 3.1 m/s. Samples
were centrifuged at 12,000× g for 6 min to pellet the debris. Total RNA was extracted using
Trizol-BCP (1-bromo-3chloropropane; ThermoFisher Life Technologies, Waltham, MA). RNA was
precipitated using isopropanol, washed in 75% ethanol, and eluted in 50 μL of nuclease-free water.
RNA extracts were analyzed using TaqMan Fast Virus 1-Step MasterMix (Applied Biosystems;
Thermo Fisher Scientific, Inc., Waltham, MA, USA) in a RT-qPCR targeting the L segment [53]:
forward primer VSVNJ7274: 5′-TGATTCAATATAATTATTTTGGGAC-3; reverse primer VSVNJ7495:
5′-AGG CTCAGAGGCATGTTCAT-3′; probe: FAM-TTGCACACCAGAACATTCAA-3′-BHQ1.
For amplification, the following temperature profile was used: Reverse-transcription 1 cycle at
50 ◦C for 5 min, denaturing and polymerase activation at 95 ◦C for 20 s, and amplification: 40 cycles of
95 ◦C for 15 s and 60 ◦C for 60 s. Samples were initially tested in pools containing RNA of 5 individual
midges followed by testing of individual samples from positive pools to determine the exact number of
positive individuals. Based on Ct values reported for VNT of dengue, Zika, and chikungunya viruses
in mosquitoes [36,37,41,45], RT-qPCR reactions with Ct ≤ 36 were considered positive for VSV RNA.
Additionally, to determine if virus acquired by venereal transmission could disseminate into salivary
glands of females, pools of bodies and heads (containing the proximal region of the salivary glands)
were assayed separately. Subsequent testing of individual bodies and heads from positive pools was
conducted to determine the exact number of positive samples.
Standard curves and calculation of Ct values were carried out with the 7500 Fast Dx software
(Applied Biosystems; Thermo Fisher Scientific, Inc., Waltham, MA, USA). Ct values were plotted
against the log of VSV genome equivalents. The linear regression (y = −3.30578x + 11.02683) was
used to determine the amount of viral genomic ssRNA per midge. Genome equivalents were
calculated with the published VSV genome molecular weight [54] and the NEBioCalulator (https:
//nebiocalculator.neb.com/#!/ssrnaamt).
4.5. Cytopathic Effect and Plaque Assays
To isolate infectious virus, frozen midges stored in 500 μL antibiotic media were thawed on ice
and individually homogenized as above. Samples were centrifuged at 12,000× g for 6 min to pellet
debris. A subsample of cleared supernatant (200 μL) was added to a monolayer of VM cells in a 24-well
plate and incubated at 37 ◦C for seven days at 5% CO2. Observation of cytopathic effects (CPE) after
one or two passages were used as an indicator of infectious virus within that sample. All CPE+ wells
were confirmed as VSV+ by testing for viral RNA by RT-qPCR, as described above. All homogenates
with positive CPE at the first passage were further analyzed to determine infectious virus titer by
standard plaque assay inoculating 200 μL of the original cleared supernatant sample on VM cells in
6-well plates and incubating at 37 ◦C for three days at 5% CO2.
4.6. Statistical Analysis
Data were pooled from independent replicates of each experiment. Statistical methods were not
used to predetermine the sample size. The proportion of infected midges was calculated by dividing
the number of infected whole midges by the total number of midges tested. A female with virus found
in the body but not in the head was considered as a non-disseminated infection. When the virus was
found in both the body and the head, the midge was determined to have a disseminated infection.
The proportion of females with disseminated infection was calculated as the number of midges with
positive heads divided by the total number of infected midges. Non-parametric tests were used to
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compare Ct distributions between gonotrophic cycles. GraphPad Prism version 8 (GraphPad Software
Inc., La Jolla, CA, USA) was used for statistical analysis and creation of graphs.
4.7. Fluorescent Immune Assay and Immunohistochemistry
To determine VSV localization in the reproductive tissues of infected C. sonorensis midges that
might allow VNT, intrathoracically injected males and females (4 dpi) were CO2 anesthetized and
reproductive tracts were dissected in PBST (PBS + 0.5% of Triton X 100; PH 7.4). Tissues were fixed in
4% paraformaldehyde for 4 h and washed in PBST. All reproductive tracts were blocked in 1% Normal
Goat Serum for one hour and sequentially incubated with rabbit anti-VSV-NJ nucleocapsid protein
antibody (dilution 1:500 or 1:1000) at room temperature (RT). After a 1-day incubation, the reproductive
tracts were washed in PBST for 4 h. Binding of primary antibodies was detected by incubating tissues
with 1:300 or 1:500 dilution of Alexa Fluor 488 IgG Alpaca anti-Rabbit (Jackson Immuno Research, West
Grove, PA, USA). Following a 4 h incubation in the dark at RT, samples were washed in PBST for 4 h.
Cell nuclei were stained with 10 ug/mL of DAPI (40,6-diamidino-2-phenylindole) (Invitrogen; Thermo
Fisher Scientific, Inc., Waltham, MA, USA). Reproductive tracts were mounted on slides using 100%
glycerol and examined in confocal microscope LSM700 (Zeiss International, Oberkochen, Germany).
Images were captured using ZEN software (Zeiss International, Oberkochen, Germany). Reproductive
tracts of non-injected midges were treated similarly and served as negative controls.
To better determine the virus localization in the reproductive organs of orally infected C. sonorensis
females, sagittal sections from sequentially sampled VSV-fed females (9–13 dpf) from a previous
study [10] were examined and captured using an All-in-One Fluorescence Microscope (BZ-X810;
Keyence Corporation, Itasca, IL, USA).
4.8. Behavioral Observations of C. sonorensis Copulation
All assays were conducted in round carton cages of 9 cm diameter and 5 cm height. Observations
of mating were made using a Nikon SMZ-1500 binocular stereo zoom microscope (Nikon Instruments
Inc., Melville, NY, USA). All observations were carried out under laboratory conditions (25 ± 2 ◦C,
65% RH).
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Abstract: Entomological surveillance for arthropod-borne viruses is vital for monitoring vector-borne
diseases and informing vector control programs. In this study, we conducted entomological
surveillance in Zika virus endemic areas. In Thailand, it is standard protocol to perform mosquito
control within 24 h of a reported dengue case. Aedes females were collected within 72 h of case reports
from villages with recent Zika–human cases in Kamphaeng Phet Province, Thailand in 2017 and 2018.
Mosquitoes were bisected into head-thorax and abdomen and then screened for Zika (ZIKV) and
dengue (DENV) viruses using real-time RT-PCR. ZIKV RNA was detected in three samples from two
female Ae. aegypti (1.4%). A partial envelope sequence analysis revealed that the ZIKV sequences
were the Asian lineage identical to sequences from ZIKV-infected cases reported in Thailand during
2016 and 2017. Dengue virus-1 (DENV-1) and dengue virus-4 (DENV-4) were found in four Ae. aegypti
females (2.8%), and partial capsid sequences were nearly identical with DENV-1 and DENV-4 from
Thai human cases reported in 2017. Findings in the current study demonstrate the importance of
entomological surveillance programs to public health mosquito-borne disease prevention measures
and control.
Keywords: zika virus; dengue virus; Aedes aegypti; mosquito surveillance; Thailand
1. Introduction
Mosquitoes are vectors of various flaviviruses, which are enveloped, positive-sense single stranded
RNA viruses (Family Flaviviridae, Genus Flavivirus). The most important mosquito transmitted
flaviviruses are the dengue (DENV), Zika (ZIKV), yellow fever (YFV), West Nile (WNV) and Japanese
encephalitis (JEV) viruses. Among them, DENV, ZIKV and JEV circulate widely in Southeast Asia,
including Thailand [1–3]. DENV and ZIKV are primarily transmitted to humans by Aedes mosquitoes,
with Aedes (Stegomyia) aegypti serving as the major vector and Aedes (Stegomyia) albopictus as a secondary
vector; whereas JEV and WNV are predominantly transmitted by Culex mosquitoes [1,4,5]. Both dengue
and Zika viral infections in humans range from asymptomatic to symptoms of fever, headache, myalgia,
arthralgia and maculopapular rash at the initial stage of illnesses [2,6]. DENV infections can be
classified as dengue fever (DF), dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS)
according to the severity of symptoms. DHF and DSS can be fatal if appropriate treatments are not
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provided, making the disease a significant public health concern, especially in endemic areas. Due to the
self-limiting nature of the illness and low mortality rates, infection with ZIKV has generally caused less
of a significant public health impact than dengue, since its first identification. Although typically milder
than infection with DENV, there are two severe ZIKV disease complications of note: Guillain–Barre
syndrome and meningoencephalitis. After the Brazilian ZIKV outbreak in 2015, public health scientist
noted Guillain–Barre syndrome and a drastic increase in the number of infants with microcephaly born
to mothers with the ZIKV infection meningoencephalitis, causing widespread alarm, especially among
pregnant women [7–9].
DENV has been postulated to have emerged about 1000 years ago in an infectious cycle involving
non-human primates and mosquitoes [10]. The first human case of DENV (DENV-1) was isolated in
Japan in 1943 [11]. Afterwards, outbreaks of four DENV serotypes (DENV-1, DENV-2, DENV-3 and
DENV-4) have been reported globally [12]. As reported by the World Health Organization (WHO),
the global incidence of dengue has increased 30-fold during the past five decades, with 50–100 million
new infections estimated to occur annually in more than 100 endemic countries. These infections
generally occur in tropical and sub-tropical regions [13]. Although more recently, DENV has been
reported from previously unaffected, more temperate areas such as France, Croatia, Portugal and
other European countries [1]. DENV incidence in Thailand has been reported since the 1950s [12]
and several major outbreaks with high morbidity have been documented since then. According to
the WHO, during 2004–2010, Thailand was ranked sixth among the 30 most highly dengue-endemic
countries in the world [13]. One of the largest DENV epidemics in Thailand was in 1987 with 174,285
cases and 1008 deaths. Recently, more than 72,000 dengue cases with a fatality rate of 0.13% were
reported in 2018 to the Ministry of Public Health, Thailand. All four DENV serotypes (DENV-1,
DENV-2, DENV-3 and DENV-4) are reported to circulate in Thailand with a recurrent circulation of
each serotype [12,14,15]. The Department of Disease Control—part of the Ministry of Public Health
(MOPH), Thailand—reported that the major DENV serotypes causing illness in 2017 were DENV-1 and
DENV-4. In 2018, DENV-1 remained the dominant serotype and the incidence of DENV-4 decreased.
ZIKV was first isolated from a sentinel rhesus monkey in the Zika forest, Uganda in 1947 and later
from a pool of Ae. africanus mosquitoes collected in the same forest [16]. Afterwards, serological evidence
of ZIKV infections in humans was reported for various African and Asian countries [6,17]. In 1975,
Moore et al. reported the first ZIKV isolation from a patient with febrile illness from Nigeria, as well as
the isolation of the virus from specimens collected in 1968 [18]. In Southeast Asia, ZIKV circulation was
suspected as early as 1954, due to reactivity in a seroprevalence study [5]. Starting in 2009, active ZIKV
circulation has been identified in Cambodia [19], Indonesia [20], Malaysia [21], the Philippines [22],
Singapore [23], Thailand [2], and Vietnam [24]. The first report of ZIKV in Thailand was in 2013 from
reports of infections in Canadian, German and Japanese travelers returning from the Southern part of
Thailand [25–27]. Later, a retrospective investigation by the Thai MOPH confirmed autochthonous
ZIKV cases in several different provinces across Thailand during 2012–2014, indicating wide-spread
distribution of ZIKV in the country [2]. ZIKV isolated from this study was from the Asian lineage
and is closely related to an isolate from the 2013 French Polynesia outbreak [2]. According to the
Bureau of Emerging Infectious Diseases, Department of Disease Control, Thai MOPH, in 2016 and
2017, more than 1600 confirmed ZIKV-infected cases were reported from different regions across the
central, north, east and west of Thailand [28].
Although many human cases of ZIKV and DENV infections have been reported in Thailand,
there are few reports of ZIKV circulation in wild-caught mosquitoes [29]. In this study,
entomological surveillance for arthropod-borne viruses was conducted in Kampheang Phet (KPP)
Province, Thailand, a dengue-endemic area where human Zika cases had been recently reported.
Aedes mosquitoes were screened for ZIKV and DENV and the virus sequences were analyzed.
Findings from this study can be used as the critical first step toward developing a routine entomological
surveillance and vector control program in Thailand.
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2. Results
2.1. Mosquito Collection
Over 86 trap-days, 488 mosquitoes belonging to four genera, Aedes, Culex, Armigeres and Anopheles,
were captured (Table 1). The majority (40.8%) of mosquitoes collected inside houses belonged to the
genus Aedes with 187 Ae. aegypti (130 females and 57 males) and 12 Ae. albopictus (11 females and
one male).
Table 1. Total number of collected mosquitoes in Kampheang Phet between July 2017 and February 2018.
Species Female Male Total
Ae. aegypti 130 57 187
Ae. albopictus 11 1 12
An. peditaeniatus 1 - 1
An. tessellatus 1 - 1
An. sp. 1 - 1
Ar. subalbatus 4 - 4
Cx. brevipalpis 3 - 3
Cx. quinquefasciatus 62 123 185
Cx. vishnui 88 5 93
Cx. sp 1 - 1
2.2. Virus Detection
A total of 282 samples from 141 Aedes females (130 Ae. aegypti and 11 Ae. albopictus) were screened
for ZIKV and DENV. Each female mosquito was separated in two parts (head-thorax and abdomen)
to determine virus dissemination. Both samples were tested from each mosquito. ZIKV and DENV
RNA was detected only in Ae. aegypti collected from houses that had recent human cases of ZIKV.
No ZIKV or DENV RNA was detected in Ae. aegypti from surveyed households within a 50 m radius
from detected human cases. A TaqMan® real-time RT-PCR and ZDC multiplex real-time RT-PCR
assay detected a ZIKV genome in three samples (R012, R013 and R015) from two Ae. aegypti females
(1.4%, 2/141). A partial ZIKV envelope gene was amplified from two samples from the same mosquito
(R012, head-thorax and R013, abdomen) by a conventional RT-PCR. DNA sequencing was performed
and analyzed by a BLAST search; sequences were identified as ZIKV and shared 100% sequence
identity. Four Aedes females (2.8%, 4/141) were DENV positive by real-time RT-PCR. Analysis of
partial capsid/prM sequences identified three DENV-1 (R248, R251 and R290) and one DENV-4 (R097).
The DNA sequences obtained from this study were submitted to the NCBI database and the accession
numbers were assigned as MN527290 for R012 (ZIKV), and MN527286, MN527287, MN527288 and
MN527289 for R097, R248, R251 and R290 (DENV), respectively.
2.3. Phylogenetic Relationship of ZIKV
A partial envelope sequence of R012 (MN527290) was compared with other ZIKV strains using
multiple sequence alignment. The genetic relationship was analyzed by construction of a phylogenetic
tree (Figure 1). The result showed that the R012 sequence belonged to the Asian lineage ZIKV
clade (nucleotide sequence identity ≥ 96%) and the alignment is shown in Supplementary Figure S1.
In addition, the E gene sequence was 100% identical to the sequence from a ZIKV detected in a citizen
from Thailand, reported in 2016 (MG548660.1), from patient serum collected in 2017 from Thailand
(MK237998.1), and the sequence from a ZIKV-infected Japanese tourist, who visited Thailand in 2017
(LC369584.1) [30].
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Figure 1. Maximum likelihood phylogenetic tree of Zika virus (ZIKV) partial envelope gene (331 bp).
The E gene sequences of ZIKV (R012) found in this study are indicated with black circles. Accession
numbers of all reference sequences are provided in the phylogenetic tree. Bootstrap values > 50% are
indicated at nodes. A scale bar represents nucleotide substitutions per site. A sequence of Spondweni
virus was used as an outlier.
2.4. Phylogenetic Relationship of DENV
One sequence from an Ae. aegypti collected in 2017 (MN527286) was identified as DENV-4 based
on sequence analysis of a partial DENV capsid/prM (nucleotide sequence identity > 98%), whereas the
other three sequences from Ae. aegypti females caught in 2018 (MN527287-MN527289) were DENV-1
(nucleotide sequence identity > 96%, Figure 2). They were closely related to DENV-1 (LC410183.1)
and DENV-4 (LC410203.1) detected in patients from Thailand reported in 2017 [14]. The sequence
alignment is shown in Supplementary Figure S2.
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Figure 2. Maximum likelihood phylogenetic tree of dengue virus (DENV) partial capsid/prM gene
(395 bp). All DENV capsid/prM sequences found in this study were indicated with black circles.
All accession numbers of reference sequences are provided in the phylogenetic tree. Bootstrap values> 50
are indicated at nodes. A scale bar represents nucleotide substitutions per site. Yellow fever virus was
used as an outlier.
3. Discussion
Mosquito-based ZIKV and DENV surveillance in KPP was conducted in areas where Zika–human
cases were reported recently. Among the four endophilic mosquito genera caught, the majority were
Aedes mosquitoes (40.8%). Only female Ae. aegypti and Ae. albopictus were subsequently tested for
ZIKV and DENV, as they are considered the major vectors to transmit these viruses. A total of 488
mosquitoes were captured from 86 trap-days (5.7 mosquitoes/trap). This is considerably high since
mosquito collections were performed within 72 h after receiving information about human cases of
ZIKV from the local hospitals. Local regulations required all houses with confirmed DENV or ZIKV
cases to be sprayed with an adulticide within this time period. Surprisingly, both ZIKV and DENV
infected mosquitoes were found in adulticide sprayed houses (index houses).
ZIKV was detected in two Ae. aegypti samples from the same mosquito specimen collected from
a Zika index house. Based on a sequence analysis of the E gene, which has been used to classify
ZIKV into African and Asian lineages, the ZIKV detected in this study was of the Asian lineage [31].
Analysis showed the ZIKV sequence was 100% identical to previous human cases of ZIKV reported
in Thailand during 2016–2017 [30]. This confirms that the same ZIKV lineage was still circulating in
Thailand. The Asian lineage is presently responsible for various global outbreaks, including outbreaks
in Thailand [32]. No virus was detected in Ae. albopictus specimens but this may be due to the low
number of specimens (n = 11) collected in this study. Since the mosquito traps were set inside houses,
it was not surprising that Ae. albopictus was collected less frequently since it is more exophilic than
Ae. aegypti [5]. In a recent report from Thailand, both Ae. aegypti and Ae. albopictus were screened for
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ZIKV and ZIKV was detected in female, male and larvae of field-caught Ae. aegypti collected around
active ZIKV patients’ houses [29]. That study also did not detect ZIKV in Ae. albopictus.
Additionally, we detected DENV in mosquitoes collected from ZIKV patient homes, although no
DENV outbreak or dengue cases were reported in the study area during this period. It is possible that
the mosquitoes may have acquired DENV from unreported, asymptomatic infected humans, or by
vertical transmission [33]. The two DENV serotypes, DENV-1 and DENV-4, found in this study were
identical (more than 96% identity) to DENV from human cases reported in 2017 [14], which suggests a
connection to an outbreak of those DENV serotypes in Thailand during that time.
This study demonstrates the importance of entomological surveillance for public health programs
and to provide guidance to mosquito-borne disease prevention and control. The entomological
surveillance is crucial for the planning, implementation, and monitoring of vector control programs.
Both adult and larval control measures should be conducted focusing on index houses which can serve
as major hubs for transmission of the virus during an outbreak. In this study, disease vectors and
infected mosquitoes were captured in index houses although vector control, including adulticide and
larvicide application, was performed in homes within 24 h after cases of human disease were confirmed.
Therefore, a surveillance system for efficacy of vector control operations (e.g., mosquito sentinel,
larval bioassay, etc.) is warranted. This system will provide a warning to local public health officers
regarding the effectiveness of the current vector control program.
4. Conclusions
The presence of ZIKV and DENV in Ae. aegypti mosquitoes collected from houses recently sprayed
with adulticide has implications for public health and vector control measures in areas at risk for
flavivirus transmission. Since there are no effective vaccines or specific therapeutic treatments for
DENV and ZIKV infections, vector control is the only effective tool to mitigate disease transmission.
Vector surveillance before and after vector control is essential to validate the efficacy of the control
measures employed. Our study suggests that a single application of non-residual adulticide alone
may not be sufficient to reduce the risk of further spread of ZIKV by controlling the Aedes vector.
Routine entomological surveillance is essential for the planning and implementation of an effective
vector control program.
5. Materials and Methods
5.1. Study Site
From July 2017 to February 2018, mosquito surveillance was performed in 5 districts in KPP,
which is located approximately 360 km northeast of Bangkok. The climate in KPP is tropical with
three seasons: rainy (June to October), winter (November to February), and summer (March to May).
These five districts include Khanu Woralaksaburi, Khlong Lan, Kosamphi Nakhon, Mueang, and Sai
Ngam (Figure 3). These are DENV endemic areas but have recently reported human cases of ZIKV.
During the study period, there were nine human cases of ZIKV in these study villages reported to the
Provincial Public Health Office. Almost all Zika cases (8/9 cases) were reported in the rainy season.
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Figure 3. Mosquito collections from 9 Zika index case houses and 25 neighboring houses (within a 50 m
radius from the Zika index cases) located in 5 districts, Kamphaeng Phet Province, Thailand during
July 2017–February 2018.
5.2. Mosquito Collection
BG Sentinel traps (Biogents AG, Regensburg, Germany) baited with 1 kg of dry ice and BG-lure
containing ammonia, lactic acid and caproic acid, were used to collect mosquitoes. Traps were placed
inside 34 houses, including houses with ZIKV reported cases (n = 9) and neighboring houses within a
50 m radius of Zika index houses (n= 25). Based on the feeding behavior of Aedes mosquitoes, traps were
continuously operated to collect daytime biting mosquitoes for 8 h (0800–1600). Mosquito collection
was conducted no longer than 72 h after receiving information about human cases of ZIKV from
the local hospitals. Mosquito samples in each trap were stored in a cooler containing dry ice for
transportation to the Armed Forces Research Institute of Medical Sciences (AFRIMS) Entomology
laboratory in Bangkok, where the samples were further processed. All collected mosquitoes were
morphologically identified to species under the stereomicroscope [34]. They were sorted by sex and
location prior to keeping in a −80 ◦C freezer until use.
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5.3. Detection of ZIKV and DENV by Real-Time RT-PCR
Both Ae. aegypti and Ae. albopictus females were screened for ZIKV and DENV by real-time
RT-PCR. Aedes head-thorax parts were dissected from the abdominal parts and separately transferred
into microfuge tubes containing RPMI medium. Both mosquito parts (head-thorax and abdomen) were
homogenized in RPMI medium using a Bullet Blender® Storm (Next Advance, Inc., Troy, NY, USA).
Supernatant was collected for a total nucleic acid extraction using a PureLinkTM Viral RNA/DNA
Mini Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer’s instruction.
A TaqMan® Fast Virus 1-Step Master Mix (Applied Biosystems, Foster City, CA, USA) and specific
primers and probes were used in the real-time RT-PCR for detection of ZIKV [35] as shown in Table 2.
The real-time RT-PCR reaction contained 1× TaqMan® Fast Virus 1-Step Master Mix, 0.5 μM each
of forward (ZIKV835 or ZIKV1086) and reverse (ZIKV911c or ZIKV1162c) primers, 0.125 μM probe
(ZIKV860-FAM or ZIKV1107-FAM), and 5 μL of the total RNA in a final volume of 20 μL. Thermal
cycling conditions were: 50 ◦C for 15 min, 95 ◦C for 30 s, followed by 40 cycles of 95 ◦C for 10 s and
60 ◦C for 30 s in a CFX96TM Real-Time System (Bio-Rad, Hercules, CA, USA).
Table 2. Primer and probe sequences used in this study.
Primer Sequence (5′→3′) Position (nt) a Virus Region
Real-Time RT-PCR
ZIKV835 TTGGTCATGATACTGCTGATTGC 835–857 ZIKV Matrix
ZIKV911c CCTTCCACAAAGTCCCTATTGC 911–890 Envelope
ZIKV860-FAM b CGGCATACAGCATCAGGTGCATAGGAG 860–886 Envelope
ZIKV1086 CCGCTGCCCAACACAAG 1086–1102 ZIKV Envelope
ZIKV1162c CCACTAACGTTCTTTTGCAGACAT 1162–1139 Envelope
ZIKV1107-FAM b AGCCTACCTTGACAAGCAGTCAGACACTCAA 1107–1137 Envelope
RT-PCR for Sequencing
ZIKENVF GCTGGDGCRGACACHGGRACT 1643–1663 ZIKV Envelope
ZIKENVR RTCYACYGCCATYTGGRCTG 1989–2008 Envelope
D1 TCAATATGCTGAAACGCGCGAGAAACCG 132–159 DENV Capsid/prM
D2 TTGCACCAACAGTCAATGTCTTCAGGTTC 614–642 Capsid/prM
a. The nucleotide numbering corresponds to that of the published ZIKV sequence [GenBank: AY632535.2] or DENV
sequence [GenBank: DQ863638.1]. b. Probes are labeled with 5′ 6-FAM and 3′ TAMRA-N.
The real-time RT-PCR detection of ZIKV and DENV was done using a ZDC Multiplex RT-PCR
Assay (Bio-Rad) according to the manufacturer’s instruction. The real-time RT-PCR reaction contained
1× iTaqTM Universal Probes One-Step Reaction Mix, 0.6 μL of iScriptTM Reverse Transcriptase, 1× ZDC
Multiplex PCR Assay Mix and 5 μL of the total nucleic acid in a final volume of 25 μL. The thermal
cycler (CFX96TM Real-Time System) with conditions of 50 ◦C for 15 min, 94 ◦C for 2 min, followed by
45 cycles of 94 ◦C for 15 s, 55 ◦C for 40 s and 68 ◦C for 30 s was set.
5.4. DNA Sequencing and Phylogenetic Analysis
For nucleotide sequencing, the total RNA extracted from the ZIKV and DENV real-time RT-PCR
positive samples were subjected to the RT-PCR with sequencing primers (Table 2) using a SuperScript®
III One-Step RT-PCR System with a Platinum® Taq DNA Polymerase kit (Invitrogen, Carlsbad, CA,
Bio-Rad). The reaction mixture contained 1× reaction mix, 0.4 μM of each forward (ZIKENVF or D1)
and reverse primer (ZIKENVR or D2), 1 μL of SuperScript® III RT/Platinum® Taq Mix, and 5 μL
of the total RNA in a final volume of 25 μL. The thermal cycling conditions were set as a reverse
transcription at 50 ◦C for 30 min, followed by an initial denaturation of cDNA at 94 ◦C for 2 min,
40 cycles of denaturation at 94 ◦C for 15 s, annealing at 54 ◦C for 30 s, and an extension at 68 ◦C for
45 s, followed by a final elongation step at 68 ◦C for 10 min. The PCR products of 365 bp and 511 bp,
for ZIKV and DENV, respectively, were resolved on a 1.5% agarose gel, stained with ethidium bromide,
and visualized under a gel documentation system (Gel DocTM XR+ imaging system, Molecular Imager®,
Bio-Rad). The PCR products were extracted from gel using the QIAquick gel extraction kit (Qiagen,
112
Pathogens 2020, 9, 442
Hilden, Germany) following the manufacturer’s instructions. Purified DNA was sequenced using
the forward and reverse primers. Sequencing chromatograms were inspected and processed using
BioEdit 7.0.4.1. [36]. Nucleotide sequences were queried against the NCBI database using BLAST
and aligned with published reference sequences using ClustalW in BioEdit. Phylogenetic trees were
constructed using the Molecular Evolutionary Genetics Analysis software (MEGA, version 7.0.21) [37].
The maximum likelihood method was applied based on the phylogenetic model analysis. Bootstrap
resampling analysis of 1000 replicates was used.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/6/442/s1,
Figure S1: Alignment of 331 bp ZIKV partial envelop sequences, Figure S2: Alignment of 395 bp DENV partial
capsid/prM sequences.
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Abstract: Zika virus (ZIKV) has caused severe epidemics in South America beginning in 2015,
following its spread through the Pacific. We comparatively assessed the vector competence of
ten populations of Aedes aegypti and Ae. albopictus from Brazil and two of Ae. aegypti and one of
Culex quinquefasciatus from New Caledonia to transmit three ZIKV isolates belonging to African,
Asian and American lineages. Recently colonized mosquitoes from eight distinct sites from both
countries were orally challenged with the same viral load (107 TCID50/mL) and examined after 7,
14 and 21 days. Cx. quinquefasciatus was refractory to infection with all virus strains. In contrast,
although competence varied with geographical origin, Brazilian and New Caledonian Ae. aegypti
could transmit the three ZIKV lineages, with a strong advantage for the African lineage (the only one
reaching saliva one-week after challenge). Brazilian Ae. albopictus populations were less competent
than Ae. aegypti populations. Ae. albopictus generally exhibited almost no transmission for Asian
and American lineages, but was efficient in transmitting the African ZIKV. Viral surveillance and
mosquito control measures must be strengthened to avoid the spread of new ZIKV lineages and
minimize the transmission of viruses currently circulating.
Keywords: transmission efficiency; vector capacity; susceptibility
1. Introduction
Zika virus (ZIKV) is an arbovirus (Flaviviridae, Flavivirus) that originated in Africa, where it is
transmitted either in the wild or modified environments by Aedes mosquitoes. The virus was little
known for many decades after its discovery in the 1940s. However, beginning in 2007, when it caused
the first outbreak detected outside Africa (Yap Island, Federated States of Micronesia, Pacific region)
the virus gained notoriety [1,2]. In 2013, ZIKV emerged in French Polynesia [3], leading to more
than 8700 suspected cases and 30,000 medical consultations reported by the sentinel surveillance
network [4]. A recent seroprevalence study estimated that more than half of the population was
infected by ZIKV in French Polynesia [5]. From French Polynesia, ZIKV spread to New Caledonia
in 2013 [6,7], affecting the whole territory. The New Caledonia Health Authorities estimated the
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number of cases at about 11,000 [8]. From 2014 to 2017, ZIKV was detected in the Cook Islands,
Easter Islands, Vanuatu, Fiji, Samoa, Solomon Islands, Tonga and American Samoa [8,9]. During the
same period, ZIKV spread to the American continent, being first detected in northeastern Brazil in
2015 [10]. Subsequently, countrywide epidemics were reported in Brazil as well as several South and
Central American localities. In 2015, Brazil reported 37,011 probable Zika symptomatic infections
and the first cases of microcephaly associated with ZIKV [10,11]. The number of cases in Brazil
peaked in 2016 with nearly 215,320 probable Zika cases [12], followed by 17,593 and 10,768 reported
cases annually between 2017 and 2019 [13,14]. The occurrence of microcephaly and other congenital
neurological malformations associated with ZIKV infections has been described worldwide [15–17],
and the virus continues to be considered an important threat [18].
Although ZIKV can be directly transmitted between humans, vector borne transmission is
believed to play a major role in virus spread [19,20]. Aedes aegypti is generally considered the primary
vector of ZIKV in all surveyed areas [20–22]. Substantial variation in vector competence, however,
has been described in populations of Ae. aegypti of different geographical origins when challenged
with distinct ZIKV strains controlling for titer in infectious blood meal [20,23]. In ZIKV epidemic
and endemic areas, Ae. aegypti cooccurs with other domestic and peridomestic mosquitoes such as
Culex quinquefasciatus and Aedes albopictus that frequently bite humans. Natural ZIKV infections have
been reported in these species, and thus, they came under suspicion as alternative vectors [24–27].
Concerning Ae. albopictus, results of vector competence evaluations to date have shown that this
mosquito is susceptible to ZIKV but with a transmission efficiency that is significantly inferior to that
of Ae. aegypti [20,25]. In contrast, domestic Culex species tested worldwide to date have consistently
been shown to be essentially refractory to ZIKV, and thus, their potential role in ZIKV transmission
has become controversial [28–31].
Phylogenetic studies have shown that Brazilian ZIKV isolates clustered with other American
isolates in the so-called American lineage, sharing common ancestry with the Asian genotype that
includes strains that circulated in French Polynesia and other Pacific areas such as New Caledonia
in 2013–2014 [32–34]. Interestingly, Ae. aegypti and Ae. albopictus from Brazil exhibited lower vector
competence for a ZIKV from New Caledonia than for isolates from Brazil [28,35]. And curiously,
Ae. aegypti from Singapore was also less competent in experimentally transmitting a French Polynesian
isolate than a Brazilian one [36].
It is clear that vector competence is dependent on the specific combination of mosquito and
virus genotypes from different geographic regions [37,38]. Determining vector competence of human
biting mosquito populations from endemic ZIKV territories is required to inform control measures.
Here, we comparatively assessed the vector competence of 13 mosquito populations of Ae. aegypti,
Ae. albopictus and Cx. quinquefasciatus from New Caledonia and Brazil to African, Asian and American
ZIKV strains.
2. Results
2.1. Aedes aegypti from All Brazilian Regions Can Experimentally Transmit ZIKV Isolated from Africa, Asia
and America, but with Different Competence
Five Brazilian populations of Ae. aegypti were orally challenged with three strains of ZIKV;
the population represented the five geographic regions of the country. While infection was detected
in mosquitoes of all populations, regardless of the incubation time and the virus tested (Figure 1A,
Table S1), quantitative infection rates (IR) varied depending on the virus strain and the incubation
time. In general, IR did not increase with incubation time, regardless of the tested ZIKV isolates; the
results from the African isolate were a very representative example of this trend (Figure 1). Except for
the population of Natal, the IRs with the African genotype were always above 90%, being 100% for
most populations, regardless of the incubation time. There was greater heterogeneity in the IR with
the different viruses at 7 d.p.i. than at 14 and 21 d.p.i., except for the population of Rio de Janeiro,
where significant differences were detected between essentially all viruses in all incubation times
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(Figure 1A). At 7 d.p.i., the IRs were significantly lower for the ZIKV isolate of the Asian lineage in all
challenged Brazilian Ae. aegypti except for Natal. In general, IRs tended to be similar among viruses at
14 d.p.i., except for the Rio de Janeiro Ae. aegypti population.
Figure 1. Vector competence results for Aedes aegypti from different cities of Brazil (Cuiabá,Londrina,
Manaus, Natal and Rio de Janeiro) and New Caledonia (Kone and Noumea) orally challenged with
three ZIKV isolates: DAK 84 (African lineage), MASS 66 (Asian lineage), MRS OPY (American lineage).
(A) Infection rate, (B) dissemination rate, (C) transmission rate and (D) transmission efficiency at 7, 14
and 21 days after challenge. Error bars represent 95% confidence intervals. Significant differences are
indicated by asterisks (Fisher’s Exact test: * p < 0.05; ** p < 0.01; *** p < 0.001).
All three viruses tested were able to disseminate to secondary tissues (head) in all challenged
Brazilian Ae. aegypti populations, albeit to varying extents (Figure 1B, Table S1). However, in contrast
to IR, the dissemination rates (DR) were quite heterogeneous among the tested viruses and Brazilian
populations. At 7 d.p.i., DR were generally null or nonsignificant for all mosquito populations
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challenged with the two ZIKV isolates of the Asian genotype. In contrast, at this same incubation time,
the African genotype isolate had already surprisingly disseminated to the heads of more than 80% of
Ae. aegypti from Rio de Janeiro, Manaus and Natal. Albeit with lower rates, the African genotype also
disseminated in significantly higher rates and more rapidly than the other viruses in the mosquitoes of
Londrina and Cuiaba. At 14 d.p.i., all three tested viruses disseminated to the heads of mosquitoes of all
five Brazilian populations, but with heterogeneous DR. Again, regardless of the mosquito population,
the DRs of the Asian lineage were lower than those detected for African and American lineages at 14
and 21 d.p.i. (Figure 1B). In general, from two weeks after the infectious meal, these two viral isolates
disseminated in more than 75% of infected mosquitoes. The DR values increased over the incubation
time (p < 0.05) in the Cuiabá and Londrina Ae. aegypti infected with any of the ZIKV isolates and in the
Manaus and Natal populations infected with the Asian and American lineages (Tables S3–S5).
Interestingly, from 14 d.p.i. on, transmission was achieved in all combinations of Brazilian
Ae. aegypti and virus lineages, except for the isolate belonging to the African lineage which was
transmitted as early as 7 d.p.i. by four out of the five challenged populations (Figures 1C and 2D,
Table S1). It is noteworthy that from 14 d.p.i. on, infectious particles of the ZIKV of the African
genotype were detected in over 75% of individuals from all five mosquito populations in which the
virus had disseminated, and the transmission rates (i.e., the proportion of mosquitoes with infectious
viral particles in saliva among those with disseminated infection, or TR) increased with incubation
time (p < 0.05). In general, transmission efficiency values (the proportion of mosquitoes with virus in
saliva among all orally challenged mosquitoes, or TE) were higher in the African lineage compared to
the other two lineages. With few exceptions (TE for Manaus, Londrina and Rio de Janeiro; p < 0.05),
there was no significant difference between the TRs or TEs of the two ZIKV isolates of the Asian and
American lineages in any population of Ae. aegypti from Brazil.
Figure 2. ZIKV load in saliva of Ae. aegypti from five Brazilian cities at 7, 14 and 21 days
after oral challenge with three isolates: DAK 84 (African lineage), MASS 66 (Asian lineage),
MRS OPY (American lineage). Virus was detected by plaque forming unit (PFU) assays on Vero
cells. Significant difference is indicated by asterisk (Wilcoxon test: * p < 0.05).
The median viral load in Brazilian Ae. aegypti saliva ranged from 2 to 36, 2 to 160.5 and 2 to 97 PFU
at 7, 14 and 21 d.p.i., respectively (Table S2). The viral load per saliva sample reached values as high
as 685, 502 and 230 PFU when infected with the African, American and Asian lineage, respectively.
No difference was found when comparing viral load in positive saliva expectorated by Ae. aegypti
individuals belonging to the same population infected with the three different viruses, regardless of
incubation time, except for those from Rio de Janeiro infected with the African genotype compared to
the American lineage at 14 d.p.i. (p = 0.02) (Figure 2).
Comparing Ae. aegypti populations, only the viral titers in the saliva of mosquitoes from Natal
were higher than those from Rio de Janeiro (p = 0.001) infected with the African ZIKV at 21 d.p.i,
whereas the pairwise comparisons with the American and Asian lineages and incubation times did not
differ (Tables S3–S5).
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2.2. Two Populations of Aedes aegypti from New Caledonia Can Experimentally Transmit ZIKV Isolated from
Africa, Asia and America, but with Different Competence
Two New Caledonian populations of Ae. aegypti were orally challenged with three strains of ZIKV.
Infection was detected in mosquitoes of both populations, regardless of the incubation time and the
virus tested (Figure 1A, Table S1). In general, IR was already high at 7 d.p.i, and did not increase with
incubation time with any of the three ZIKV isolates. The IRs with the African genotype were always
above 85%, regardless of the incubation time. Some heterogeneity between the three ZIKV strains
could be observed with Ae. aegypti from Kone, with the IR ranging from 62% to 89% at 7 d.p.i.
All three viruses tested were able to disseminate to secondary tissues in both New Caledonian
Ae. aegypti populations (Figure 1B, Table S1). The DRs increased over time and ranged from 61 to
100% across the three virus isolates and two New Caledonian mosquito populations. Only at 7 d.p.i.,
a significantly higher DR for the African ZIKV genotype was observed compared to the Asian genotype
for both Ae. aegypti populations (p = 0.01 for Kone, and p = 0.01 and =0.01 for Noumea, compared to
ZIKV American and Asian lineages respectively).
Transmission was achieved in all combinations of New Caledonian Ae. aegypti and virus lineages
assayed from 14 d.p.i. on, except for the isolate belonging to the African genotype, which was
transmitted as early as 7 d.p.i. (Figure 1C,D, Table S1). For the African genotype, TR increased
over time for both Ae. aegypti populations (57 to 82%) except for Ae. aegypti from Kone at 21 d.p.i,
with a lower level of infectious saliva detected in individuals (17%). In general, the African genotype
was also by far the most efficiently transmitted for both Ae. aegypti populations compared to the Asian
one (p < 0.001). There was no significant difference between the TR or TE of the two ZIKV isolates of
the Asian genotype in any population of Ae. aegypti from New Caledonia, except at 14 d.p.i. for Kone
(p < 0.01).
Comparing the two New Caledonian Ae. aegypti populations, no significant differences were
detected for IR and DR, irrespective of the d.p.i. and the ZIKV strains. Regarding the TR, Ae. aegypti
from Noumea was higher at 21 d.p.i. for the African genotype compared to Ae. aegypti from Kone
(p < 0.001). Likewise, the TE of African genotype was higher for Ae. aegypti from Noumea compared
to those from Kone at 21 d.p.i. (p < 0.001). Unfortunately, due to technical issues, it was not possible to
estimate the viral load in the saliva of New Caledonia Ae. aegypti.
2.3. Aedes aegypti from Brazil and New Caledonia Have Similar Transmission Efficiency for ZIKV of the
American Lineage, but Differ Regarding the African and Asian Lineages at Some Incubation Periods
In comparisons of Ae. aegypti populations, no significant differences (p > 0.05) were found between
the TR and TE values exhibited by the seven Brazilian and two New Caledonian Ae. aegypti populations
challenged with ZKV of the American lineage, irrespective of incubation time (Tables S3–S5). On the
other hand, some significant differences were found in TR and/or TE with the African and Asian ZIKV
lineages. Interestingly, with the African ZIKV isolate, TR and TE values at 7 d.p.i were significantly
much higher for both New Caledonian populations (Noumea: p < 0.001 and Kone: p < 0.05) when
compared with any Brazilian Ae. aegypti. However, at 14 d.p.i., TR and TE values were statistically
similar (p > 0.05) for all comparisons with the African isolate. At 21 d.p.i, TR and TE values were also
essentially similar for all comparisons, with one exception: the New Caledonian Ae. aegypti from Kone
were significantly much less efficient (p < 0.01) in transmitting the African isolate than all other tested
populations. When considering transmission of the Asian lineage, TR values did not differ in any
pairwise comparisons at 7, 14 and 21 d.p.i. In contrast, when considering TE at 14 d.p.i., values for the
Asian lineage were much higher (p < 0.01) for the New Caledonian Kone population compared to all
Brazilian ones except Manaus. At 21 d.p.i., TE values for Kone continued to be lower than Manaus,
Rio (p < 0.05) when challenged with ZIKV of the Asian lineage.
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2.4. Brazilian Ae. albopictus Poorly Transmits ZIKV Isolates of the Asian Genotype Compared to the
African One
We assessed vector competence for the same three strains of ZIKV in five Brazilian populations
of Ae. albopictus sympatric to the tested Ae. aegypti populations. All orally challenged Ae. albopictus
populations became infected with the three virus isolates, but with significantly higher IR for the
African lineage compared to the Asian and American ones (Figure 3A, Table S1). This difference is
quite evident for all tested Ae. albopictus populations, except for that of Natal, where no significant
differences were found between IRs with the American and African isolates at 14 d.p.i. As for the
viruses of the Asian ZIKV genotype, the population of Natal could not be challenged with the Asian
lineage due to an insufficient number of mosquitoes.
Figure 3. Vector competence results for Aedes albopictus from different Brazilian cities orally challenged
with three ZIKV three isolates: DAK 84 (African lineage), MASS 66 (Asian lineage), MRS OPY
(American lineage). (A) Infection rate, (B) dissemination rate, (C) transmission rate and (D) transmission
efficiency at 7, 14 and 21 days after oral challenge. Error bars represent 95% confidence intervals.
Significant differences are indicated by asterisks (Fisher’s Exact test: * p < 0.05; ** p < 0.01; *** p < 0.001).
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All three ZIKVs disseminated in all Ae. albopictus populations at some time point (Figure 3B,
Table S1). Values of DRs significatively increased over time (p < 0.05) in all Ae. albopictus populations
infected with the African ZIKV, except in the mosquitoes from Manaus. No difference in DR values
was detected at 7 d.p.i. At 14 or 21 d.p.i., the African virus disseminated at a significantly higher rate
than the isolates of the Asian genotype, except for the Londrina and Natal populations. The ZIKV
isolate of the American lineage took longer than the other lineages to disseminate to secondary tissues
in Ae. albopictus from Cuiabá, Manaus (14 d.p.i.) and Londrina (21 d.p.i.).
Transmission was detected from 14 d.p.i. in all tested Ae. albopictus populations. With the
population of Londrina infected with the African virus, infective particles were detected in saliva
even earlier, i.e., at 7 d.p.i. (Figure 3C,D, Table S1). Only the African ZIKV was transmitted by all
Ae. albopictus populations. Transmission of the Asian and American lineages was heterogeneous among
Ae. albopictus, and very low to null TR and TE were usually recorded. The populations of Cuiabá and
Manaus were unable to transmit any virus of the Asian genotype, while those from Londrina and Rio
de Janeiro were able to transmit only the Asian isolate but not the American one; the latter isolate was
transmitted by Natal Ae. albopictus. When considering the initial number of challenged Ae. albopictus,
TE values were zero to less than 20% for almost all combinations of mosquito population, virus isolate
and incubation time, with a few exceptions with the African genotype. For instance, transmission
was detected in ~70% of Ae. albopictus from Rio de Janeiro and Cuiabá challenged with ZIKV of the
African genotype.
No difference was detected between viral load in saliva expectorated by Brazilian Ae. albopictus of
the same population infected with the three different isolates (Figure 4). The maximum viral load per
saliva of Ae. albopictus were 638, 337 and 127 PFU when infected with the African, American and Asian
lineages, respectively. Among all Ae. albopictus saliva samples at 7 d.p.i, the only positive ones were
from four individuals from Londrina with a median of only 2 PFU of ZIKV of the African genotype.
The median viral loads varied from 6.5 to 80 and 3 to 60 PFU at 14 and 21 d.p.i., respectively (Table S6).
Figure 4. ZIKV load in saliva of Ae. albopictus from five Brazilian cities at 7, 14 and 21 days after
oral challenge with three isolates: DAK 84 (African lineage), MASS 66 (Asian lineage), MRS OPY
(American lineage). Virus was detected by plaque forming unit (PFU) assays on Vero cells.
When comparing viral load per positive saliva between populations of Brazilian Ae. albopictus
challenged with the same isolate, no significant difference was detected (Tables S3–S5).
2.5. Brazilian Ae. aegypti Are Superior in Vector Competence to All Tested ZIKV Compared to Sympatric
Ae. albopictus
The comparison of vector competence of sympatric Aedes species from the five Brazilian localities
revealed that Ae. aegypti is generally much more permissive than Ae. albopictus for infection with all three
ZIKV lineages. The IR values for Ae. aegypti were significantly higher than for sympatric Ae. albopictus
challenged with the same ZIKV isolate and incubation period in 62% of the 37 possible pairwise
comparisons; differences were expressively high (p < 0.001 or <0.01) in 15 out of the 37 comparisons
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(see Table S1). In general, the IRs for Londrina Cuiabá, Manaus and Rio de Janeiro Ae. aegypti were
significantly higher than for sympatric Ae. albopictus despite the ZIKV isolates and incubation times
(Tables S3–S5). Curiously, no difference in IR (p > 0.05) was found between mosquito species from Natal,
although the number of possible comparisons in this case is relatively small. There was a clear tendency
for a superiority of Ae. aegypti compared to sympatric Brazilian Ae. albopictus in the dissemination and
transmission of the tested virus, although we were unable to demonstrate this trend statistically in
most cases due to the sample size. In fact, the number of individuals with infectious heads among
infected mosquitoes, and of individuals with infectious saliva among those with disseminated infection,
in Ae. albopictus populations was extremely low or nonexistent, greatly decreasing the usefulness of
making interspecies comparisons. Despite this limitation, significant differences (p < 0.05) in DR and
TE between sympatric Ae. aegypti and Ae. albopictus could be demonstrated, specially concerning the
challenges with the African ZIKV isolate, and to a lesser extent, with the American lineage (Table S1).
Despite being heterogeneous, all populations of Ae. aegypti were able to transmit the two ZIKV isolates
of the Asian genotype at 14 and/or 21 d.p.i, while the sympatric Ae. albopictus were often unable to
transmit or transmitted with very low efficiency. No difference was detected when comparing viral
load in positive salivas of sympatric Ae. albopictus and Ae. aegypti infected with the same ZIKV isolate
(Tables S3–S5).
2.6. Culex quinquefasciatus from New Caledonia Is Refractory to ZIKV
No infection was observed for Cx. quinquefasciatus from New Caledonia, irrespective of the d.p.i.
and the ZIKV strain tested (Table S1).
3. Discussion
We evaluated vector competence to three ZIKV lineages among 13 mosquito populations from
Brazil and New Caledonia including Ae. aegypti, Ae. albopictus and Cx. quinquefasciatus. This study is
unique in including a number of mosquito populations of three mosquito species from two continents
and testing multiple ZIKV strains from three continents all under identical experimental conditions.
The two territories focused on, i.e., Brazil and New Caledonia, were at the origin of the recent
ZIVK pandemic.
With the exception of Cx. quinquefasciatus, all challenged New Caledonian and Brazilian Aedes
were susceptible to infection with all tested ZIKV strains. However, viral dissemination to secondary
tissues and transmission was highly variable among the 12 Aedes populations; ZIVK lineage and
incubation time strongly influenced differences. The African ZIKV disseminated faster and at higher
rates, regardless of incubation time in all 12 Aedes populations, compared to the Asian and American
ZIKV lineages with a single exception, i.e., Kone Ae. aegypti at 21 d.p.i. The decrease in susceptibility to
infection in these mosquitoes suggests that Ae. aegypti from Kone could be more resistant to infection by
African ZIKV than those from Noumea. The African strain was the only one to have been transmitted
as early as 7 d.p.i. in both Ae. aegypti and Ae. albopictus, with the two New Caledonian Ae. aegypti
populations being significantly more efficient in transmitting this strain than the Brazilian populations.
These advantages in transmission rates of the African ZIKV genotype relative to the Asian genotype
were similarly described for Guadalupian Ae. aegypti, challenged with the same isolates and viral
load [39]. Previous studies with other African ZIKV strains have shown greater transmission rates in
Ae. aegypti from Mexico, USA, Brazil and New Caledonia, as well as higher fitness in vitro compared to
ZIKV of the Asian genotype [8,31,40,41]. Curiously, it has been shown that New Caledonian Ae. aegypti
are able to transmit African ZIKV isolates earlier than both the American and Asian ZIKV isolates [42].
It is worth noting that all seven New Caledonian and Brazilian Ae. aegypti tested here transmitted all
virus lineages from two weeks or more after oral challenge, with the viral load in positive Brazilian
Ae. aegypti salivas not differing among the tested viruses, except for those from Rio de Janeiro,
which presented higher viral loads when infected with the African isolate compared to the American
one at 14 d.p.i. When considering the performance of the two ZIKV strains belonging to the Asian
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genotype in Ae. aegypti, we found that the dissemination rates of the Asian lineage were lower than
those detected for the American lineage, independent of the mosquito population origin, while rates of
transmission did not differ. Interestingly, the seven Brazilian and New Caledonian Ae. aegypti did not
differ in their efficiency of transmitting the American ZKV lineage at 14 and 21 days’ extrinsic incubation.
The American ZIKV lineage, the only one circulating in Brazil, has caused disease outbreaks with
distinct incidences in the five Brazilian regions that were the origin of Ae. aegypti populations assessed
herein. During the 2016 outbreak, the Central-western region had the highest incidence of probable
Zika cases (222.0/100 thousand inhabitants), followed by the Northeast (134.4/100 thousand inhab.),
Southeast (106.2/100 thousand inhab.) and South (3.4/100 thousand inhab.) [12]. Annual incidences
in all regions have decreased considerably in recent years, but the Northeast continues to report the
highest rates (9.5/100 thousand inhab. in 2019) [14]. In this context, it is important to point out that
vector competence is only one component determining the vectorial capacity of Ae. aegypti populations,
the accurate assessment of which requires analyses of epidemiological, environmental and climate
factors to help better understand the vector transmission dynamics and extent and intensity of urban
arbovirus transmission [20,43,44].
The vector competence of Brazilian Ae. albopictus has been poorly evaluated [35,45]. Here, we
assessed the vector competence of sympatric Ae. aegypti and Ae. albopictus from five Brazilian cities.
In agreement with previous works [25,35,46,47], Ae. aegypti displayed greater susceptibility to infection
and likelihood of transmitting the three tested ZIKVs compared to Ae. albopictus from Brazil. In the
present study, the dissemination rates and transmission efficiency in Ae. aegypti were significantly
higher than in Ae. albopictus, especially for the African ZIKV, although this isolate could be detected
in the saliva of all five tested Ae. albopictus populations. Ciota et al. (2017) [48] found that USA
Ae. albopictus were more susceptible to infection than Ae. aegypti, but that transmission efficiency was
lower than Ae. aegypti, a result that suggested the existence of important transmission barriers in
Ae. albopictus. In contrast to the African ZIKV, Brazilian Ae. albopictus were incapable of transmitting
ZIKV of the Asian and American lineages in essentially all cases. The inefficiency in transmitting
American strains of ZIKV was previously reported [45]. Importantly, in spite of its potential to
transmit ZIKV, including reports of natural ZIKV infections elsewhere, there is no solid evidence that
Ae. albopictus has caused human ZIKV transmission in Brazil [20,21,23,25].
The epidemiological histories of ZIKV differ in Brazil and New Caledonia, but they are quite
related by the fact that the rapid spread of the virus in Brazil was preceded by the epidemic passage of
the same genotype in the Pacific, particular in New Caledonia [49,50]. On the other hand, the histories
of colonization by the two Aedes species tested herein differed considerably. While Ae. aegypti is
very widespread in Brazil as well as in most of the Pacific islands, the invasive Asian mosquito
Ae. albopictus has not yet colonized New Caledonia [51]. The invasion and colonization of the Americas
by the African mosquito Ae. aegypti dates back more than four centuries; the species was eradicated
in Brazil in the 1950s and later reintroduced from populations from neighboring countries [52–54],
while the Pacific area and New Caledonia were colonized more recently, mostly at the end of the XIXth
and beginning of the XXth century by founders of Asian, Australian and American origins [51,55].
In addition, the establishment of populations in distinct ecosystems, climates and environments, as well
as exposure to control measures, differently influenced natural history, microbiota and population
genetics, which, in turn, modulated phenotypes like vector competence [38,56].
The Brazilian mosquito populations tested here originated from five cities with differing
demographic and infrastructural conditions, as well as being environmentally distinct, varying
from semiarid to equatorial, with primary vegetation coverage from the savanna-like cerrado to the
Atlantic and Amazon rain forest. The relatively low human population densities of the inland cities
of Cuiabá, Manaus and Londrina (163.88, 158.06 and 306.49 inhabitants/Km2, respectively) contrast
with high densities in the coastal Natal and Rio de Janeiro (4808.20 and 5265.81 inhab./Km2) [57].
Insecticide-induced changes in resistant mosquitoes may be associated with phenotypic variations in
vector competence, either through sublethal exposure to insecticides or indirectly through changes
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in the environment [56]. Genes controlling resistance to insecticides can have pleiotropic effects and
result in changes in the insect’s vector capacity, such as longevity, behavior, and vector competence [58].
The Brazilian Aedes mosquito populations tested here differed considerably in terms of their resistance
to insecticides such as Temephos and Deltramethrin which were employed in the National Dengue
Control Program [59–66]. The Natal and Rio de Janeiro Ae. aegypti populations exhibit greater resistance
rates to the larvicide Temephos (an organophosphate), while Londrina and Manaus exhibit higher
resistance to the adulticide Deltramethrin (a pyrethroid) [65]. The high frequency of kdr alleles that
contribute to pyrethroid resistance is widespread in Brazilian Ae. aegypti, including the populations
challenged here [65], and the Phe1534Cys kdr mutation has been detected in Ae. albopictus populations,
including in the nearby of Londrina [64]. In New Caledonia, important resistant kdr mutations were not
detected in Noumea Ae. aegypti, which display low resistance levels to Deltramethrin [67]. Large genetic
differentiation has been reported among Brazilian Ae. aegypti [68–72]. In contrast, lower genetic
differentiation has been recorded between New Caledonian Ae. aegypti from the main island (Noumea
and Poindimie) than from a smaller island (from Ouvea) [51]. Additionally, except for differences in
demographic densities, Noumea (2186.6 inhabitants/Km2) and Kone (19.6 inhabitants/Km2) are quite
similar with regard to climate (http://www.meteo.nc/nouvelle-caledonie/climat/fiches-climatologiques).
Together, these observations help to explain similarities in the infection and dissemination rates
between the two New Caledonian Ae. aegypti populations, regardless of the tested viruses.
However, transmission rates and efficiency differed, which may suggest different frequencies in
transmission barriers. In sum, heterogeneity in vector competence to different ZIKV lineages in
Ae. aegypti and Ae. albopictus is not surprising, considering their differing origins and histories [20,23,45].
As expected, the New Caledonian Cx. quinquefasciatus was refractory to all three ZIKV strains.
This result agrees with the repeated vector competence evaluations performed with ZIKV isolates and
Cx. quinquefasciatus, as well as Cx. pipiens from several origins [28,30,40,48,73–81]. In view of these
data, no role in the human transmission of ZIKV can be attributed to Cx. quinquefasciatus from New
Caledonian or elsewhere [30,74,81].
There are likely genetic, technical and environmental factors that contribute to the variations in
vector competence in Aedes mosquitoes observed in the laboratory that may not always be relevant to
phenotypic variations in nature [38,40,45,82,83]. For example, mosquitoes fed directly on viremic ZIKV
vertebrates tend to become more infected and transmit better. Thus, it is possible that Brazilian and
New Caledonian Aedes are more competent than what we observed in the laboratory, which indirectly
suggests a potentially greater risk of transmission. While population origin influences transmission
efficiency, Brazilian and New Caledonian Ae. aegypti are competent vectors for ZIKV of African,
Asian and American lineages, with advantages for the African lineage, which can also be transmitted
by Brazilian Ae. albopictus. Reinforcing viral surveillance and improving and strengthening control
measures to reduce infestation by domestic and peridomestic Aedes are imperative if endemic Brazilian
and New Caledonian territories are to avoid the spread of new ZIKV lineages and mitigate the
transmission of locally circulating ZIKV in Brazil.
4. Materials and Methods
4.1. Ethic Statements
This study was done in compliance with New Caledonia Ethic regulations and the Institutional
Ethics Committee on Animal Use (CEUA-IOC license LW-34/14) at the Instituto Oswaldo Cruz.
This study did not involve endangered or protected species.
4.2. Viral Strains
Three ZIKV strains were used, each representing a viral lineage: DAK 84 (Senegal 1984, African
genotype), MRS_OPY_Martinique_PaRi_2015 (Martinique 2015, Asian genotype, American lineage)
and MASS 66 (Malaysia 1966, Asian genotype, Asian lineage). Viruses were provided by the Emergence
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Virus Unit (Marseilles, France) via the European EVAg project. Lyophilizates were resuspended in
sterile distilled water and inoculated onto Vero cells (ATCC, ref. CCL-81) for viral production using
a multiplicity of infection of 0.1 and DMEM medium supplemented with 2% fetal bovine serum
(FBS). Supernatants were collected after three days of growth and stored at −80 ◦C prior to vector
competence experiments. The viral titer of each virus strain was determined by serial 10-fold dilutions
of viral stock on Vero cells, and was expressed as 50% tissue culture infective dose per milliliter
(TCID50/mL). In the case of MRS_OPY_Martinique_PaRi_2015 ZIKV strain, virus stock was centrifuged
using Vivaspin 6 centrifugal concentrator (Sartorius, Stonehouse, UK) to achieve the final concentration
at 107 TCID50/mL used in the oral challenge experiments.
4.3. Mosquito Populations
Three mosquito species of eight populations were orally challenged: two of Ae. aegypti
(F1 generation) and one of Cx. quinquefasciatus (F0 generation) from New Caledonia, and five
of Ae. aegypti (F2–F4 generation) and Ae. albopictus (F2–F4 generation) from Brazil (Figure 5).
In New Caledonia, Ae. aegypti (larvae) and Cx. quinquefasciatus (eggs rafts) were collected in Noumea
(Southwestern), Kone (Northwestern) and Dumbea (Southwestern) during the hot season (April and
March 2018) (Figure 1). The Brazilian Ae. aegypti and Ae. albopictus were derived from eggs collected
with ovitraps set in Manaus (Northern, Amazon), Natal (Northeastern), Rio de Janeiro (Southeastern),
Cuiabá (West-Central), Londrina (Southern) at different periods (Figure 5). Larvae were reared in 2 L
plastic pans, with a density of 150–200 larvae per pan containing dechlorinated tap water, supplemented
with brewer’s yeast which was renewed every 2–3 days. Pupae were then transferred to rearing cages
where adults were maintained at 28 ± 1 ◦C, 70–80% relative humidity and a 12:12 h light:dark cycle,
with access to 10% sucrose solution ad libitum.
 
Figure 5. Species and localization of mosquitoes from Brazil and New Caledonia challenged with Zika
virus. The generations of tested mosquitoes are in parenthesis.
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4.4. Oral Challenge
Seven- to ten-day-old nulliparous females were used for oral infection, with a preliminary
starvation of 24 h and 48 h for Aedes species and Cx. quinquefasciatus, respectively. The infectious blood
meal consisted of a mix (2:1) of washed rabbit erythrocytes and viral suspension at 3 × 107 TCID50/mL
(final concentration at 107 TCID50/mL) supplemented with a phagostimulant (5 mM ATP). Mosquito
feeding was performed for 20 min with a Hemotek system (Hemotek Limited, Great Harwood, UK).
Fully engorged females were transferred into cardboard containers and maintained with 10% sucrose
solution at 28 ± 1 ◦C, 70–80% relative humidity and a 12:12 h light:dark cycle for further analysis.
4.5. Infection, Dissemination and Transmission Analyses
For each combination of viral strain and mosquito population, 20–30 females were randomly
analyzed at 7, 14 and 21 days after oral challenge (hereinafter abbreviated as d.p.i.). Mosquitoes were
individually processed using disposable and disinfected supplies to avoid contamination between
individuals and between tissues of the same mosquito, as previously described [84]. After brief
anesthesia by exposure to cold (ice bath) and removal of the wings and legs, mosquito saliva was
collected in 5 μL of FBS for 30 min at room temperature. Each saliva sample was added to 45 μL
of DMEM medium and stored at −80 ◦C until use. For the determination of viral infection and
dissemination, each mosquito body (abdomen and thorax) and head was separately ground in 350 μL
of DMEM medium supplemented with 2% FBS and antibiotics/antifungals (100 units/mL of penicillin,
0.1 mg/mL of streptomycin and 0.25 μg/mL amphotericin B). The obtained homogenates were then
centrifuged at 10,000 g for 5 min at 4 ◦C before inoculation in cell culture. The infectious status
was determinate by the presence of cytopathogenic effect (CPE). Briefly, 100 μL of diluted samples
were inoculated onto confluent monolayer Vero cells in 96-well plates, and incubated for 7 days at
37 ◦C with 5% CO2 under 2.4% CMC (carboxymethyl cellulose) or agarose. Plates were then stained
with a 0.2% crystal violet solution (in 10% formaldehyde and 20% ethanol). The presence of ZIKV
particles in saliva and viral titer were determined by plaque assay. Saliva samples were inoculated in
six-well plates seeded with Vero cells, and incubated and stained as described above. Saliva titers were
expressed as plaque forming units (PFU) per saliva sample. The infection rate corresponded to the
proportion of mosquitoes with infected bodies among all the tested mosquitoes. The dissemination
rate represented the proportion of mosquitoes with infectious heads among infected mosquitoes.
The transmission rate corresponded to the proportion of mosquitoes with infectious viral particles
in saliva among mosquitoes with infected heads. The transmission efficiency corresponded to the
proportion of mosquitoes with virus in saliva among all the orally challenged mosquitoes.
4.6. Statistical Analyses
The different rates and efficiencies calculated either by mosquito populations, viral strains or days
postchallenge were compared by a Fisher’s exact test. Quantitative data corresponding to viral titer
per saliva were compared using Wilcoxon test. All tests were corrected for multiple comparisons using
the Holm method. All statistical analyses were performed with the R v3.6.1 software [85] considering
p-values < 0.05 as significant.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/7/575/s1,
Table S1: Infection rates, dissemination rates, transmission rates and transmission efficiencies obtained for all the
mosquito populations tested with the three Zika virus isolates at 7, 14 and 21 days after oral challenge. Table S2:
Medians and interquartile rages of viral load in saliva of Aedes aegypti Brazilian populations challenged with the
three Zika virus isolates at 7, 14 and 21 days after challenge. Table S3: Summarize of the p-values obtained with
the Fisher’Exact test and the Wilcoxon test corrected with the Holm method of infection rates, dissemination rates,
transmission rates, transmission efficiencies and viral loads in saliva obtained for all the mosquito populations
tested with the Zika virus of the African lineage at 7, 14 and 21 days after oral challenge. Table S4: Summarize of
the p-values obtained with the Fisher’Exact test and the Wilcoxon test corrected with the Holm method of infection
rates, dissemination rates, transmission rates, transmission efficiencies and viral loads in saliva obtained for all the
mosquito populations tested with the Zika virus of the Asian lineage at 7, 14 and 21 days after oral challenge.
Table S5: Summarize of the p-values obtained with the Fisher’Exact test and the Wilcoxon test corrected with the
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Holm method of infection rates, dissemination rates, transmission rates, transmission efficiencies and viral loads
in saliva obtained for all the mosquito populations tested with the Zika virus of the American lineage at 7, 14 and
21 days after oral challenge. Table S6: Medians and interquartile rages of viral load in saliva of Aedes albopictus
Brazilian populations challenged with the three Zika virus isolates at 7, 14 and 21 days after challenge.
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Abstract: Dynamics of dengue serotype 2 virus isolated from patients with different disease severity,
namely flu-like classic dengue fever (DF) and dengue shock syndrome (DSS) were studied in
its mosquito vector Aedes aegypti. We compared isolate infectivity and vector competence (VC)
among thirty two A. aegypti-viral isolate pairs. Mosquito populations from high dengue incidence
area exhibited overall greater VC than those from low dengue incidence area at 58.1% and 52.5%,
respectively. On the other hand, the overall infection rates for the isolates ThNR2/772 (DF, 62.3%) and
ThNR2/391 (DSS, 60.9%), were significantly higher than those for isolates ThNR2/406 (DF, 55.2%) and
ThNR2/479 (DSS, 54.8%). These results suggest that the efficacy of dengue virus circulation was likely
to vary according to the combination between the virus strains and origin of the mosquito strains,
and this may have epidemiologic implications toward the incidence of flu-like classic dengue fever
(DF) and dengue shock syndrome (DSS).
Keywords: dengue virus; disease severity; vector competence
1. Introduction
Flulike classic dengue fever (DF) and dengue hemorrhagic fever (DHF) are increasingly important
public health problems issues in the tropical region. Annually, an estimated 390 million dengue
infections per year and 96 million of symptomatic dengue infections occur [1]. It has been predicted
that population at risk of dengue will rise by 2.25 (1.27–2.80) billion by the year 2080 compared to 2015,
which will put over 6.1 (4.7–6.9) billion at risk—nearly 60% of the world’s projected 2080 population [2].
DF/DHF and DSS has re-emerged in tropical and subtropical zones, with DHF as the prominent cause
of pediatric mortality and hospitalization during the past 20 years in Southeast Asia [3,4]. All dengue
viruses (DENV) can result to DHF cases, but the severe form is mostly associated with DENV-2 and
DENV-3 [5]. It has been suggested that DHF epidemics occur as a consequence of a very complex
mechanism comprising the intersection of three groups of factors (viral, host, and epidemiological) [6].
In addition, some amino acid changes on the premembrane (prM) and envelope (E) proteins of DEN-2
strains have been related to DHF epidemics [7]. Furthermore, Pandy and Igarashi classified Thailand
DENV-2, according to the non-synonymous amino acid replacement, in three subtypes (I, II, and III)
and proposed that viruses’ molecular structures and patients’ serological responses influence clinical
severity [8].
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Aedes aegypti, the primary vector of dengue, is well-adapted to cohabitate with humans by breeding
in man-made containers. Several population genetic and vector competence (VC) studies have been
done on A. aegypti because of its ability to transmit dengue and yellow fever flaviviruses [9–16]. Genetic
markers have been used to identify biotypes, biting behavior, and other epidemiologically relevant
traits [17]. Vector movement among disease foci or from a site of initial colonization can be investigated
through genetic similarity between geographically heterogeneous populations [18]. The genetically
intrinsic leniency of a vector to infection, replication, and virus transmission, vector competence [19],
present significant variability among A. aegypti populations particularly for DENV-2es [10,11,20]. Genes
or sets of genes controlling the midgut infection and escape barriers have been found to be associated
with the VC of A. aegypti for flaviviruses [14–16].
There are several possible mechanisms that can affect the transmission potential of different
dengue virus strains. Some strains may infect and replicate target cells more efficiently, sustain higher
viremia in the human host, and infect more mosquitoes [21–23]. Studies have shown that dengue virus
serotypes and strains within a serotype, between and within a genotype may vary in their ability to
infect and disseminate in mosquitoes [10,11,24–26].
Several studies have reported variation in the oral receptivity of A. aegypti for DENV-2 at a
regional geographic scale [27–29], as well as VC [30]. Furthermore, it has also been reported that
DENV-2 vary according to the genotype in their efficiency to infect and disseminate in A. aegypti [24–26].
However, these studies were done using only a few mosquito collections or virus strains resulting in
the evaluation of patterns of differential infection in a small number of virus–vector pairs.
In the present study, we address the potential variation in VC and patterns of oral infection of
dengue virus isolates representing distinct disease severity in sympatric DENV-2-A. aegypti pairs on a
regional geographic scale in Thailand. In particular, eight geographically heterogeneous mosquito
strains collected from areas with high and low dengue incidence were orally challenged with four
virus isolates recently isolated from patients exhibiting flu-like classic dengue fever (DF) and dengue
shock syndrome (DSS).
2. Results
Disseminated infection rates: Variations in the disseminated infection rates of the virus isolates
in Aedes aegypti were observed according to the mosquito origin (dengue incidence at the area and
location), mosquito strain, disease severity of the patients from whom the virus was isolated, and the
virus isolate (Table 1 and Figure 1).
Table 1. Infection and dissemination rates (%) A of DENV-2es isolated from patients with different
disease severity in orally challenged Aedes aegypti strains.
Mosquito
Strains
ThNR2/406 (DF) B ThNR2/772 (DF) ThNR2/391 (DSS) ThNR2/479 (DSS)
Infec Disse Infec Disse Infec Disse Infec Disse
TAL 66.7 58.3 (60) C 57.1 52.4 (63) 56.4 56.4 (55) 55.5 52.4 (63)
KAO 75.0 70.4 (44) 73.1 67.3 (52) 61.3 61.4 (44) 21.6 19.6 (51)
BPA 48.1 42.6 (54) 66.7 63.6 (66) 55.5 53.7 (54) 72.7 72.7 (44)
TAK 40.7 37.0 (54) 73.1 73.1 (52) 80.0 78.0 (50) 85.4 85.4 (48)
KKR 88.6 81.8 (44) 64.0 60.0 (50) 70.1 67.3 (48) 48.1 46.3 (54)
GKE 70.7 69.3 (75) 59.4 56.3 (64) 40.6 40.6 (64) 62.7 59.3 (59)
RBK 18.8 18.8 (69) 40.0 40.0 (60) 61.2 55.1 (49) 51.4 47.2 (72)
RBA 44.8 41.4 (58) 68.3 61.7 (60) 67.2 65.5 (58) 51.7 51.7 (58)
A Infection and dissemination: number of mosquitoes for viral RNA in abdomen and head tissue,
respectively; B DF: dengue fever; DSS: dengue shock syndrome; C Total number of mosquitoes tested for each
mosquito/virus combination.
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Figure 1. Disseminated infection rate variations of dengue virus serotype 2 isolated from patients with
different disease severity in Aedes aegypti according to dengue incidence at the mosquito origin area
(A), mosquito geographic origin and districts (B), mosquito strains (C), patient disease severity (D),
and virus isolate (E). Mosquitoes were scored positive if RNA dengue virus was detected in head tissue
by RT-PCR. Bars and error bars show the mean percentage of positive mosquitoes and the standard
error, respectively. Bars with the same letter are not significantly different (p < 0.05), while bars without
or different letter are significantly different (p > 0.05), based on Tukey’s test for means comparison.
Overall, the disseminated infection rates of dengue viruses in mosquito strains ranged from 66.7%
(TAK, 136 of 204 mosquitoes) to 39.2% (RBK, 98 of 250 mosquitoes). Mosquito strains collected from
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high dengue incidence areas showed a higher infection rate (58.1% of 854 mosquitoes) compared
to mosquitoes from low dengue incidence area (52.5% of 953 mosquitoes). However, no significant
statistical difference was observed (Figure 1A). Significant differences in infection rates were observed
among geographic origin. Mosquitoes collected from Bang Pakong district exhibited the highest
infection rate (62.1% of 422 mosquitoes) while mosquitoes collected from Ratchasan district exhibited
the lowest disseminated infection rate (46.9% of 484 mosquitoes). Mosquito strains collected from the
Muang district, despite being the most urbanized and with the highest reported dengue incidence,
showed lower disseminated infection rate (54.9% of 432 mosquitoes) compared to mosquito strains from
the rural Krong Kruang district (59.5% of 459 mosquitoes) that has lower reported dengue incidence
(Table 2 and Figure 1B). Among mosquito strains, significantly different disseminated infection rates
were observed, except for the BPA-GKE, BPA-TAL, BPA-KAO, GKE-RBA, and GKE-TAL pairs of
mosquito strains (Figure 1C). For virus isolates grouped according to the disease severity of the patients
from whom they were isolated, no differences in disseminated infection rate was observed between DF
and DSS virus isolates (Figure 1D). However, disseminated infection rates of the isolates ThNR2/772
(from DF patient) and ThNR2/391 (from DSS patient), were overall significantly different from isolates
ThNR2/406 (DF) and ThNR2/479 (DSS) with p < 0.005 (Figure 1E).
Table 2. Demographic information and dengue (DEN) background of the origin of Aedes aegypti strains
from Chachoengsao province, central eastern Thailand, used in this study.
Strain
At Collection Site At Collection Area
Subdistrict Demographic A Incidence B District Demographic A Incidence B
TAL Na Muang 4480.9/1640.4 153.2 Muang 369.2/106.8 141.3KAO
BPA BangPaakong 207.4/89.5 284.9
Bang
Pakong 306.1/89.6 105.8
TAK Tha Kam 542.5/345.2 204.2
KKR KrongKruang 114.2/30.9 117.3
Krong
Kruang 106.5/25.9 91.7
GKE Gon Kheo 99.7/21.2 88.45
RBK Bang Kla 70.4/18.3 40.3 Ratchasan 92.4/23.4 72.1RBA
A Numbers of people/houses per square Km. Based on census of 2002, Public Health Office, Chachoengsao; B Dengue
(DHF + DSS) annual average incidence, cases/100,000 habitants. Public Health Office, Chachoengsao, 1999–2002.
Vector competence variation: As a proxy of vector competence (VC), the VC was calculated as the
number of mosquitoes positive for the viral RNA in head tissues divided by the number of mosquitoes
exposed to the respective viruses. To better understand the geographical variation in the A. aegypti
vector competence for dengue viruses isolated from patients exhibiting different disease severity
(DF and DSS), the mosquito strains were grouped by dengue incidence at the area of mosquito origin
(sub-district level). High dengue incidence sub-districts comprises TAL, KAO, BPA, and TAK strains,
while low incidence sub-districts were KKR, GKE, RBK, and RBA strains. Mosquito strains were
further classified location at the district administrative level Muang (TAL and KAO), Bang Pakong
(BPA and TAK), Krong Kruang (KKR and GKE) and Ratchasan (RBK and RBA).
For the first grouping, the VC among mosquitoes from high dengue incidence for DSS isolates
ranged from 19.6% (KAO mosquito strain for the ThNR2/479 virus isolate) to 85.4% (TAK for the
ThNR2/479 virus isolate). DF isolates ranged from 37.0% (TAK mosquito strain for the ThNR2/406
virus isolate) to 73.1% (TAK mosquito strain for the ThNR2/772 virus isolate). Although no statistically
significant differences were observed between the overall VC for DF and DSS, mosquito strains
collected from high dengue incidence areas showed an overall higher competence for viruses isolated
from DSS patients than from DF patients. Whereas mosquito strains collected from low dengue
incidence areas exhibited a similar overall VC for either DF or DSS virus isolates, with VC ranging
from 40.6% (GKE mosquito strain for the ThNR2/391 virus isolate) to 67.3% (KKR mosquito strain
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for the ThNR2/391) for DSS isolates, and 18.8% (RBK mosquito strain for the ThNR2/406) to 81.8%
(KKR mosquito strain for the ThNR2/406) for DF isolates (Table 1). For the second grouping, mosquito
strains from Bang Pakong and Ratchasan districts showed a significantly higher VC for viruses isolated
from patients with DSS compared to patients with DF symptoms (Figure 2B). The VC for mosquito
strains from Bang Pakong ranged from 53.7% (for ThNR2/391 isolate virus) to 85.4% (ThNR2/479 isolate
virus) for DSS isolates, whereas DF isolates ranged from 37.0% (for ThNR2/406 isolate virus) to 73.1%
(ThNR2/772). The VC for mosquito strains from Ratchasan ranged from 47.2% (for ThNR2/479) to 65.5%
(for ThNR2/391) for DSS isolates, and from 18.8% (for ThNR2/406) to 61.7% (ThNR2/772) for DF isolates
(Table 1). In contrast, mosquito strains from Muang and Krong Kruang districts showed a significantly
higher VC for viruses isolated from patients with DF than from those with DSS, (Figure 2B). The VC
for mosquito strains from Muang ranged from 52.3% (for ThNR2/772) to 70.4% (ThNR2/406) for DF
isolates and from 19.6% (for ThNR2/479) to 61.4% (for ThNR2/391) DSS. The VC for mosquito strains
from Krong Kruang ranged from 56.2% (for ThNR2/772) to 81.8% (for ThNR2/406 isolate virus) for DF,
and from 40.6% (for ThNR2/391) to 67.3% (for ThNR2/391) for DSS isolates (Table 1).
The VC of individual mosquito strains significantly differed between virus isolated from patients
with DSS and DF, p < 0.05. Females of the TAL, KAO, GKE, and KKR strains exhibited a significantly
higher VC for DF virus isolates than for DSS, while BPA, TAK, and RBK showed a significantly higher
VC for DSS than for DF virus isolates, (p < 0.05) as shown on Figure 2C. As summarized on Table 1,
the VC among mosquito strains for the four isolates differed according to the A. aegypti strain-virus
isolate combinations which ranged from 18.8% (RBK-ThNR2/406) to 85.4% (TAK-ThNR2/479).
Viral isolates infectivity variations: The infectivity of a virus isolate for A. aegypti was calculated
as the number mosquitoes positive for viral RNA in the abdomen divided by the number exposed
to the virus isolate. Overall, ThNR2/772 (DF) and ThNR2/391 (DSS) were the most infectious virus
isolates, where 62.3% of 467 and 60.9% of 422 mosquitoes were positive, respectively; while ThNR2/406
(DF) and ThNR2/479 (DSS) were significantly less infectious where 55.2% of 458 and 54.8% of 449
mosquitoes were positive, respectively, (p < 0.05; Figure 1E).
Different patterns of infection dynamics among individual virus isolates in mosquitoes were
observed. Infection rates for ThNR2/772 (DF) and ThNR2/391 (DSS) isolates were more uniform.
ThNR2/772 ranged from 40% (RBK mosquito strain) to 73.1% (KAO mosquito strain), while ThNR2/391
ranged from 40% (GKE mosquito strain) to 80% (TAK mosquito strain). In contrast, virus isolates
ThNR2/406 (DF) and ThNR2/479 (DSS), exhibited more phenotypic variation where infection rates
ranged from 18.8% (RBK mosquito strain) to 88.6% (KKR mosquito strain), and from 21.6 (KAO
mosquito strain) to 85.4% (TAK mosquito strain), respectively, (Table 1). Furthermore, according to the
mosquito strains, significant differences in the number of infected mosquitoes were observed among
individual viral isolates. The proportion of mosquitoes infected by the ThNR2/406 (DF) virus isolate
was not significantly different only between KAO-GKE and TAK-RBA mosquito strain pairs, and by the
ThNR2/772 (DF) virus isolate was not significantly different between GKE-KKR-RBA mosquito strains,
and by the ThNR2/391 (DSS) virus isolate was not significantly different between TAL-KAO-BPA-RBK
mosquito strains, and by the ThNR2/479 (DSS) viral isolate was not significantly different only between
KKR-RBA mosquito strains.
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Figure 2. Vector competence of Aedes aegypti for dengue serotype 2 virus isolated from patients
exhibiting different disease severity according to dengue incidence at the mosquito strain origin area
(A), mosquito geographic origin, districts (B), and mosquito strains (C). Vector competence is expressed
as the number of mosquitoes positive for viral RNA in head tissues/number tested. Bars and error bars
show the mean percentage of positive mosquitoes and the standard error, respectively. Bars with the
same letter within the same group are not significantly different (p < 0.05) based on Tukey’s test for
means comparison.
3. Discussion
Vector, viral, and environmental factors determine the capacity of dengue virus to infect and
disseminate in its mosquito vector. In the present study, we challenged each mosquito strain with all
four virus isolates at the same time and mosquitoes were held together during the same environmental
fluctuations of the incubation period (14 days), to minimize the effect of environmental variation.
Even though all mosquito strains may not have experienced the same environmental conditions no
statistical significant differences were observed when mean temperature and humidity that each
mosquito strain experienced during the incubation period were compared among strains (data not
shown). Nonetheless, some of the observed mosquito VC and viral isolate infectivity variations may
have been influenced by environmental variation among experimental groups.
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Variations in infection rates of A. aegypti experimentally infected with DEN virus has been
reported [10,11,20,27–30]. Differences on the proportion of infected mosquitoes between DENV-2
with SEA and American genotype have also been reported in geographically separated A. aegypti
populations [24–26]. In contrast to previous studies, the present study used low-passage virus isolates
that were recently isolated from patients exhibiting different disease severity (i.e., DF and DSS), which
were of sympatric geographic origin with the used A. aegypti strains. Although the A. aegypti were
collected in the same province, considerable variability in overall infection rates was observed according
to the dengue incidence in the collection area, geographic origin (districts), mosquito strain, individual
virus isolate, and disease severity of the patients from whom the virus was isolated (Figure 1A–E).
From our observations, although neither high or low dengue incidence mosquito strains showed
significantly different VC for DF or DSS viral isolates (Figure 2A), the mosquito strains collected from
high dengue incidence sites exhibited higher overall VC for virus isolates either isolated from patients
exhibiting mild (DF) or severe (DSS) disease severity than mosquito strains from sites with low dengue
incidence site (Table 3). However, significant differences in VC for DF and DSS virus isolates were
observed among mosquito strains from different geographic origins (districts) (Figure 2B). Furthermore,
most individual mosquito strains showed significantly different VC either for DF or DSS virus isolates.
Only the RBA mosquito strain did not show significantly different VC between DF and DSS viral
isolates (Figure 2C). Therefore, we speculate that factors such as the origins of mosquitoes, the viral
strains (DF or DSS) circulating in a given locale, and mosquito factors, per se play an important role
in determining A. aegypti VC. A detailed genetic analysis is needed to determine if these mosquito
strains are actually isolated and constitute independent populations that differ in susceptibility to the
infection with dengue virus. In previous studies, it has been shown that mosquitoes from populated
and urbanized areas are genetically highly differentiated and exhibit high and heterogeneous infection
rates, and this genetic differentiation has been related to the intensity of insecticide control and human
population density [16,27–29]. As for mosquito factors, the VC for arboviruses is associated with
anatomic barriers to productive vector infection, including a midgut infection barrier (MIB), a midgut
escape barrier (MEB), and a salivary gland barrier [30,31]. A. aegypti VC for DENV-2 is considered
as being universally proportional to the level of MIB and MEB found in mosquito collections, where
strong MIBs and MEBs decrease transmission potential [30]. It is also important to remember that
there is potential for different loci to affect VC in different populations [14,16]. Thus, the need to look
for genetic variation is evident. This study also raised the possibility that VC for a virus isolate is not
randomly distributed across the disease severity of the patient from whom the virus was isolated.
We found that mosquito strains from the same district exhibited the same VC pattern, namely TAL,
KAO, and GKE, KKR mosquito strains collected from Muang and Krong Kruang districts, respectively,
were significantly more competent for DF virus isolates than for DSS viral isolates. In addition, the BPA
and TAK mosquito strains collected from Bang Pakong districts and RBK and RBA from Rachasan
district, though RBA did not show significant different VC, exhibited the same VC pattern, indeed,
were more competent for DSS than for DF viral isolate (Figure 2C).
Dengue viruses’ efficiency to infect and disseminate in their vector mosquitoes can vary greatly.
In the present study, virus infectivity was evaluated by measuring the proportion of mosquitoes infected
by individual virus isolates. Overall, we found variation in the proportion of mosquitoes infected with
individual virus isolates. Specifically, the ThNR2/772 and ThNR2/391 isolates were more infective
than the ThNR2/406 and ThNR2/479 viral isolates (Figure 1E). However, the virus isolate infectivity
seems likely to be differentiated according to mosquito strain–viral isolate pairs, Figure 3. Therefore,
we speculate that differences in the proportions of infected mosquitoes among individual virus isolate
are probably due to certain genetic elements of the isolated virus. Few genetic differences among
dengue virus isolates may have a significant effect on their infection, dissemination and transmission by
vector mosquitoes. Previous studies on DENV-2 revealed differences in the proportions of mosquitoes
infected by individual virus isolates and have been associated with molecular differences among virus
isolates [24–26,32].
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Table 3. Medical data and in vitro infectivity results of four DEN-2 isolates virus isolated patients of














ThNR02/406 M 16 DF NA A 7 0 1.2 × 105
ThNR02/772 M 14 DF NA 14 9 8.5 × 103
ThNR02/391 M 12 DSS NA 29 2 1.38 × 105
ThNR02/479 M 12 DSS Secondary 3 0 1.0 × 102
149 B 56
A Due to the lack of a second serum sample; B Second serum sample was obtained 2 weeks after the first sample.
Figure 3. Infectivity of four dengue 2 viruses isolated from patients exhibiting different disease severity
for geographically different Aedes aegypti strains. Virus infectivity is expressed as the number of
mosquitoes positive for viral RNA in abdomen/number tested. Bars and error bars show the mean
percentage of positive mosquitoes and the standard error, respectively. Bars with the same letter within
the same virus isolate are not significantly different (p < 0.05), while bars without or different letter are
significantly different (p > 0.05), based on Tukey’s test for means comparison.
4. Materials and Methods
Collection sites: Four districts in Chachoengsao province situated in eastern Thailand, with the
highest (Muang and Bang Pakong) and lowest (Krong Kruang and Ratchasan) dengue (DF/DHF/DSS)
incidence (per 100,000 population) reported during the past 20 years were selected. Within these
districts the sub-districts (tambon) with the highest (Na Muang, Bang Pakong, and Tha Kam) and
lowest (Krong Kruang, Gon Kheo, and Bang Kla) dengue incidence from 1999 to 2002 were selected
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as mosquito collection sites (Figure 4). Sub-districts were classified as high and low dengue risk
areas based on annual incidence of DHF/DSS (cases/100,000 habitants), and the number of houses and
inhabitants per square kilometer. The selected locations covered a wide geographical distribution
of A. aegypti, including urban and rural environments. The shortest distance between study areas
(districts) was ca. 20 km, and between sub-districts was ca. more than 30 km.
Figure 4. Geographic localization of the collection sites of Aedes aegypti used depicting the habitat type
corresponding to each district.
Mosquito collections: A. aegypti were collected from two sites in each sub-district, (Table 2).
Samples from high dengue incidence areas were collected from houses with recent report of dengue
cases and from low incidence areas in house without dengue cases for the last two years. The mosquitoes
were collected as fourth stage larvae and/or pupae, at least 200 per collection site, from water containers
found outside and inside the house within a radius of ca. 2 km, at collection sites separated by at
least ca.5 km. Field collected mosquitoes (F0 generation) were reared to adults under room conditions
(26 ◦C ± 2 ◦C, RH 75% ± 10%). After morphological identification, based on the illustrated key to the
mosquitoes of Thailand [33], adults were kept in cages and females were blood-engorged on mice to
produce eggs. The onward generations of mosquitoes were reared in plastic pans (33 cm × 25 cm ×
11 cm) containing 3 L of aged tap water with a density of 180–210 larvae per container. The larvae were
fed on a diet of mouse food powder and maintained at 26 ◦C ± 2 ◦C, RH 75% ± 10%. Adults were fed
on 3% sucrose soaked cotton and females were allowed to mate and then blood-feed on mice to enable
egg production. The F0 mosquitoes were stored at −80 ◦C for future genetic analysis. Oral infection
experiments were performed with females from the first (F1) or second (F2) generations generated
from the F0 proved to be free of dengue virus infection. The mosquito strains used for oral infection
experiments and the dengue background of the district where the mosquitoes were collected are given
in Table 2 and Figure 4.
Virus strains: The four virus isolates were obtained from the sera of patients from Nakorn
Ratchasima Provincial Hospital, Northeastern Thailand, diagnosed with DF and DSS in 2002. Clinical
diagnosis confirmation and serological assays (ELISA IgG and IgM) were performed at the hospital,
while virus isolation and serotype determination were performed by the staff of the Arbovirus Section,
National Institute of Health, Medical Science Center, Nonthaburi. The clinical diagnosis and clinical
severity gradings of each isolate was classified using the World Health Organization criteria (WHO,
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1986) [34]. The serotype was determined as dengue virus type 2 by reverse transcription-polymerase
chain reaction (RT-PCR). Relevant patient information is summarized in Table 3.
All isolates were passaged four times in Aedes albopictus clone C6/36 cell line from the patient
serum before using for experiments. To ensure that the virus specimens were not altered significantly
from their wild type character as found in the host patient, none of the isolate has been purified by any
methodology before inoculation into mosquito cells.
Plaque assay: A seed virus was prepared by inoculation into a monolayer culture of Ae. albopictus
clone C6/36 cell line and incubated at 28 ◦C for 8 days in Eagle’s medium supplemented with 2%
heat-inactivated fetal bovine serum (FBS) and 0.2 mM each of nonessential amino acids plus antibiotics
(20 μg/mL Gentamicin, 5 μg/mL Amphotericin B, 200 U/mL). The infected culture fluid was harvested
8 days after inoculation, aliquoted, and stored at −80 ◦C until used. The virus titer of the isolates was
measured by the focus formation test by using BHK-21 cells on 96-well plates [35]. The virus isolates
were then used for preparation of the infectious meal, which was a blood virus sucrose solution (BVS).
Oral Infection: Only 4 to 5 day-old female mosquitoes were used to minimize age factors effects.
About 60 females were placed in cylindrical pint cardboard cages covered at one end with fine
non-wettable nylon mesh. These females were deprived of food for 36–40 h prior to the infectious
meal, then were allowed to feed on the infectious meal (BVS) consisting of equal volumes of isolate
virus suspension, washed rabbit erythrocytes, and 10% sucrose solution (as a source of energy). Drops
of the infectious meal were placed on the mesh covering the cardboard cage containing mosquitoes as
previously described [11,25]. Feeding time was limited to 1 h, mosquitoes were cold anesthetized and
fully engorged mosquitoes were collected with an aspirator at 30 min intervals, transferred into clean
carton cups and maintained for up to 14 days at 30 ± 1 ◦C as a virus extrinsic incubation period (EIP).
After the EIP completed survived mosquitoes were frozen at −80 ◦C, then transfer individually into
1.5 mL tube and kept at −80 ◦C until further use for viral RNA detection. Mosquito strains were orally
challenged on different days; however, each strain was challenged simultaneously with the four virus
isolates on the same day. All feeding suspensions contained the same virus titer (1 × 102 PFU/mL)
with an aliquot of the same virus pool. The titers of the post feeding virus suspensions did not
change significantly.
Detection of virus infection: After has completed the EIP (14 days) mosquito head and abdomen
were severed and homogenized in Trizol LS reagent for total RNA extraction, and then assayed for
dengue virus genome by using RT-PCR method. The detection of viral RNA in the homogenized
abdomen was interpreted as indicating that the mosquito midgut had become infected. Detection of
RNA viral in the homogenized head indicated disseminated from the infected midgut to a secondary
target organs.
RNA extraction and RT-PCR: Total RNA was extracted from individual mosquito head and
abdomen severed using Trizol LS (Invitrogen) according to the manufacturer’s recommendations.
Briefly, the head and abdomen of mosquito were separately homogenized in 300μL of Trizol reagent then
99.9 μL of chloroform was added. The resulting mixed suspension was centrifuged at 14,000 rpm/min
for 10 min at 4 ◦C. RNA was precipitated from the aqueous phase (ca. 145 μL) by mixing with 133.2 μL
of isopropyl alcohol. Isopropyl alcohol-RNA precipitate was recovered by centrifugation and the
RNA pellet was washed once with 90 μL of 75% ethanol followed by a second wash with absolute
ethanol and then air dried. The RNA pellet was resuspended in 10 μL of RNase-free water and used
as a template RNA in reverse transcriptase PCR (RT-PCR). Synthetic oligonucleotide primer pairs
were designed based on published sequence data for dengue virus serotype specific primer, sense
(D2-S) and complementary (D2-C) genome nucleotide (nt) regions 1203 to 1222 and 1432 to 1413
respectively [36,37].
Dengue virus RNA was assayed by using one step RT-PCR kit (Quiagen) following the
manufacturer’s recommendations with slight modifications. Briefly, 2 μL of RNA, 8 μL of reaction
mix, and RNase free water was reverse transcribed and amplified following the thermal cycle protocol
recommended in the kit instruction manual, with some modifications, as follows: one cycle at 53 ◦C
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for 30 min, one cycle at 94 ◦C for 2 min, followed by 45 cycles at 94 ◦C for minute, 53 ◦C for 1 min,
and 68 ◦C for 2 min, followed by one cycle at 68 ◦C for 7 min. The reaction mixture solution contained
a mixture of 5 μL of 5× buffer (contains 12.5 mM MgCl2), 1 μL of dNTP mix (containing 10 mM of each
dNTP), 0.5 μL (25 pmol) of corresponding primers, D2-S (5′-GTTCGTCTGCAAACACTCCA-3′) and
D2-C (5′-GTGTTATTTTGATTTCCTTG-3′), and 1 μL of enzyme mix (an optimized combination of
Omnscript Reverse Transciptase, Sensiscript Reverse Transcriptase, and HotStarttTap DNA Polymerase).
Nine microliters of PCR product was subjected to agarose gel electrophoresis, and amplified DNA
fragments were visualized with ethidium bromide staining.
Statistical analysis: One-way analysis of variance was used to test the variation among disseminated
infection rates, vector competence measures, and virus infectivity rates. Tukey’s HSD was used for
pairwise comparisons. Analogous non-parametric test were used when departures from normality or
equality of variance were encountered. Statistical Package for the Social Sciences (SPSS) 11.5 software
package was used to generate all the results and graphs in this study.
5. Conclusions
In this study, we analyzed 32 recently collected vector–virus pairs (eight geographically different
mosquito strains versus four isolate virus strains). Among vector–virus pairs infection rates were
different; indeed, many of those were significantly different. This leads us to conclude that the observed
variations in susceptibility among mosquito strains is probably due to the combination of certain
genetic elements of the vector and the virus as has been previously observed in similar researches.
Furthermore, these results suggest that the efficacy of dengue virus circulation in a given locale may
vary according to the interaction of virus strains with the origin of the vector mosquitoes. This study
contributes to the knowledge of the role of the association between mosquito genetic determinants of
susceptibility and genetic variation of dengue virus in the occurrence of different disease severity.
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Abstract: Dengue outbreaks have regularly been recorded in Lao People’s Democratic Republic
(PDR) since the first detection of the disease in 1979. In 2012, an integrated arbovirus surveillance
network was set up in Lao PDR and an entomological surveillance has been implemented since
2016 in Vientiane Capital. Here, we report a study combining epidemiological, phylogenetic, and
entomological analyzes during the largest DENV-4 epidemic ever recorded in Lao PDR (2015–2019).
Strikingly, from 2015 to 2019, we reported the DENV-4 emergence and spread at the country level
after two large epidemics predominated by DENV-3 and DENV-1, respectively, in 2012–2013 and
2015. Our data revealed a significant difference in the median age of the patient infected by DENV-4
compared to the other serotypes. Phylogenetic analysis demonstrated the circulation of DENV-4
Genotype I at the country level since at least 2013. The entomological surveillance showed a
predominance of Aedes aegypti compared to Aedes albopictus and high abundance of these vectors in
dry and rainy seasons between 2016 and 2019, in Vientiane Capital. Overall, these results emphasized
the importance of an integrated approach to evaluate factors, which could impact the circulation and
the epidemiological profile of dengue viruses, especially in endemic countries like Lao PDR.
Keywords: dengue; DENV-4; epidemic; Lao PDR; phylogeny; Aedes vectors
1. Introduction
In the context of globalization of trade and travel, the arboviruses’ epidemiology profiles have
changed and their expansion is in constant progression [1]. Dengue fever is the most prevalent human
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arboviral disease in the world. Recent World Health Organization (WHO) statistics revealed an increase
of the number of dengue cases reported from 505,430 cases in 2000 to 4.2 million in 2019, among which
70% of the burden is supported by Asia, and a modelling study estimated that 390 million people are
infected by dengue virus per year [2–4]. Even if these data should be interpreted cautiously, due to
changes in declaration systems and the increased number of contributing countries, they do reflect
an alarming evolution of dengue virus (DENV) epidemiology. In 2017, WHO estimated that, every
year, more than 500,000 people, including a high proportion of children, experience severe clinical
presentations that require hospitalization. The number of fatal dengue cases has increased from 960 in
2000 to 4032 in 2015 [4].
Dengue fever is due to an infection of one of the four DENV serotypes transmitted to humans
through the bite of an infected female mosquito of the Aedes genus [5]. In Lao People’s Democratic
Republic (Lao PDR), the main vector in urban areas is Aedes aegypti [6], whereas Aedes albopictus is
considered a secondary vector, specifically in suburban, rural, and forested areas [5,7,8].
DENV are single-stranded, positive-sense RNA viruses belonging to the Flavivirus genus,
Flaviviridae family. Antigenic studies identified four distinct serotypes (DENV-1 to 4) [9]. Genetic
studies confirmed the segregation of DENV strains into four main groups matching with the serotypes,
but also into genotype subdivisions that are often characteristic of the geographical origin of the viral
strains [10–14]. Previous genetic studies have suggested that the four DENV serotypes emerged from
sylvatic cycles in Asia [11,15,16]. Dengue outbreaks caused by the four serotypes have regularly been
recorded in Asia over the last decades [17]. DENV-4 was identified for the first time in the Philippines
and in Thailand in 1953 [17]. Since then, DENV-4 has been reported yearly in the Indochinese peninsula,
but with a global burden significantly lower compared to the three other DENV serotypes [17]. From a
genetic point of view, DENV-4 isolates segregate in four different genotypes: Genotype I (Asia) is
frequently reported in South East Asia [18]; Genotype II (Asia, South Pacific, and South America);
Genotype III (Thailand); and Genotype IV (sylvatic strains from Malaysia) [11,16,19–21].
Lao PDR is a land-locked country located in the middle of the Indochinese peninsula, surrounded
by China (North), Cambodia (South), Thailand and Myanmar (West), and Vietnam (East). Lao PDR
was a least-developed country of 7 million people in 2018, among which nearly 40% are under 20 years
old (WHO and www.lsb.gov.la). The country is divided into 18 provinces. Since the first report of
dengue hemorrhagic fever (DHF) cases in Lao PDR in 1979, DENV outbreaks have been regularly
declared by the country and dengue fever has become a major national public health problem [22–24].
All four dengue serotypes now circulate in rural and urban areas in Lao PDR [22,23,25–27]. In 2008,
a DENV-1 epidemic was described only in the North-West part of the country [28]. Then, in 2013,
an extensive dengue outbreak with a predominance of DENV-3 caused 48,772 cases and 95 deaths at
the country scale [29].
Interestingly, DENV-4 has been rarely detected in Lao PDR. Previous studies reported a lower
prevalence of this serotype compared to the others in 1990 in Vientiane Capital and in other provinces
in 2008–2009 [22,29,30]. Only sporadic cases have been detected in villages located around Vientiane
Capital in 2006–2007 [30]. In 2012, an integrated arbovirus surveillance system, involving virologists
and medical entomologists, was set up in Vientiane Capital by the Institut Pasteur du Laos and was
gradually extended to different provinces in Lao PDR for the detection and monitoring of arbovirus
epidemics [19,20,31]. This surveillance system detected DENV-4 transmission in 2013 in Vientiane
Capital’s suburban areas and subsequently its spread into the different districts of the city and then
throughout the country.
This study aims to describe the DENV-4 switch from an endemic-sporadic circulation to a
country-wide epidemic in Lao PDR in the context of multiple DENV serotypes co-circulation.
A retrospective epidemiological study was conducted in Vientiane Capital to characterize the impact
of the disease burden on the population. Furthermore, an entomological study was implemented in
Vientiane Capital to estimate the population dynamics of the vectors at different time points between
2016 and 2019.
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2. Results
2.1. Dengue Surveillance Activity between 2012 and 2019.
From 2012 to 2019, 15,152 samples were collected through the arbovirus surveillance system in 15
of the 18 provinces of Lao PDR (Table S1; Figure S1).
Of the 15,152 samples tested, 8771 (57.9%) were confirmed for a DENV infection by means of
real-time RT-PCR and/or NS1 antigen detection. Among the confirmed cases, 8315 (54.9%) were found
positives for DENV by RT-PCR and 448 (5%) cases were confirmed by NS1 antigen detection in plasma
or in urine samples. The DENV serotypes were determined by real-time RT-PCR or sequencing after a
viral culture for 3616 cases (43.5%).
Overall, 11,858 samples (78.4%) were collected in Vientiane Capital, notwithstanding the
progressive extension of the surveillance system to other Lao provinces from 2015 and onwards.
In 2012 and 2013, DENV serotype identification was mainly performed for isolates collected in
Vientiane Capital, which represented, respectively, 80% and 87% of the samples tested. In 2014, only
134 suspected cases were investigated. The dramatically low number of samples tested by the arbovirus
surveillance network was consistent with the poor syndromic activity recorded at the country level by
the National Center for Laboratory and Epidemiology in charge of the centralization of the mandatory
clinical declaration system (Figure 1). Furthermore, since 2012, the laboratory-based survey seemed
to follow the same dengue epidemiological profile as the national syndromic surveillance system
(Figure 1). A total of 14 (10.4%) were confirmed by DENV RT-PCR in 2014 and the DENV serotype
could be determined for 11 samples (78.6%) (Figure 2).
Figure 1. National syndromic surveillance system versus laboratory-based survey in Lao PDR.
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Figure 2. Dengue serotype distribution between 2012 and 2019 from samples collected by the Institut
Pasteur du Laos arbovirus surveillance network. In parentheses, number of samples tested per year.
Among the cases confirmed by RT-PCR in Vientiane Capital, 85.7% and 62.4% were respectively
serotyped in 2016 and in 2018 (Table S1). The proportion of samples serotyped varied from year to year
(from 28.2% in 2019 to 76.6% in 2014), but the proportion of samples from Vientiane Capital remained
constant over time (between 50% and 65%) (Table S1).
In 2012 and 2013, all four DENV serotypes were detected, but DENV-3 serotype was predominant
(62% in 2012 and 92% in 2013) (Figure 2). This serotype gradually decreased and vanished in December
2013 [29]. Since then, only 2 DENV-3 sporadic cases were collected in Saravane in 2016 and 3 cases
were detected in Vientiane Capital in 2017. In 2015, DENV-1 was at the origin of 85% of the confirmed
dengue cases at the country level and this serotype continued to circulate at a low level in Lao PDR
until 2019.
Between 2012 and 2015, DENV-4 samples represented less than 9% of the total cases (Figure 2) and
were only recorded in the sub-urban districts of Vientiane Capital and in Vientiane Province, which
are mainly rural areas. In 2014, clusters of DENV-4 cases were identified in Vientiane Capital. At the
end of 2015, the dengue epidemiological profile changed in Vientiane capital with the identification
of grouped cases of DENV-4 in urban districts of Vientiane Capital followed by a rapid increase of
the proportion of DENV-4 cases in Vientiane Capital from 9% in 2015 to 70% and 67%, respectively,
in 2016 and 2017. The outbreak peaked between June and August 2017 (Figure 3). The same trend was
observed at the country level (Figure 3). In 2018, the proportion of DENV-4 samples decreased to 43%
and DENV-2 became the predominant serotype at the end of the year. In 2019, at the country level,
DENV-4 still represented 13% of the cases serotyped (13.2% in Vientiane Capital) with a co-circulation
of DENV-1 and DENV-2 (Figure 2).
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Figure 3. Dengue serotype 4 distribution between 2012 and 2019 per month from samples collected
by the Institut Pasteur du Laos arbovirus surveillance network in Vientiane Capital and in other
Lao provinces.
2.2. Epidemiological Analysis of the Patients Infected by DENV-4
Demographic and clinical characteristics of the patients reported by the surveillance network are
presented in Table 1. Patients infected with DENV-4 serotype were significantly older (mean age 27.4
vs. 24.5, p < 0.0001) than patients infected with other DENV serotypes (Table 1 and Figure 4). Sex ratio,
days to diagnosis, and severity were no different for DENV-4 when compared to the other serotypes.
Table 1. Demographic and clinical characteristics of the 15,152 patients investigated by the Institut
Pasteurs du Laos arbovirus surveillance system between 2012 and 2019.







DENV-4 (n = 1187)
Mean age (SD) 23.5 (15.7) n =15,062 23.9 (14.4) n = 8718 24.5 (14.5) n = 3589 27.4 (14.6) n = 1181
Sex
Female (%) 6197 (40.9) 3775 (43.0) 1526 (42.3) 620 (52.2)
Male (%) 5945 (39.2) 3243 (39.3) 1403 (38.8) 557 (46.9)
Unknown (%) † 3010 (19.9) 1550 (17.7) 682 (18.9) 10 (0.8)
Mean number of
days of fever (SD) 3.8 (2.4) 3.6 (1.8) 3.4 (1.8) 3.6 (1.7)
Clinical diagnosis b
DF (%) 11,910 (78.6) 7036 (80.2) 2868 (79.4) 1154 (97.2)
DHF (%) 213 (1.4) 168 (1.9) 49 (1.4) 13 (1.1)
DSS (%) 27 (0.2) 23 (0.3) 17 (0.5) 9 (0.8)
Unknown (%) † 3002 (19.8) 1541 (17.6) 677 (18.8) 11 (0.9)
Note: a Dengue-positive: RT-PCR and or NS1-positive. b Data concerning clinical diagnosis were collected from
2015 onwards. DF: Dengue fever, DHF: Dengue hemorrhagic fever, DSS: Dengue shock syndrome. † No clinical data.
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Figure 4. Age distribution of patients investigated by the Institut Pasteur du Laos arbovirus
surveillance network.
Among the 52 DENV fatal cases investigated by the arbovirus surveillance network between
2012 and 2019, 9 were infected by DENV-4. These nine cases were identified between 2016 and
2019. In Vientiane Capital, four cases were detected in September 2016, August 2017, January 2019,
and December 2019. In Attapeu province, 2 DENV-4 fatal cases were identified in July and September
2017. Two fatal cases were also recorded in June 2018 in Xayaboury and Champassak provinces and 1
case in Saravane province in April 2019 (Figure S1).
2.3. Phylogenetic Analysis of DENV-4
A panel of 45 samples, i.e., plasma (n = 29) or cell supernatant (n = 16), from DENV-4 cases
collected between 2013 and 2019, were investigated for the phylogenetic analysis (Table 2). This panel
included samples from different Lao provinces, cases imported from foreign Asian countries, patients
with different degrees of dengue severity, and fatal cases. The sequence analysis based on a fragment
spanning 1485 nucleotides of the envelop gene revealed that DENV-4 isolates grouped in two different
genotypes (i.e., Genotype I and Genotype II) (Figure 5).
Table 2. References of Lao DENV-4 isolates.
Sample Identification Years of Collection Isolation Source Genbank Number
LaoPDR-Vientiane, 2013-2769 2013 Cell supernatant MT122852
LaoPDR-Vientiane (ex Thailand), 2014-2864 2014 Cell supernatant MT122853
LaoPDR-Vientiane (ex Malaysia), 2014-2867 2014 Cell supernatant MT122854
LaoPDR-Vientiane, 2015–3131 2015 Cell supernatant MT122855
LaoPDR-Vientiane, 2015–3401 2015 Cell supernatant MT122856
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Table 2. Cont.
Sample Identification Years of Collection Isolation Source Genbank Number
LaoPDR-Vientiane, 2015–3480 2015 Cell supernatant MT122857
LaoPDR-Vientiane, 2016–3599 2016 Cell supernatant MT122858
LaoPDR-Vientiane, 2016–3869 2016 Cell supernatant MT122859
LaoPDR-Vientiane, 2016–3932 2016 Cell supernatant MT122860
LaoPDR-Vientiane, 2016–4108 2016 Cell supernatant MT122861
LaoPDR-Vientiane, 2016–4132 2016 Cell supernatant MT122862
LaoPDR-Vientiane, 2016–4291 2016 Cell supernatant MT122863
LaoPDR-Vientiane, 2016–4441 (Fatal case) 2016 Plasma MT122864
LaoPDR-Saravane, 2017–5506 2017 Plasma MT122865
LaoPDR-Saravane, 2017–5534 2017 Cell supernatant MT122866
LaoPDR-Attapeu, 2017–5797 2017 Cell supernatant MT122867
LaoPDR-Vientiane, 2017–5842 2017 Cell supernatant MT122868
LaoPDR-Vientiane, 2017–5871 2017 Plasma MT122869
LaoPDR-Attapeu, 2017–5876 (Fatal case) 2017 Plasma MT122870
LaoPDR-Vientiane, 2017–5988 2017 Plasma MT122871
LaoPDR-Vientiane, 2017–6237 2017 Plasma MT122872
LaoPDR-Attapeu, 2017–6243 2017 Plasma MT122873
LaoPDR-Vientiane, 2017–6358 (Fatal case) 2017 Plasma MT122874
LaoPDR-Attapeu, 2017–6583 (Fatal case) 2017 Plasma MT122875
LaoPDR-Vientiane, 2017–6509 2017 Plasma MT122876
LaoPDR-Bolikhamxay, 2017–7305 2017 Plasma MT122877
LaoPDR-Vientiane, 2017–7321 2017 Plasma MT122878
LaoPDR-Attapeu, 2018–7509 2018 Plasma MT122879
LaoPDR-Vientiane, 2018–7590 2018 Plasma MT122880
LaoPDR-Xayaboury, 2018–7626 (Fatal case) 2018 Plasma MT122881
LaoPDR-Savannakhet, 2018–7842 2018 Plasma MT122882
LaoPDR-Saravane, 2018–7983 2018 Plasma MT122883
LaoPDR-Vientiane-2018–8364 2018 Plasma MT122884
LaoPDR-Vientiane, 2018–9161 (Fatal case) 2018 Plasma MT122885
LaoPDR-Champassak, 2018-DS18-698-16
(Fatal case) 2018 Cell supernatant MT122886
LaoPDR-Attapeu, 2019–9310 2019 Plasma MT122887
LaoPDR-Saravane, 2019–9566 (Fatal case) 2019 Plasma MT122888
LaoPDR-Vientiane, 2019–9831 2019 Plasma MT122889
LaoPDR-Vientiane, 2019–10299 2019 Plasma MT122890
LaoPDR-Saravane, 2019–10310 2019 Plasma MT122891
LaoPDR-Saravane, 2019–10439 2019 Plasma MT122892
LaoPDR-VientianeProvince, 2019–11393 2019 Plasma MT122893
LaoPDR-Vientiane, 2019–15448 2019 Plasma MT122894
LaoPDR-Vientiane, 2019–15460 2019 Plasma MT122895
LaoPDR-Vientiane, 2019–15690 2019 Plasma MT122896
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Figure 5. Maximum likelihood phylogenetic tree of DENV-4 sequences from Lao PDR. The tree was
constructed on the envelope protein gene (1485 nt). Only the bootstrap values > 70 are shown. Scale
bar indicates the nucleotide substitution per site. The Lao strains sequenced in this study are indicated
in red and the triangles highlight the strains from fatal cases. The Lao strain previously described is
indicated in blue. Black triangles identify isolates obtained from fatal cases.
156
Pathogens 2020, 9, 728
Genotype II was identified in samples from European tourists traveling in Southeast Asia (Thailand
and Malaysia) in 2014 and who developed a dengue-like syndrome during their stay in Vientiane.
These isolates clustered with DENV-4 strains identified in Malaysia in 2009 and 2014 (>99% identity)
(Figure 5) [32].
All autochthonous DENV-4 sequences belonged to the Genotype I. Among the Genotype I,
the Lao strains isolated between 2013 and 2019 displayed a maximum nucleotide distance of 2.7%
from each other. Interestingly, our series of isolates showed 3.1% to 4.1% of divergence with a Lao
strain (KY849762) isolated in 2009 in Saravane province (Figure 5) [30]. When compared to DENV-4
reference strains collected in other Asian countries from 2011 to 2016, less than 2.5% of nucleotide
divergence was found with the Lao DENV-4 isolates (Figure 5). In this study, eight DENV-4 isolates
from fatal cases could be analyzed. These isolates belonged to the Genotype I but segregated in different
phylogenetic clusters formed by the different Lao isolates characterized since 2013 (Figure 5). Globally,
the phylogenetic analysis revealed the active circulation of DENV-4 Genotype I since at least 2013
in Lao PDR. Furthermore, several clusters were detected and could emphasize several introduction
events in the country from neighboring countries such as Thailand (Figure 5).
2.4. Entomological Survey on the Aedes sp. Vectors in Vientiane Capital
The results of the abundance of the adult dengue vectors collected between 2016 and 2019 are
presented in Figure 6. A total of 1276 specimens were collected and Aedes aegypti was the most abundant
species, representing more than 86% of the total. Aedes albopictus represented 14% of the total. The
percentage of Ae. albopictus varied between 3.2% in 2018 to 57.8% in 2016 when the study only started
in May. In 2017 and 2019, the percentages were 12.6% and 9.9%, respectively. Every year, the vectors
were more abundant during the rainy season between May and August, but the mosquito populations
remained throughout the dry season albeit at a low level. Of note, no collections were made during the
month of April; and in 2016, the collection started in May only.
Figure 6. Monthly rainfall (mm; in blue) and mean temperature in the air (◦C; in red) recorded between
2012 and 2019 in Vientiane Capital (17◦58′12” N, 102◦34′14” E). Number of Aedes aegypti and Aedes
albopictus adult mosquitoes collected monthly between 2016 and 2019 in Vientiane Capital (in black).
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3. Discussion
Since the first report on dengue in Lao PDR, limited data have been published on DENV
serotypes/genotypes circulating at the country level [22]. Nevertheless, recent studies suggest a complex
and dynamic dengue virus circulation countrywide, but without reference to DENV-4 [22,28–30].
This study is a first step in filling this gap by providing genetic and epidemiologic information on the
first DENV-4 epidemic recorded in Lao PDR. The progressive increase of DENV-4 burden occurred in a
context of the co-circulation of different DENV serotypes previously described and maintained over the
eight years of surveillance (i.e., 2012–2019) [29–31]. Since 2009, DENV-4 circulated sporadically in the
country [29,30]. Sporadic cases or small clusters of grouped cases were observed in Vientiane Capital
between February 2014 and August 2015. Subsequently, the proportion of DENV-4 cases gradually
increased among the samples tested by the arbovirus surveillance network in Vientiane Capital and
became predominant in 2016 at the country level until October 2018. Since then, DENV-2 has overcome
DENV-4 in Vientiane Capital and at the country level [33]. However, DENV-4 still circulated at a
significant level in 2019 (13%; Figure 2). These data reveal a circulation of DENV-4 during at least six
years (2014–2019) in Lao PDR and could be correlated with an insufficient immunity protection of the
Lao population against this serotype as suggested by the impact of DENV-4 in the different age groups.
This study highlighted the significant difference in the age of the patients infected with DENV.
The syndromic patients infected with DENV-4 were significantly older than the patients infected with
other serotypes. The Lao population is young (~40% under 20 years old) (WHO and www.lsb.gov.la)
and this data emphasize the risk of dengue emergence in Lao PDR due to a high percentage of
the population immunologically naive for DENV. In this study, the mean age (27.4) of the patients
infected by DENV-4 appeared to be consistent with studies from other DENV-endemic countries [34,35].
However, the fact that syndromic DENV-4 patients were older could suggest the recent emergence
of this serotype and/or a low DENV-4 circulation in Lao PDR at least since 2009 [30]. These findings
demonstrate that a large proportion of the Lao population is susceptible to DENV-4 and highlights the
need to study the immune status of populations living in dengue-endemic countries in order to predict
and prevent future DENV outbreaks as previously done in Lao PDR [22] and in Asia in general [36–38].
Furthermore, this study highlights the need to perform serotype-specific studies of the immune status
of the population.
Here, we describe the pre-epidemic circulation of DENV-4 in Lao PDR and the specific features of
this serotype during the outbreak in Vientiane Capital and at the country level in the context of DENV
serotypes co-circulation. Clusters of DENV-4 infections were identified sporadically several years
before the outbreak started. Indeed, serotype-specific surveillance networks are able to finely monitor
the profile of DENV circulating and detect early warning signals. Strengthening the prediction capacity
of DENV outbreaks by combining syndromic surveillance systems with a laboratory surveillance
system has been demonstrated in Lao PDR ([30]; present study). Even if a systematic exhaustive
investigation of suspected cases was clearly unrealistic, an appropriate sample size allowed for the
drawing of an accurate picture of DENV serotypes’ history in a country over the last eight years.
In this way, the actual disease burden of dengue could be calculated, including at the serotype level.
The amplitude over time and the burden by serotype and by age groups could be used as proxies
to estimate the level of herd immunity in the Lao population. Interestingly, the local lab-based
surveillance system in Vientiane city followed the trends of the syndromic surveillance data. Based on
this approach, mathematical models could be developed to determine parameters including costs of
long-term sustainable, combined surveillance systems.
The disease severity of dengue fever was not associated with the predominance of DENV-4 in Lao
PDR. Indeed, no significant difference in the disease severity was found between the DENV serotypes
in the confirmed samples collected by the arbovirus surveillance network. This finding is in agreement
with previous observations, such as during a DENV-4 outbreak in Brazil, which failed to show any link
between this serotype and dengue severe symptoms [20]. Furthermore, in Lao PDR, the fatal cases
due to a DENV-4 infection were recorded during the entire outbreak and no link could be established
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with the number of positive DENV-4 cases. Indeed, in our study, the same number of fatal cases was
recorded in 2017 and 2019, respectively, during the peak of the outbreak and at the end of the outbreak.
Moreover, dengue fatal cases were observed during the active DENV transmission period, as well as
when dengue cases were recorded at a low level.
Previous phylogenetic studies showed the recent circulation of two DENV-4 genotypes (Genotype
I and II) in Southeast Asia [18,32]. Both genotypes were detected in Lao PDR, but in two different and
independent types of patients, i.e., Lao native autochthonous cases and imported cases by foreigners.
All autochthonous cases recorded at the country level investigated here belonged to DENV-4 Genotype
I. The first evidence of the presence of DENV-4 Genotype I in Lao PDR came from a strain that was
first identified in Saravane Province isolated in 2009 [30]. Our serial investigation suggests that this
genotype has spread and circulated at least since 2013 at the country level. The genetic difference
(2.7% of nucleotide divergence) between the former strain and the recent isolates could be the result of
several introductions of DENV-4 Genotype I in Lao PDR since 2009 from different Asian countries.
The composition of the different clusters and the circulation of the Lao isolates over several years are a
signature of successful consecutive emergences of those independent introduction events. DENV-4
Genotype II was only detected in two imported cases from Thailand/Malaysia in 2014 (Figure 5).
Interestingly, the predominant circulation of the DENV-4 Genotype I in Lao PDR contrasted with
some results obtained in South East Asia. Indeed, in the Philippines, a genotype turnover from
Genotype I to Genotype II was observed before 2013, and this seemed to match with a high DENV-4
circulation in the country between 2012 and 2016 [39]. The results found in the Philippines were
consistent with those from Malaysia in 2001 that showed the circulation of the DENV-4 Genotype
II [40]. However, both introductions of DENV-4 Genotype II were recorded in February 2014, the dry
season in Lao PDR (October–April) and a decrease of vector density. This context, associated with the
abnormal lack of rainfalls until August 2015, could explain the non-emergence of DENV-4 Genotype II
in Vientiane Capital. However, these dramatically unfavorable conditions for DENV transmission
did not hamper the maintenance of a sufficient inoculum of a mixt population of DENV-4 Genotype
I isolates at the origin of the rapid spread-off since September 2015. Hence, the genotype selection
could impact the epidemiology of DENV emergence and expansion of the virus. Indeed, as previously
described in India, China, or the WHO Pacific region, a DENV genotype switch could increase the risk
of dengue outbreak [41–43]. This selection of DENV genotype could be influenced by several factors,
such as serotype-specific herd immunity, viremia titer in humans, and the ability of local mosquito
populations, such as Aedes aegypti, to transmit the virus under the influence of environmental and
climatic conditions [44–49]. These factors need to be investigated for DENV serotypes and genotypes,
which circulated in a specific geographical context to improve the knowledge on DENV epidemiology
and to prevent DENV outbreaks [50].
The entomological results demonstrate the presence of both Ae. aegypti and Ae. albopictus in
Vientiane Capital with an increase of vector density during the rainfall season as previously described
in Asia. The dynamic of DENV transmission in human population follows the trend of the dynamic
of Aedes vectors [51]. Moreover, predominance of Ae. aegypti was highlighted since 2016 in Vientiane
Capital. Vector competence of Ae. aegypti from Lao PDR was investigated for DENV-1 and showed
that 50% of the females orally exposed to the virus could transmit DENV-1 [52]. These data indicate
a high efficiency of transmission of this serotype by Ae. aegypti from Lao PDR compared to other
Ae. aegypti populations from the Pacific region (3–37% transmission efficiency), from French Guiana
(<10% transmission efficiency), and from Florida (33% transmission efficiency) in the USA [53–55].
DENV transmission ability appeared to be a specific interaction between the mosquito population and
a virus strain [49,56]. Vazeille et al. [54] suggested a possible competition between serotypes at the
midgut level in co-infected mosquitoes leading to a drastically different transmission potential and,
in this case, favoring the competitive displacement of DENV-1 by DENV-4. Thus, the ability of Lao
vectors for DENV-4 must be investigated to determine how this factor could influence the onset of new
dengue epidemics in Lao PDR.
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DENV emergence and spread are complex mechanisms, especially in endemic countries like
Lao PDR. This study shows the need to combine results obtained by the DENV laboratory-based
surveillance system and epidemiologic studies, combined with entomological data, along with more
research oriented approaches, such as virus genetic, viral kinetic, or virus/vector interaction findings,
to determine the impact of these factors on DENV transmission in each specific geographical context.
4. Materials and Methods
4.1. Human Samples Collection
In 2012, an arbovirus surveillance system was set up and coordinated by the Institut Pasteur du
Laos. It was first implemented in Vientiane Capital and then progressively extended to hospitals in 18
provinces, with Vientiane Capital’s hospital network being the most active. From 2012 to 2019, human
samples were collected through this surveillance hospital network. Suspected dengue fever cases were
defined according to the WHO’s definition (fever onset ≥ 38 ◦C for less than 7 days with at least one of
the following accompanying symptoms: headache; myalgia; arthralgia; retro-orbital pain; digestive
troubles or hemorrhaging) [29]. After obtaining informed consent, clinicians filled a standardized
clinical report form (CRF). Cases were classified according to the WHO criteria (1997), defining
the severity as Dengue fever (DF), Dengue hemorrhagic fever (DHF), or Dengue shock syndrome
(DSS). Venous blood samples (5 mL) were taken from patients. Samples were stored at 4 ◦C during
transportation to the Institut Pasteur du Laos for analysis and serotypes and genotypes investigation.
4.2. Ethical Statement
Ethics approval was obtained from the Lao National Ethics Committee for Health Research
(N◦2018.116). Oral and written informed consent were obtained from all participants, or a parent or
legal guardian.
4.3. Dengue Virus Screening
Samples collected by the arbovirus surveillance system were screened by RT-PCR as previously
described [29] with a pan-dengue real-time RT-PCR [57] and the DENV serotypes were determined
with specific real-time RT-PCR [58].
4.4. Gene E Sequencing Analysis
Viral genomic RNA was extracted from 45 human plasma using a Nucleospin DX or Nucleospin
96 core kit purification kit (Macherey-Nagel) according to the manufacturer’s instructions (Table 2).
Gene E sequencing (1485nt) was performed using primers FGT1, FGT2, and F3 (Table 3). First
Stand cDNA were generated using a Maxima H Minus First Stand cDNA Synthesis kit (Thermo
Scientific, Waltham, MA, USA) and the PCR was performed using a Phusion Flash High-Fidelity PCR
Master Kit (New England Biolabs® Inc, Waltham, MA, USA). Amplified fragments were purified using
ExoSAP-ITTM PCR Product Cleanup Reagent (Thermo Fisher Scientific, Waltham, MA, USA). Purified
fragments were sequenced using a BigDye Terminator v3.1 Cycle sequencing kit (Applied Biosystem,
Waltham, MA, USA) on a Genetic Analyzer 3500xL (Applied Biosystem, Waltham, MA, USA).
Sequences were analyzed using Chromas software (www.technelysium.com.au) and aligned with
the multiple sequence alignment software Clustal W integrated in BioEdit version 7.0.5.3 software
(Manchester, United Kingdom) [59,60]. For the phylogenetic analysis, a maximum likelihood tree
was constructed using MEGA version 7 (www.megasoftware.net), with a kimura-2 parameter model
with a bootstrap of 1000 replication [61] as previously described for dengue virus phylogenetic
analysis [29,43,62–64]).
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Table 3. List and positions of primers used for DENV-4 complete envelope gene RT-PCR and sequencing.






















The genome positions are given according to the dengue virus serotype 4 reference genome (GenBank: NC_002640).
4.5. Epidemiological Analysis
Demographic and clinical data were extracted from the surveillance network’s de-identified
database. Continuous variables were summarized using mean and standard deviation (SD),
and categorical variables were summarized using frequencies and percentages. Continuous data were
compared using parametric Student test and rates using the Chi-square and Fisher exact test. Statistical
significance was set at the 5% level. Analyses were conducted using STATA software (version 14.0;
StatCorp LP, College Station, TX, USA).
4.6. Mosquito Surveillance
Five mosquito sentinel sites in five different villages of Vientiane Capital were chosen for the
mosquito surveillance and the GPS locations are presented in Table 4. The vectors abundance study
took place during both dry and rainy seasons between 2016 and 2019. BG sentinel traps® (Biogents,
Regensburg, Germany) were used to follow the dynamics of mosquito population abundance in the
city (4 traps per locations, except at Kao-Gnot with two traps). After every weekly collection, the adult
mosquitoes were brought back to the laboratory for morphological identification.
Table 4. Mosquito collection locations in Vientiane Capital.
District Village Latitude Longitude
Sittattanak Donkoy 17.562677 102.390768
Sittattanak Kao-Gnot 17.962684 102.615035
Xaysettha Sengsavang 17.995816 102.664895
Xaithany Sivilay 18.003705 102.380003
Sittattanak Saphanthong Tai 17.949470 102.628487
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